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ABSTRACT OF THIS THESIS 
Introduction: Stroke is a leading cause of mortality and disability worldwide. There is 
limited evidence on the natural history, predictors, and outcomes of depression in the long 
term after stroke.  
Objectives: 
-To describe the natural history of depression within 15 years of stroke 
-To identify the predictors of depression within 15 years of stroke. 
-To identify the health outcomes of post-stroke depression. 
Methods: A systematic review and meta-analysis of studies of the natural history, predictors 
and associated outcomes of post-stroke depression was conducted.  
Incidence, prevalence, cumulative incidence, time of onset, duration, and recurrence of 
depression, within 15 years of stroke were estimated in the population based South London 
Stroke Register (SLSR). 
Predictors and outcomes of depression up to 15 years after stroke were identified. 
Results: The systematic review identified 49 studies. The pooled prevalence of depression 
was 29%. The major predictors of depression included disability and history of depression 
pre-stroke. The main outcomes of depression were lower quality of life and disability.  
The SLSR data analyses showed that the prevalence of depression was around 30% and 
remained stable within 15 years of stroke, with an annual incidence 7 to 21% and cumulative 
incidence of 55%. 
Depression started shortly after stroke, had a short duration and high recurrence rate.  
Variables associated with depression included stroke severity, disability at baseline, 
depression before stroke, together with disability, social isolation, and cognitive impairment 
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at follow-up. Depression was associated with mortality, disability, cognitive impairment and 
lower quality of life at follow-up.  
Conclusion: depression is a frequent chronic and recurrent condition after stroke, with higher 
risk among patients with previous depression and after severe strokes, and it is associated 
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CHAPTER 1: INTRODUCTION  
1.1 STROKE 
The World Health Organisation defines stroke as rapidly developing clinical signs of focal or 
global neurological deficit, lasting more than 24 hours or leading to death, with no apparent 
cause other than of a vascular origin.
1
  
Stroke, together with ischaemic heart disease, killed 12.9 million people in 2010, one in four 
deaths worldwide, compared with one in five in 1990.
2
 It has been estimated that annually, 
about 16 million first ever strokes occur in the world.
3
 Stroke causes 9% of all deaths 
globally and is the second most common cause of death.
2
 The age adjusted mortality rate of 
stroke has gone down from 105.7/100.000 in 1990 to 88.4/100.000 in 2010, showing the 
effectiveness of the stroke control strategies. However, the number of deaths from stroke has 
increased globally from 4.6 in 1990 to 5.8 million in 2010. In 1990 stroke was the fifth cause 
of years of life lost (YLLs) globally but in 2010 it was reported to be the third. Nonetheless, 
the impact of stroke varied between different geographical regions. While in Easter Sub 
Saharan Africa in 2010 it was the 14
th
 leading cause of YLLs, it was the first cause in other 
parts of the world such as East Asia or the second cause of YLLs in Western Europe.
2
 The 
shifting pattern of the number of deaths across time, regions, and age groups is consistent 
with the three key drivers of change: rising total population, rising average age of the world's 
population, and the broad epidemiological transition from communicable, maternal, neonatal, 
and nutritional causes towards non-communicable diseases.
2
 The total number of stroke 
deaths in 48 European countries is currently estimated at 1,239,000 per year.
4
  
According to the Global burden of disease study published in 2012,
5
 the age adjusted rate of 
reduced DALYs caused by stroke has decreased globally from 1,622/100.000 in 1990 to 
15 
 
1,484/100.000 in 2010. However, the overall number of reduced DALYs caused by stroke 
has increased worldwide from 86,010 in 1990 to 102,232 in 2010. Stroke has moved from 
being the fifth most common cause of reduced DALYs in 1990 to the third in 2010.
5
 This 
ranking varies in different regions of the world. While in Eastern Sub-Saharan Africa Stroke 
is only the 16
th
 most common cause of reduced DALYs, in East Asia is the first cause, and in 
Western Europe the third. The global burden of disease has continued to shift away from 




About a quarter of stroke patients die within a month, about a third by six months, and a half 
by one year.
6
 40% of stroke survivors are left with some degree of functional impairment.
7
 It 
is estimated that 25 to 74% of the 50 million stroke survivors worldwide require some 
assistance or are fully dependent on caregivers for activities of daily living (ADL).
8
  
However, evidence on the long term outcomes of stroke is still very limited.
9 10
 The burden of 
disease is estimated by counting how many years of healthy life are lost due to death and 
non-fatal illness or impairment.
5
 To calculate this, a range of data sources, including disease 
registers, epidemiological studies, and health surveys, are used, yet the data that inform these 
estimates for long-term planning are not at all comprehensive.
5 10
 Population based studies of 
long term stroke survivors would generate estimates of long-term outcomes of stroke and 
would provide a better understanding of the burden of stroke on patients, health services, and 
populations.  Studies of outcomes of stroke could also inform strategies to reduce its impact 






Depressive disorders are characterized by persistent low mood, loss of interest and 
enjoyment, and reduced energy.
11 12
 Depressive symptoms are continuously distributed in any 
population but are judged to be of clinical significance when they persistently interfere with 
normal activities. The fifth edition of the Diagnostic and Statistical Manual of Mental Health 
Disorders (DSM-V)
13
 presented the following diagnostic criteria for depression: At least five 
of the following symptoms that cause clinically significant impairment in social, work, or 
other important areas of functioning almost every day for at least two weeks. One of the 
symptoms must be depressed mood and/or loss of interest or pleasure in life activities. 
1. Depressed mood most of the day. 
2. Diminished interest or pleasure in all or most activities. 
3. Significant unintentional weight loss or gain. 
4. Insomnia or hypersomnia. 
5. Agitation or psychomotor retardation noticed by others. 
6. Fatigue or loss of energy. 
7. Feelings of worthlessness or inappropriate guilt. 
8. Diminished ability to think or concentrate, or indecisiveness. 
9. Recurrent thoughts of death or suicide. 
The age adjusted rate of reduced DALYs caused by depression has increased globally from 
1,019/100.000 in 1990 to 1,078/100.00 in 2010. The overall number of reduced DALYs 
17 
 
caused by depression has also increased worldwide from 54,010 in 1990 to 74,264 in 2010. 
Depression has moved from being the 15th most common cause of reduced DALYs in 1990 
to the 11th in 2010.
5
 This ranking varies in different regions of the world. While major 
depression in Central Sub-Saharan Africa is only the 17
th
 most common cause of reduced 
DALYs, in North Africa, Middle East and Andean Latin America is the third cause and in 
Western Europe the 12th.
5
  
Studies of burden and outcomes of depression rely on routine mortality and limited disability 
data.
5 10
 Population based observational studies of patients with depression could improve the 
estimation of loss of DALYs attributed to mental and behavioural disorders. These studies 
could also inform strategies to reduce the impact of depression.  
Depression is more common in women, in patients with chronic medical disorders, and in 
patients who have experienced stressful life events (e.g.: the loss of a spouse), functional 
decline, or social isolation.
14
 Several studies conducted in different countries reported a 
cumulative incidence of depression between 13 and 17% during patients’ life time and 
incidence between 5 and 10%.
15 16
 A cohort study observing civil servants in the United 
Kingdom reported prevalence of depression between 12 and 14% in a 20 years follow-up.
17
  
Late-life depression is often undetected or undertreated especially in men and members of 
ethnic minorities. Reasons for under-treatment include stigma associated with depression, the 
belief that depression is a normal part of aging, coexisting problems, such as chronic medical 
disorders, pain, cognitive impairment, and alcohol or substance misuse.
14
 Late-life depression 
that is untreated can last for years and is associated with a poor quality of life, difficulty with 
social and physical functioning, poor adherence to treatment, worsening of chronic medical 
problems, and increased morbidity and mortality from suicide and other causes. Effective 
treatment of late-life depression has been associated with improved emotional, social, and 
18 
 
physical functioning and quality of life. It has also been associated with better self-care for 
chronic medical conditions and reduced mortality.
14
  
Observational studies reporting the natural history of depression, identifying groups at 
highest risk and evaluating the outcomes of depression in the long term, would contribute to a 
better understanding of its impact. 
1.3 DEPRESSION AND LONG TERM CONDITIONS 
All illnesses carry both physical and psychological features.
18
 Depression in the physically ill 
may be a complication of the medical illness, a cause of it, or  a coincidental occurence.
19 20
 
Depressive disorders in the medically ill cause suffering and family disruption, they can 
exacerbate bodily symptoms, and complicate the patients’ care.11 18  
1.3.1 The relationship between depression and long term conditions 
Depression may occur in any patient secondary, directly or indirectly, to the biopsychosocial 
stress of medical illness.
19 20
 It has been postulated that the greater the medical burden the 
higher the risk of depression. However, patients with preexisting vulnerability are most likely 
to become depressed on the face of disease.
11 20 21
 It could be hypothesized then that 
depression is not randomly distributed amongst all the physically ill but is more prevalent in 
those who have previous vulnerability and suffer more severe illnesses. 
Therefore, the likelihood of depression depends on factors such as the personal 
predisposition, the clinical course of the medical disease and the effectiveness of 
individual coping strategies.
19
 Several specific direct and indirect mechanisms for 




These mechanisms include factors linked to the medical condition. There are risk factors 
for many physical diseases that are also risk factors for depression for example alcohol 
misuse or diabetes.
22 23
 The onset or diagnosis of the medical disease, the start of 
treatment, or any changes in prognosis, may also have an effect on the patients’ mood.20 24 
In some cases the therapeutic approach may be associated with depression. This would be 
the case of treatments with some drugs, such as beta blockers or steroids, or the treatment 
in intensive care, which can lead to depression.
20 25 The pain, either iatrogenic or caused 
naturally by the disease, any significant medical complications, such as a stroke following 
an arrythmia, or the long term dependence for activities of daily living, can also have a 
negative effect on patients’ mood.26 27 The uncertain or poor prognosis of the medical 
disease can lead to depression as well.
18-21
  
The involvement of psychological mechanisms for the risk of depression among the 
medically ill has also been reported.
14 19 20 28 29
 A central factor in the psychological 
response to the illness may be the personal meaning of the illness for the individual. For 
example some patients experiencing guilt or self-recrimination may interpret the illness as 
a punishment for their perceived misdeeds.
20
 Damaged self steem and dysfunctional 
attitudes, such as self judgement on unrealistic standards, may also increase the risk of 
depression.
18 30
 Other psychological mechanisms that can lead to depression are cognitive 
distortions e.g.: overgeneralization of specific poor outcomes, or selective attention 
focused on negative signs of disease.
20
 The lack of factors that can protect against 
depression, such as positive illusions, may be associated with depressive symptoms as 
well. Also maladaptive coping strategies, ineffective efforts to manage the demands of the 
medicall problem, are relevant in the development of depressive symptoms.
19
 Other 
pyschological factors include some types of personality, changes in the sense of identity 





Biological mechanisms may also play a role in the association between phisical diseases 
and depression.
14 29 31
 These would include vascular events affecting the brain, directly 
such as stroke, or indirectly such as coronary atery disease. Medical problems, with or 
without vascular physiopathology, affecting neurochemical pathways mediating mood 
may also affect the incidence of depression.
14 18-21 31
 It has been proposed that physical 
pain and depression may have a deeper biological connection than simple cause and effect 
as serotonin and norepinephrine are neurotransmitters that influence both pain and mood. 
Therefore, dysregulation of these transmitters may be linked to both depression and pain.
21
 
Immunological or endocrine disorders such as the ones observed in Graves’ disease, may 
also affect the incidence of depression.
32
 Different specific physiopathological 
mechanisms occurring during the course of various forms of cancer, infections, and 




A number of sociological factors related to the physical disease may have an effect on 
patients’ mood as well.19 These would include concerns about family and or carers e.g.: 
difficulties on the education of children depending on the patient. The loss of social roles, 
stigmatization, isolation, relocation, institutionalisation, finacial worries, the loss of 
employment or professional status, or other negative life events related to the illnes may 
increase the  risk of depression as well.
33 34
 There are also social factors for depression not 
directly linked to the disease but prevalent in some specific groups of patients, for 
example the loss of spouse in elderly patients affected by age related diseases.
18-20
 
All these factors and mechanisms contribute to the physiological, psychological and 
sociological changes, furhter increasing susceptibility to depression or triggering 
depression in already vulnerable individuals.
11 18 20 31
 Most of them  have been presented 
21 
 
as risk factors, hence associated with an increase of depression, for example social 
isolation or disability. It could be suggested that the absence of these risk factors, or the 
presence of others oposite to them, would therefore protect against depression. This would 
be the case for example of social support, the clinical improvement of the medical 
problem, or independence for activities of daily living.
19
 The medical control of 
cardiovascular risk would result in a reduction of vascular depression.
11
 A high level of 
education, which is associated with help seeking behaviour and adherence to treatment, is 
also associated with lower incidence of mood disorders.
12
  Healthy lifestyle, such as 
appropriate diet and sleep, may reduce poor mental health outcomes as well.
35
 Exercise 
has been known to improve general well-being regardless of age, gender, or physical 
ability. Older adults who exercise regularly report improved mood and self-satisfaction.
35 
36
 Other factors that may protect against depression include religiosity and spirituality,
36 37
 
and also the development of effective strategies to cope with the medical disease e.g.: 
reduction of stigmatization, cognitive reframing, and acceptance of the new situation.
36
  
Evidence on the nature and the strength of the association of all these factors with 
depression would help in the identification of patients at risk of depression in the context 
of a non psychiatric disease. It could also help in the development of interventions which 
could reduce depressive symptoms among the medically ill.  
1.3.2 The associated outcomes of depression in people with long term conditions 
Depression in patients with long term conditions is also relevant because its association 
with poor health outcomes.
38-44
 Depression in the elderly is also associated with an 





A number of plausible biobehavioural mechanisms have been hypothesized to underlie the 
relationship between depression and poor health outcome: lack of treatment adherence; 
lifestyle factors such as smoking, heavy alcohol use, and physical inactivity; traditional 
risk factors including hypertension, diabetes, and insulin resistance; changes in platelet 
reactivity; dysregulation of the autonomic nervous system and hypothalamic pituitary 
adrenal axis; and alterations in the immune response/inflammation.
46
 However, much of 
the existing evidence for the relationship between depression and poor health is derived 
from cross-sectional studies,
46 47
 with a limited number of prospective papers.
48-50
  
It would be plausible that an effective management of depression could improve not only 
patients’ mood but functionality as well, and also reduce the costs of health care.18 51 An 
effective management of medical patients with depression may also decrease the incidence of 
suicide and alcohol misuse, and reduce the number of investigations performed for physical 




1.3.3 The detection of depression in people with long term conditions 
In spite of its enormous clinical and public health importance, depressive illness is often 
underdiagnosed and undertreated, particularly when it coexists with physical illness.
19
 
Modern medical practice is clearly orientated towards detecting and treating organic 
disease.
18
 It is regarded as a greater error failing to diagnose an organic disorder than a 
psychological one, even if the later could be alleviated by appropriate treatment. This is in 
spite of the Hippocratic teaching of the nervous element in the genesis of disease, the 
awareness of psychological disorders in the writings of physicians, and the experiences 
reported by patients and the laity over centuries.
18 52
 There are some reasons behind the 
underdiagnosis of depression in the medically ill. These include the  arbitrary boundaries 
23 
 
among clinical and non pathological symptoms, the overlap between symptoms of depression 
and physical disorder, doctors’ limited experience with mental health disorders, 18 20 the belief 
that most patients with medical illness are depressed, the idea that depression is an 
understandable reaction that does not require treatment, and  the belief that treatments for 
depression are ineffective or hazardous with such patients.
20 53
 Depression may also be 
underreported by patients with physical conditions. Many patients may deny mood 
disturbance or feel threatened by the suggestion that the problem is a psychological one. 
Other factors leading to the underreporting of depression include diminished affective 
awareness, fear of stigma of reporting emotional illnes, and the lack of knowledge about 
available assitance and/or treatment.
18 20 52
  
A good understanding of the distribution of depression, and its consequences, among people 
with long term conditions may contribute to more effective communication and the timing 
and targetting of potential new management strategies.  
1.3.4 Further research on depression in people with long term conditions 
Depressive illness is usually treatable
54 55
 and there is no evidence to suggest that tactful 
questionning about emotional distress is harmful.
19 20
 One Cochrane review reported that 
antidepressants improve depression symptoms among patients with medical conditions.
54
 
Another one reported that antidepressants appeared to improve disability, neurological deficit 




Evidence on the natural history, predictors and outcomes of depression among patients with 
specific conditions is required to understand the emotional impact of disease in the long term. 
It is also essential for a better clinical management and the development of innovative 
24 
 
interventions for depression in the medically ill. Further studies should contribute to the 
identification of patients, and the time points during the course of the physical disease, in 
which the risk of depression is significant. An updated systematic review of the available 
literature on depression in specific clinical conditions should be the base of these studies.  
1.4 DEPRESSION AFTER STROKE  
Stroke is directly or indirectly associated with many of the biological, psychological and 
sociological factors, discussed in the previous section, that can lead to depression in the 
medically ill. The long term outcomes of stroke, including disability and lower quality of 
life,
10
 are also common among patients with other long term conditions that according to  a 





 chronic obstructive pulmonary disease (COPD),
58
 and kidney failure.
59
  
It is therefore accepted that stroke might predispose, precipitate, or perpetuate some late-life 
depressive syndromes.
24
   
A meta-analysis of observational studies published in 2005 reported the pooled prevalence of 
depression at any time after stroke to be 33% (95% CI 29-36%).
60
 Studies that have 
compared the post-stroke incidence of depression with that in appropriately matched 
community controls have found that the risk of depression is at least doubled after stroke 
compared with what would be expected in the general population.
61
 A systematic review, also 
published in 2005, reported four main variables associated with, or predictive of, depression 
after stroke: stroke severity, cognitive impairment, physical disability and social isolation.
62
 
Studies included in both reviews have limitations including: small samples, patients only 
being assessed once, short follow-up and weak analysis. While some research on this topic 
may have been published since 2005, there are no updated reviews of the incidence, 
25 
 
prevalence, natural history and predictors of depression after stroke that include the more 
recent studies.  
Depression after stroke is important not only because of the distress it causes for patients and 
their families, but because of its possible association with other negative health outcomes 
including increased mortality, severe physical impairment and functional dependence.
63-73
  
However, the evidence on the association between depression and other health outcomes is 
limited: most studies have small sample size and short follow-up; the nature of the 
associations between depression and some outcomes is unclear as depression could be the 
cause or the result of them; measurements of depression might be confounded by somatic 
symptoms caused by stroke itself; stroke on its own may also be responsible for some of 
these outcomes. A recent study reviewed prevalence, predictors and outcomes of depression 
within a month of stroke.
74
 However there are no updated systematic reviews summarising 
the associations between depression after stroke and other health outcomes in the long term.  
A majority of long-term stroke survivors with emotional needs reported that they did not 
receive adequate help to deal with them.
75
  Clinical guidelines recommend that stroke patients 
should be screened for depression and those patients who have depression sufficient to cause 
distress and/or to impede rehabilitation should be assessed clinically for further treatment.
76 77
 
However, two Cochrane reviews 
78 79
 reported that the effect of available preventive and 
therapeutic measures for depression after stroke is limited. The authors of these reviews 
questioned if treatments had been given for long enough, starting at the right time, and to the 
patients who actually needed to be treated. The poor epidemiological evidence in which 
interventions were based may have led to an underestimation of their real effect.  
Population based observational studies of depression among stroke survivors would provide a 
better estimation of its impact on patients, health services and populations in the long term.  
26 
 
The year-on-year estimates describing natural history of depression after stroke, reported in 
observational studies, could be used to provide more precise estimations in future 
calculations of Global Burden of Disease. It is rare that population-based studies observe 
outcomes in such a prospective manner, with  over ten years of follow-up.
10
 Observational 
studies would also help to understand the nature and the strength of the association between 
stroke and depression. Furthermore, these studies could help in the development of strategies 
for an effective management of depression afters stroke.  
An epidemiological design of future studies would provide a holistic approach to depression 
after stroke. Evidence on the natural history, predictors and associated outcomes of 
depression after stroke, produced in these studies should be easily applicable in clinical 
medicine, public health and health policy. It may also inform other studies approaching this 
topic with different methods, e.g.:  neuroradiology or neurobiology studies.  
Findings on stroke populations may also help to understand the association between 
depression and other diseases, such as heart failure or COPD, which have outcomes in 
common with stroke.  
It has been reported that patients with multiple disease often receive care from different teams 
in a disjointed way resulting in uncoordinated care, multiple different hospital visits, and 
sometimes confusing or contradictory information. This happens both in hospitals and in the 
community.
80
 A better understanding of the natural history predictors and outcomes of 
depression after stroke could help to co-ordinate and integrate an approach to depression, 





Finally, observations of depression in stroke patients may also be useful in the management 
of depression in the context of diseases which are less frequent or have received less attention 
from researchers than stroke e.g.: polyneuropathies or myopathies.   
  
1.5 THEORETICAL FRAMEWORK AND HYPOTHESIS OF THIS THESIS  
As discussed in previous sections stroke is a leading cause of mortality and disability 
worldwide. Depression is also an important cause of loss of DALYs globally and it has an 
increased prevalence among patients with long term conditions including stroke. The 
association between a medical long term condition and depression is complex and includes 
factors directly associated with the diseases, for example case severity and poor prognosis, 
psychological factors such a low self-esteem, biological mechanisms such as neurological 
damage, sociological factors for example isolation, and ineffective protective strategies.  
There is limited evidence on the long term natural history, predictors, and outcomes of 
depression after stroke. This affects the management of depression in stroke patients that 
currently has limited effectiveness.  
Population based studies, with large sample size, observing a range of outcomes in long term 
stroke survivors provide the potential sampling frame to study the natural history of 
depression after a long term condition. An ideal dataset would include previous medical 
history, sociodemographic data, clinical details of the acute event, and long term clinical data 
of depression and other outcomes. This would help to estimate the natural history of 
depression in the long term after stroke. It would also help to observe the strength and the 
nature of the association between depression and a number of variables present before and 
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after the acute event. This would result in a better understanding of the impact of depression 
on stroke survivors and would help in the development of effective management strategies.  
Epidemiological studies of depression in the long term after stroke could also help in the 
estimation of the impact of stroke in populations. Finally, these studies would test some of 
the links between mental and physical health and therefore, they could also provide evidence 
applicable in the context of other long term conditions. 
The available evidence on the natural history, predictors and outcomes of depression after 
stroke raises the hypothesis that will be tested in this thesis: 
Depression can affect stroke survivors in the long term and it may be associated with other 
health outcomes.  
An updated systematic review of observational studies of the natural history, predictors, and 
associated health outcomes, of depression after stroke is needed to understand in detail what 
is already known on this topic, and to identify the gaps in the knowledge. Prospective studies 










CHAPTER 2: DEPRESSION AFTER STROKE, NATURAL HISTORY, 
PREDICTORS AND ASSOCIATED OUTCOMES; A SYSTEMATIC LITERATURE 
REVIEW AND META-ANALYSIS 
 
2.1 ABSTRACT 
Objective: To estimate the natural history, predictors and associated outcomes of depression 
after stroke.  
Methods: systematic review and meta-analysis of studies of unselected stroke patients 
reporting at least one of the following: prevalence, incidence, cumulative incidence, duration, 
predictors or outcomes of depression after stroke. Studies published up to the 31/08/2011 
were searched in MEDLINE, EMBASE, Psyc-INFO and Web of Science. 
Results: 49 studies were included, out of the 13,558 references initially found. Most studies 
had small sample sizes and short follow-up. Pooled prevalence of depression after stroke was 
29% (25-32), and remained stable up to ten years after stroke, with a cumulative incidence 
between 39% and 48% within a year of stroke. 15% to 57% of patients depressed within the 
first few months after stroke had recovered from depression one year after stroke. Major 
predictors of depression after stroke were disability and history of depression pre-stroke. 
Other predictors included stroke severity, cognitive impairment, poor family support, and 
anxiety. Lower quality of life and disability were health outcomes independently associated 
with depression after stroke. The association between depression after stroke and higher 
mortality was also reported. 
Conclusions: The natural history of depression after stroke seems to be dynamic. Depression 
after stroke may be associated with adverse health outcomes and requires periodic clinical 
attention in the long term that should focus on patients at highest risk. The natural history, 
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predictors, and associated health outcomes, of depression in the long term after stroke remain 
unknown. Future studies of high quality are required. 
 
This literature review has been published in the British Journal of Psychiatry  

















2.2 INTRODUCTION  
In this chapter the available studies on frequency, predictors and associated outcomes of 
depression after stroke will be reviewed to identify what is already known on this topic and 
what are the gaps in the knowledge. 
The specific questions to be addressed by this thesis will arise from the results of this 
literature review 
 2.3 METHODS 
The recommendations included in the statement Meta-analysis of Observational Studies in 
Epidemiology (MOOSE)
82
 were used to undertake this review and meta-analysis. The 
Cochrane Collaboration Handbook for Systematic Reviews was also used as a reference to 
guide the methods of this chapter.
83
  
This review includes studies of stroke patients,
 
in whom an assessment of mood was 
performed at a specific
 
time point, falling into at least one of the following three groups:  
1- Studies reporting the proportion of patients who met the diagnostic category of 
depression, defined by scores above a cut-point
 






or other diagnostic criteria. 
2- Studies investigating variables potentially associated with, or predictive of, depression 
after stroke.  
3- Studies investigating the association between depression after stroke and a health 




2.3.1 Search strategy and selection of studies: 
Observational studies reporting, prevalence, incidence, cumulative incidence, duration, 
predictors or outcomes of depression after stroke were searched in the following databases: 
EMBASE (1947 – August 2011), MEDLINE (1948 – August 2011), PsycINFO (1806 – 
August 2011), and ISI Web of Science (1900 – August 2011).  
The search strategy presented in Figure 2.1, that includes controlled vocabulary and free text 
terms, was used for EMBASE, MEDLINE and PsycINFO (Ovid), and modified to suit ISI 
Web of Science. 





recommendations, to be extensive in order to ensure that as many as possible of the necessary 
and relevant studies were included in the review. The research questions addressed in this 
chapter focused on results of observational studies; however this concept may not be well 
described in the title or abstract of an article and is often not well indexed with controlled 
vocabulary terms. Therefore, the search strategy did not include terms referring to study 
designs and it included terms for the concept of stroke and depression only. The 
recommendations of the Cochrane Collaboration regarding search strategies are that is 
unnecessary, and even undesirable, to search on every aspect of the review’s question.83  
In addition, references of the following previous reviews were checked for relevant studies: 
Turner-Stokes and Hassan 2002 review on studies of frequency and impact of depression 
after stroke; 
63
 Hackett and colleagues 2005 reviews on studies of frequency  and  predictors 
of depression after stroke;
60 62
  Robinson and Spalletta 2010 review on studies of frequency, 
predictors and outcomes of depression after stroke; 
87
 Kouwenhoven and colleagues review 







were no restrictions on the basis of language, sample size,
 
or duration of follow-up. 
Studies were excluded if they had selected their participants according to criteria that had not 
been validated. These included the following: 1) studies limited to specific clinical 
characteristics (e.g., strokes in specific locations, strokes of a specific subtype); 2) they were 
limited to specific patient
 
characteristics (e.g., patients of a specific age group); 3) studies of 
mixed populations
 
(e.g., stroke and head injury) unless separate results for stroke patients 
were identified; 4) convenience sampling. Although in some cases these ways of selecting 
participants made these studies feasible, it was considered that estimates produced in these 
samples could be substantially different from the ones of the real stroke population. It was 
also acknowledged that including these studies in a meta-analysis together with those of 
unselected stroke patients could introduce error and make the results difficult to interpret. 
Other methodological considerations that were used to exclude studies were: 1) unstructured 
assessment of mood; 2) mood reported only as a continuous variable (not categorising 
patients as depressed or not depressed); and 3) studies with retrospective recruitment.  
Following the Cochrane methodology
83
 some of the studies that did not fit the inclusion 
criteria are also presented. This covers all studies that may on the surface appear to meet the 
eligibility criteria but on further inspection do not, and also those that do not meet all of the 
criteria but are well known and likely to be thought relevant by some readers. These studies 
that are presented do not include however all the reports that were identified by the 
comprehensive search.  
The results of these excluded studies, close to fitting the inclusion criteria, were observed and 
discussed carefully and they revealed to be very heterogeneous. Such heterogeneity was 
attributed to the diverse methods used, which included selection of specific groups of 
patients, non validated ways of assessing for depression and unusual statistical analysis. It 
was considered very difficult to translate these heterogeneous results into clinical 
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recommendations or into new research questions that could inform the analysis of the SLSR 
data. The observation of these results helped to re-asses the inclusion criteria of this review.  
While it is acknowledged that no inclusion criteria guarantees the identification of absolutely 
all the relevant literature, the criteria used in this review were considered appropriate to 
minimise error. The uniformity of the methods of the included papers provided results which 
were still diverse but more consistent across studies.  This led to clearer clinical 
recommendations and to the definition of the original research questions that are elaborated 
in the following chapters. Nonetheless, some of the results and ideas presented in these 
excluded papers are mentioned in the discussion section of this chapter and they also have 
been used in the design, methods, and discussion of the studies undertaken in this thesis. 
In some cases, similarities between studies indicated
 
the possibility of multiple publications 
from the same cohort.
 
In the absence of explicit cross-referencing, we considered articles
 
to 
be from the same cohort if there was evidence of overlapping recruitment sites, study dates,
 
and grant funding numbers, or there were similar reported patient characteristics in the 
studies. Where several
 
articles reported results from the same population, data were taken 
from the publication with longest follow-up. When more than one method of assessment for 
depression was used, the result of the assessment that was discussed more in depth by the 
authors was included in the meta-analysis. When the prevalence of “major” and “minor” 
depression was reported separately, they were grouped as depression. 
Studies of predictors of depression that were included used depression as a dependent 
variable in a statistical model where potential predictors were explanatory variables. Studies 
of outcomes of depression that were included used outcomes as a dependent variable in a 
model where depression was an explanatory variable. Studies using only univariate analysis 
were not included as their results could be highly confounded.
88
 For studies of predictors or 
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outcomes, information was collected on all variables
 
analysed as potential predictors, 
outcomes and confounders.  
Only studies reporting outcomes measured at a later time point than depression were 
included. Information was collected on all of the variables
 
analysed as potential predictors, 
outcomes and confounders. The quality of studies was assessed according to accepted 
criteria.
62
 Authors of studies were contacted when there were questions about whether papers 
















1. exp Cerebrovascular Disorders/ 
2. stroke*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
3. poststroke*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
4. cerebrovascular*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
5. cerebral vascular.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
6. 2 or 3 
7. 4 or 5 
8. infarct*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
9. isch?emi*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
10. thrombo*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
11. emboli*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
12. apoplexy.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
13. 8 or 9 or 10 or 11 or 12 
14. cerebral.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
15. intracerebral.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
16. intracranial.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
17. brain*.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
18. cerebellar.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
19. vertebrobasilar.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
20. 14 or 15 or 16 or 17 or 18 or 19 
21. h?emorrhage.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
22. bleed.mp. [mp=ti, ot, ab, nm, hw, ui, an, tc, id, sh, tn, dm, mf] 
23. 21 or 22 
24. 13 and 20 
25. 20 and 23 
26. 1 or 6 or 7 or 24 or 25 
27. Depression/ 
28. Depressive Disorder/ 
29. 27 or 28 
30. 26 and 29 
31. limit 30 to human 
32. limit 31 to yr="2000 - 2011" 




2.3.2 Statistical methods 
A meta-analysis was undertaken to obtain pooled estimates of prevalence of depression. 
Since the different study settings and follow-up periods could introduce heterogeneity a 
classification of studies was first conducted and a subgroup analysis was then carried out. In 
the first meta-analysis studies were classified in four categories: "acute phase" (within one 
month of stroke); "medium-term phase" (one to six months); "long-term phase" (six months 
to one year); “very long-term” (more than one year after stroke). Second, a meta-analysis was 
conducted in which studies were classified as population, hospital or rehabilitation studies. 
Different models for the meta-analysis, fixed-effect or random-effect, were considered. For a 
fixed-effect meta-analysis the assumption is made that the observed differences among study 
results are due solely to the play of chance, e.g.: that there is no statistical heterogeneity. A 
random-effects meta-analysis model involves an assumption that the effects being estimated 
in the different studies are not identical, but follow some distribution. The conventional 
choice of distribution is a normal distribution. It is difficult to establish the validity of any 
distributional assumption, and this is a common criticism of random-effects meta-analyses. 
The importance of the particular assumed shape for this distribution is not known. The 
confidence interval from a random-effects meta-analysis describes uncertainty in the location 
of the mean of systematically different prevalence in the different studies.
83
 After studying its 
advantages and disadvantages a random-effect model was considered more appropriate for 
this analysis than the fixed-effect one.  
 The assessment of patients at an exact time after stroke was judged to be logistically very 
difficult therefore studies with time of follow-up reported as an interval e.g.: three to nine 
months, were included in this review. In the meta-analysis they were included in the category 
of the earliest time point as it was considered to be the least affected by drop out due to 
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mortality. For example a study reporting estimates obtained between three and nine months 
would be included in the category of one to six months. Categorisation of these studies 
according to their mid time point of follow-up was also attempted. For example studies 
assessing patients between three and seven months after stroke would have been categorised 
as if all patients had been seen at five months. However, the differences of the estimates 
using earliest time point and mid time point were found to be negligible. It was considered 
that the mid time point categorisation would have allowed for higher error introduced by 
mortality than the categorisation by the earliest time point.  
For studies
 
with follow–up assessments at more than one time point only results from the last 
follow–up were included in the meta-analysis. This was done to obtain pooled estimates of 
prevalence long term after stroke avoiding the bias that would have been introduced by 
entering repeated estimates of a study in the same meta-analysis. However, data from 
measurements at all time points were also recorded and presented in the tables.  
A funnel plot was used to investigate possible publication bias. 
The number of studies reporting estimates of natural history of depression after stroke other 
than prevalence (e.g.: incidence) was small. The assessments for depression had been 
conducted at different time points in each of these studies. Therefore, a meta-analysis to 
obtained pooled estimates of other measures of natural history was not conducted. Results 
presented by individual studies were reported separately. 
2.4 RESULTS 
9799 references were found in EMBASE, MEDLINE and PsycINFO, and another 3859 
references were found in ISI Web of science. After removing duplicates, the title of the 
12907 remaining studies was read and 505 studies were assessed for inclusion/exclusion 
39 
 
criteria. Finally 49 studies, published between 1983 and 2011, reporting incidence, 
prevalence, cumulative incidence, duration, predictors or associated outcomes, of depression 



















Figure 2.2 Results of the literature search.   
*Many studies, together with prevalence of depression after stroke, reported either predictors 
or outcomes of depression after stroke. 
Medline +  EMBASE + 
PsycInfo (OVID) search 
results: 
9,799 references 




506 full text studies assessed for 
inclusion/exclusion criteria 
49 studies included reporting at least one of the three outcomes of the review*:   
- incidence and/or prevalence of depression after stroke reported in 43 studies 
- Predictors of depression after stroke reported in 10 studies 
- Outcomes of depression after stroke reported in 5 studies 
751 duplicates 
12,907 abstracts 
12,401 not relevant 
501 originals 5  reviews 







9 additional studies 
4 eligible 
studies 
5 not fitting 
inclusion 
criteria 





In all the studies included the analyses were based on the result of assessments for depression 
conducted after stroke, not accounting for whether the onset of depression occurred before or 
after the stroke. 
2.4.1 Natural history of depression after stroke 
44 studies, including 20,293 patients, reported prevalence of depression after stroke (Tables 
2.1, 2.2 and 2.3). Six of them were population based studies
10 89-93
, fifteen were hospital 
studies
94-108
, and 23 were rehabilitation studies.
109-130
  The number of patients assessed for 
depression in each study ranged from 14 to 13,999. Only nine studies assessed more than 200 
patients,
10 89 90 92 93 98 107 118 123
 and only one of them assessed more than 1,000 patients.
98    
Across the 43 studies, eleven different methods were used to assess depression. 29 studies 
used validated scales, twelve studies used the Diagnostic and Statistical Manual of Mental 
disorders (DSM)
85
 criteria, and two studies used a validated question. The cut-off points for 
the same scale used to diagnose depression in different studies were not consistent. Only 
eight studies reported the prevalence of depression more than one year after stroke, and only 
thirteen studies assessed patients at more than one time point.  
The search also identified several studies reporting rates of depression after stroke, that did 
not fit the inclusion criteria: 12 studies that excluded patients with haemorrhagic strokes,
71 100 
131-140
 eight that excluded patients with subarachnoid haemorrhages,
141-148
 seven studies that 
only included patients with supratentorial strokes,
135 149-154
, and three studies that excluded 
patients with more than one lesion.
148 155 156
   
In the studies fitting the inclusion criteria, the reported prevalence of depression ranged from 
12 to 60%. The pooled prevalence of depression, and its 95% confidence interval (CI), 
observed at any time point was 29% (25-32), with a prevalence of 28% (23-34) within a 
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month of stroke, 31% (24-39) at on to six months, 33% (23-43) at six months to one year, and 
25% (19-32) at more than one year (Figure 2.3). The pooled prevalence of depression at any 
time point in population studies was 22% (17-28), in hospital studies 30% (24-36), and 30% 
(25-36) in rehabilitation studies (Figure 2.4). The prevalence rates did not differ significantly 
over time or in studies of different settings. Heterogeneity was significant for all investigated 
categories. The studies using a simple single question to diagnose depression
98 123
 reported 
low prevalence of depression, 14 and 16%. Studies with small sample size tended to report 





















Depressed (n) Depressed (%) 
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Wolfe 2011
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Table 2.1 Population based studies of Prevalence of depression after stroke 
WDI: Wakefield Depression Inventory 
BDI: Beck Depression Inventory 
DSM: Diagnostic and Statistical Manual of Mental Disorders 
IDA: Irritability Depression and Anxiety Scale 
MADRS: Montgomery-Åsberg Depression Rating Scale 

























UK HAD>7 <1m 
1m after 
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3 m 13999 1999 14  
Fure 2006 
100
   Norway HAD>6 
 
3-7 d 178 25 14  
Kaji 2006 
103
  Japan HDRS >10 
 




Portugal  DSM IV 
 





Australia HDRS>12 Acute 
phase 
 




Nigeria BDI>9 1m-2 y 118 47 40 
Beghi 2009 
95
 Italy DSM IV  Acute 
phase 
 






Poland GDS>5 3 m 242 82 34 
Raju 2010 
105
 India HAD>7 1 m – 3 y 162 60 37  
 
Table 2.2 Hospital studies of prevalence of depression after stroke 
GHQ: General Health Questionnaire  
HAD: Hospital Anxiety and Depression Scale 
DSM: Diagnostic and Statistical Manual of Mental Disorders 
BDI: Beck Depression Inventory 
HDRS: Hamilton Depression Rating Scale,  














 USA HDRS 7 d 32 5 16  
Eastwood 1989 
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Aström  1993 
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 Japan DSM-III R 3m-10y 68 41 60 
Diamond 1995 
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  Italy BDI>14 2 y 180 62 34 
Lincoln 1998 
124
 UK HAD>10 1 m 84 11 13  
Kauhanen 1999 
120












DSM-III 3-6 w 85 30 35  
Jürgensen 1999 
119
 Germany DSM IV 6 m 77 15 20  
Löfgren 1999 
125










Acute phase 311 50 16  
Gillen 2001 
118
 USA GDS >14 15 d 243 31 13  
Mast 2004 
160
 USA GDS >10 1w  195 71 36  
B-Collo 2007 
161















Bergersen  2010 
162
 
Norway HAD>7 3.5 y 162 45 28  
Kitisom.2010 
122
 Thailand GDS >12 3 d 83 47 57 
Table 2.3 Rehabilitation studies of prevalence of depression after stroke 
HDRS: Hamilton Depression Rating Scale,  
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GDS: Geriatric Depression Scale 
ZDS: Zung Depression Scale 
DSM: Diagnostic and Statistical Manual of Mental Disorders 
BDI: Beck Depression Inventory 
HAD: Hospital Anxiety and Depression Scale 
MADRS: Montgomery-Åsberg Depression Rating Scale 




Figure 2.3 Pooled prevalence of depression stratified by length of follow-up 
 


































































































































































                     Figure 2.4 Pooled Prevalence of depression stratified by study setting 
Four studies reported other measures of natural history of depression after stroke including 
incidence, cumulative incidence, and duration of depression (Table 2.4).
91 93 110 117 163
 Another 
study reporting measures of natural history of depression afters stroke, and fitting the 
inclusion criteria, was identified, but it was not included as it reported preliminary results 




Overall  (I-squared = 93.9%, p = 0.000)
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from this thesis.163 Incidence in year one was 10% in the only study reporting it. Cumulative 
incidence ranged from 39 to 48% in two studies with one year of follow-up. Two studies 
reported that 15 to 57% of patients depressed within three months of stroke had recovered 
one year after stroke. Three studies reported the proportion of patients depressed in all the 
assessments, which ranged from 7%, in a study with one year follow-up, to 36% in a study 
with three years of follow-up. All the longitudinal studies presented a dynamic natural 
history, with new cases and recovery of depression occurring over time.
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2.4.2 Predictors of depression after stroke 
A total of 14,898 patients were assessed in nine studies reporting predictors of depression 
after stroke fitting the inclusion criteria. The search strategy identified another study 
reporting predictors of depression after stroke, fitting the inclusion criteria, which was not 
included in this review as it reports preliminary results of this thesis.163 
The number of patients assessed for depression in each study ranged from 40 to 13,999. Six 
of them assessed more than 100 patients
96 98 99 105 117 164
 of which only one assessed more than 
1,000 patients.
98
 The quality assessment of these studies is presented in table 2.5. There were 
no population based studies. Eight studies were based in hospitals
95 96 98 99 105 108 164 165
, and 
one was a rehabilitation based study.
117
 Only three studies assessed the patients more than 
one year after stroke.
105 117 165
  
The assessments for depression were carried out using scales in six studies, DSM criteria in 
two studies, and a validated question in another one. The time of these assessments ranged 
from the acute phase to three years after stroke.  Six studies stated all the variables included 
in the models. Six studies did not report that potential confounders had been included in the 
models. In five studies depression and its predictors had been measured at the same time, 
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Table 2.5 Quality of the studies of predictors of depression after stroke 
H: Hospital, R: Rehabilitation 
The search identified a number of studies reporting predictors of depression after stroke that 
did not fit the inclusion criteria. These included twenty studies from which patients with 
haemorrhagic strokes were excluded, 
71 100 107 111 122 128 132-134 137 151 154 166-173
 another ten 
studies excluding patients with subarachnoid haemorrhages, 
106 110 142 144 146-148 153 174 175
 two 
studies excluding patients with a past history of depression,
122 176
 and one study excluding 






Many different predictors were investigated across the nine studies (Table 2.6). Disability 
was investigated in four studies. One of them reported disability at baseline as a predictor of 
depression.
163 165
 Another two studies reported disability to be associated with depression at 
follow-up.
98 105
 Finally, another study found that disability after stroke was not associated 
with depression.
164
 Past medical history of psychiatric disorders was investigated in different 
ways in four studies: pre-stroke depression was reported as a predictor of depression after 
stroke in one study;
96
  three studies investigated past medical history of psychiatric 
disorders
95 99 108
 and two of them found a significant association with depression after 
stroke.
99 108
 Cognitive impairment after stroke predicted depression in one study that 
investigated the association.
99
 In this study cognitive impairment had been defined with a 
score in a scale so no details were given on whether the association was between depression 
and the executive domain or with other domains of cognitive function. Three studies reported 
stroke severity not to be associated with depression after stroke.
95 105 165
 Another study 
reported hemiparesis to be associated with depression.
99
 Anxiety predicted depression in two 
studies
164 165
 and was associated with depression at follow-up in another one.
105
 One study 
reported an association between living alone after stroke and depression.
98
 Age and gender 
did not predict depression in six out of seven studies. Other potential predictors investigated 
in fewer number of studies, including co-morbidities, previous history of stroke, education, 
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Table 2.6 Predictors of depression after stroke 
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2.4.3 Associated outcomes of depression after stroke 
Five studies reported health outcomes associated with depression after stroke (Table 2.7). A 
total of 887 patients were assessed for depression in the five studies. Three of them were 
hospital studies
177-179
 and the other two were rehabilitation studies.
117 180
 The number of 
patients assessed for outcomes ranged from 84 to 293. Depression was assessed between the 
acute phase and three months after stroke. Three studies reported outcomes observed more 
than a year after stroke.
117 177 178
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Table 2.7 Outcomes of depression after stroke 
QoL: quality of life. MRS: modified Rankin Scale 
The search also identified several studies reporting outcomes of depression after stroke, not 
fitting the inclusion criteria. These included five papers from which patients with 
haemorrhagic strokes had been excluded, 
143 181-184
  two papers that presented estimates for 
55 
 
patients with stroke or transient ischaemic attack together,
185 186
 two studies excluding 




 and one paper from which patients of non-




Disability was found to be an outcome of depression in one study with OR: 2.68 (1.50-
4.78)
179
. Lower quality of life (QoL) was found to be an outcome of depression in the two 
studies that investigated the association. Both of them used linear regression. One of them 
reported coefficient for QoL: -0.52 (-0.70- -0.33) 
179
 and the other one presented separated 
coefficients for the physical domain of QoL -1.8 (-1.4 - -2.2), psychological domain -2·6 (-
2.4- -2.8),  social domain -1.2 (-0.8- -1.6)  and environmental domain -2.0 (-1.6 - -2.4).
180
 
Higher mortality was found to be an outcome of depression in two of the three studies that 
investigated the association. One of them presented strong evidence of association, with OR: 
3.4 (1.4-8.9) p=0.007
178





Depression after stroke has been investigated in studies of diverse quality across the world. 
Some evidence has been provided on its natural history, predictors, and association with 
health outcomes, although in order to inform effective interventions some areas need further 
research. 
2.5.1 Natural history of depression after stroke 
Available studies show that depression has a cumulative incidence up to 48% within a year of 
stroke with a pooled prevalence of 29% that remained stable in the first ten years after stroke 
in different study settings. Studies assessing patients more than once suggested that most 
56 
 
patients who have depression after stroke became depressed shortly after the acute event, a 
significant proportion of them recovered from depression in subsequent assessments, and new 
cases made the overall prevalence of depression stable. The natural history of depression 
more than three years after stroke remains unknown. Factors affecting the variation of 
prevalence of depression reported by individual studies included the different methods used 
to diagnose depression, source of patient recruitment, and
 
the timing of assessment, together 
with the different study settings. Without greater methodological uniformity in the studies, it 
will remain difficult to determine
 
whether heterogeneity in study findings is showing real 
differences
 
in characteristics of populations or is simply an artefact caused
 
by measurement 
bias and other errors. These estimates may still be inaccurate because of potential under-
reporting of abnormal mood, especially in patients with communication impairment
60
, and 
the possibility of over reporting depression by using screening questionnaires.   
A previous systematic review published in 2005 reported that the prevalence of depression 
after stroke was stable across studies conducted at different time points and in different 
settings.
60
 This systematic review includes fourteen new studies with six studies conducted in 
Europe, three studies conducted in Oceania, three in Asia, one in America and one in Africa. 
However, there is no significant difference between the prevalence observed in this study and 
the one previously reported.
60
 Our results show the great stability of the prevalence of 
depression across studies conducted in different time points. The prevalence of depression 
was stable, despite the fact that aetiological factors of depression may be different at different 
time points. Stroke survivors in the first weeks were coping with the consequences of the 
direct neurological damage, the experience of a life-threatening event, and the initial stages of 
rehabilitation. In the medium to long term, survivors were more likely to be adjusting to 










 They reported that the prevalence of depression in stroke survivors 
was twice
 
that in controls, although this difference was only significant at the six months 
follow-up assessment. Another robust examination of the relative risk of depression
 
in stroke 
survivors was undertaken in The Framingham Study,
 
a prospective, observational, 
community-based study that enrolled
 
middle-aged subjects who have been followed-up 
biennially since
 
the middle of the past century. They reported that significantly more stroke 
survivors were
 
depressed than controls matched for age and gender.
189
 
2.5.2 Predictors of depression after stroke 
Disability after stroke and history of depression pre-stroke are the predictors of depression 
after stroke most consistently reported with three studies presenting a significant association. 
Other predictors were cognitive impairment, stroke severity, lack of social or family support, 
and anxiety.  
Depression pre-stroke and anxiety were not reported as predictors of depression after stroke 
in a previous review.
62
 Risk factors for depression, connected or not to stroke (e.g.: genetic 
factors), may explain the strong association between depression before and after stroke.  
The associations between stroke severity and depression were not completely consistent. The 
association between stroke severity and disability may be a possible explanation for the 
inconsistent association between severity and depression observed in this study.  Whether the 
association between stroke severity and depression is independent or partly, or completely 
explained by the association between severity and disability remains unknown.  
The association observed in this chapter between depression and impaired cognition is 
complex as both can be cause or effect of each other and they also have common risk factors. 
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Patients with cognitive impairment deserve special attention in any case as their risk of 
depression may be increased and they may be unable to report their symptoms.  
No association was found between depression and other variables representing neurological 
damage, such as stroke subtype, lesion location or laterality of stroke.  A previous systematic 
review of depression and stroke lesion location concluded that there was no evidence 
suggesting that the risk of depression after stroke is affected by the location of the brain 
lesion.
190
 The importance of neurological damage on depression after stroke appears to be 
limited to cognitive impairment and stroke severity.  
Other medical conditions did not predict depression after stroke. Despite the well established 
association between chronic illness and depression,
191-193
 the results of this review suggest 
that depression after stroke is mostly associated with the experience and consequences of 
stroke itself.  
The negative impact that social isolation has on general health may play a role in its 
association with depression after stroke.
194 195
 Other variables connected to personal, 
professional and social life, such as education level and family structure, have been 
investigated in a little number of studies of good quality. Therefore, there is still insufficient 
evidence about their possible association with depression.  
Age and gender were found not to be predictors of depression in most studies investigating 
these associations. In general population the prevalence of depression is higher in women.
14
 
However, our observations suggest that after stroke prevalence of depression becomes similar 





2.5.3 Associated outcomes of depression after stroke 
The evidence on the outcomes of depression after stroke is still limited, with only five studies 
of unselected stroke patients investigating this area. The very brief description of the 
statistical models reported in most studies makes it difficult to assess the validity of the 
results. Low quality of life was an outcome identified repeated times.177 179 Another study of 
good quality identified in the electronic search observed an association between depression 
and lower quality of life but patients with TIAs had been included together with patients with 
stroke and that made the results difficult to interpret.
185
 Mortality was observed to be an 




 The electronic search identified other studies 
including two of good quality, from which patients with haemorrhagic strokes had been 
excluded, observing an association between depression and mortality. The interpretation of 
these results was made with caution as the difference in the populations with the studies of 
unselected stroke patients was noted.
181 187
 In an attempt to investigate the causal associations 
between depression and its outcomes, only studies were the outcomes had been assessed after 
depression were included in this review. A previous systematic review reported many 
possible outcomes of depression after stroke, including higher disability rates, higher 
mortality, and poor involvement in rehabilitation, longer hospital stay and poor cognitive 
function. However in that review, they included studies where depression and its potential 
outcomes had been assessed at the same time. This makes difficult to know whether 
depression is actually cause or consequence of the variable investigated as potential 
outcome.
63
 We found weak evidence, or none at all, supporting that other variables apart 





2.5.4 Strengths and limitations of this review 
The comprehensive search, and critical assessment, of studies of unselected stroke patients 
conducted in this review allows estimation of the natural history predictors and outcomes of 
depression after stroke obtained over a large number of patients across the world. The search 
strategy used in this chapter was comprehensive in order to include all the relevant studies.
83
 
The specific design of the studies may not be part of their title, and it may not be one of the 
key words indexed, therefore the search strategy was made extensive, very sensitive and not 
that specific, to include as many relevant papers as possible. It is acknowledged that no 
search strategy can guarantee the inclusion of all relevant literature therefore some papers 
may have been missed. Although the guidelines for reporting meta-analyses of observational 
studies were used as a reference, the data was extracted only by the author of this thesis and 
this can be another source of inaccuracy in the results. Even so, all the data were checked for 
accuracy on multiple occasions and all analyses were conducted repeated times and checked 
by a senior statistician.  
The methods for research synthesis proposed by the Cochrane collaboration and the MOOSE 
statement,
82 83
 used in this chapter, are considered to be at the highest standard.
196
 Medical 
journals invariably require compliance with these guidelines.
196
 However, these methods 
have limitations as well and the application of formal meta-analytic methods to observational 
studies has been debated.
197
 One reason for this has been that potential biases in the original 
studies make the calculation of a single summary estimate of effect of exposure potentially 
misleading. Acknowledging this potential error the systematic review presented in this 
chapter reports individual data from each study as well as pooled estimates. It has also been 
reported that diversity of study designs and populations in epidemiology makes the 
interpretation of simple summaries problematic, at best.
197
 In order to deal with this limitation 
61 
 
the inclusion criteria was defined aiming to remove most of the methodological and clinical 
heterogeneity. Some of the studies identified in the electronic search, not fitting the inclusion 
criteria, are cited in the results section, the discussion, and also in the following chapters as 
their results were considered of interest. Despite these challenges, the methods used in this 
chapter for meta-analyses of observational studies are one of the few methods for reliable 
synthesis of previous research
68
 The rationale for using these methods was therefore to 
improve the reporting of these analyses so that readers could understand exactly what was 
done in a given analysis, who did it, and why was it done. Methodological and 
interpretational concerns make the clear and thorough reporting of meta-analyses of 
observational studies absolutely essential.
82
 
This systematic review aimed to identify studies reporting three types of results: natural 
history estimates, predictors, and outcomes of depression after stroke. This introduced some 
complexity when assessing and selecting studies after the automatic search. However, this 
approach allowed producing an integrated piece of research, providing the current evidence 
on the epidemiology of depression after stroke required to raise the questions to be answered 
in this thesis. All searched studies were observational, and their design had little variation. In 
fact, many identified papers presented more than one type of results e.g.: prevalence and 
predictors, or prevalence and outcomes. These advantages were also considered when 
designing the search strategy.   
The diversity of the methods used across studies may have an effect on the external validity 
of each individual one. In this review, this effect was minimized by conducting a 
comprehensive search, and the categorization of studies by setting and length of follow-up. 
The summary of results of individual studies provides estimates that can be used in clinical 
practice and in the development of further research. 
62 
 
The funnel plot was asymmetrical (Figure 2.5.) Different reasons for such asymmetry were 
considered.
83
 Papers on depression after stroke have been published regularly since the 
eighties so bias caused by delayed publication, “time-line” or “pipeline” bias, was thought to 
be unlikely. The search strategy did not have limitations for language so the possibility of 
language bias was not considered to be relevant. While the search strategy included checking 
references from previous systematic reviews, most results came from an electronic search of 
studies indexed in four databases. Therefore, citation bias was also considered to have little or 
no impact on the funnel plot asymmetry. As described in the methods section, the publication 
of results from the same study in different papers, without referencing a common data source, 
was addressed by checking all papers carefully. After this assessment, if doubts about the 
similarities of different papers remained, the authors were contacted. However, it is possible 
that some "multiple
 
publications" may have been miscoded or missed altogether. The lack of 
cross-referencing of data from some
 
cohorts has served to mislead the research community, 
specifically
 
in the area of depression after stroke.
60
 Another explanation for the asymmetry of 
the funnel plot is that some authors obtaining low figures of prevalence may have chosen not 
to report them, or editors of medical literature may have rejected to publish these 
manuscripts. The low prevalence of depression may make it look less relevant and therefore 
studies with such results may not have been published. All these reasons may explain the bias 


















Figure 2.5 Funnel plot of studies included 
2.5.5 Implications for clinical practice 
Clinicians patients and carers should be aware that depression after stroke is a frequent 
clinical problem that may make the overall prognosis of stroke poorer. The natural history of 
depression after stroke, which appears to be dynamic, should also be considered 
acknowledging that patients depressed at one point may remain depressed in the following 
years, and also the significant risk of depression in patients who are not depressed shortly 
after stroke 
Particular attention should be paid to patients with disability and previous history of 
depression, as the risk of depression after stroke seems to be higher in these groups. Patients 






























Funnel plot with pseudo 95% confidence limits 
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2.5.6 Implications for further research 
The available studies provide insufficient evidence to understand the burden of depression in 
the long term after stroke and to inform effective interventions for it.
78 79
 The long term 
natural history, predictors, and outcomes of depression after stroke need further research. A 
detailed description of the natural history of depression after stroke, including its prevalence, 
incidence, cumulative incidence in the long term, time after stroke of depression onset, 
duration of the episodes, and recurrence rate, would provide strong evidence on when and for 
how long interventions may be required. The identification of predictors of depression after 
stroke would help clinicians to identify patients at a highest risk of this problem, in which 
interventions should focus. Finally, in order to understand the impact of depression in stroke 
patients, the association between depression after stroke and other health outcomes, including 
mortality, disability and stroke recurrence, should be investigated further.  
Population based studies, providing the least biased sampling frame, with large sample size 
and repeated assessments of patients for long follow-up, are needed to describe the natural 
history of depression after stroke, its predictors and outcomes in the long term.  
The lack of a formal study design may substantially impair the interpretation of the results, 
and selective reporting of results can be detrimental. The ethical duty of researchers includes 
reporting findings with accuracy, completeness and transparency, and in sufficient detail to 
allow the scientific community to consider them adequately, assess their strengths and 
weaknesses and make fair comparisons. The adherence of future studies to standard validated 
methods accepted for prognostic models in stroke cohorts,
26 88 198
 will help in the 
interpretation of their results. Evidence produced in these studies should be robust and easily 
applicable in health policy, clinical practice and research. 
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2.5.7 Questions to be addressed by this thesis: 
This thesis aims to provide evidence in areas, identified in the systematic review, where it is 
poor or lacking by addressing the following questions that are still unanswered:  
I. Frequency of depression after stroke in the long term: 
- What is the incidence of depression in the long terms after stroke? 
- What is the cumulative incidence of depression after stroke? 
- What is the prevalence of depression in the long term after stroke? 
II. Natural history of depression after stroke 
- When after stroke do patients become depressed? 
- How long do episodes of depression last? 
- What proportion of patients has recurrent depression? 
III. Predictors and associations 
- What social and clinical variables, present at baseline or at follow-up, are associated     
with depression in the long term after stroke? 
IV. Outcomes: 
- Is depression after stroke associated with higher rates of mortality, stroke recurrence, 











CHAPTER 3: THE SOUTH LONDON STROKE REGISTER (SLSR) 
FRAMEWORK FOR THIS THESIS 
3.1 ABSTRACT 
Background: population based registers provide the least biased information of the 
epidemiology of a specific disease and its long term outcomes.   
Objective: To describe the methods used in the SLSR and present the rationale to use its data 
on this thesis. 
Methods: The SLSR is a prospective ongoing population-based stroke register set up in 
January 1995, recording all first-ever strokes in patients of all age groups from a defined 
multi-ethnic area of South London. Stroke is defined according to WHO criteria. 
Standardized criteria are applied for ensuring completeness of cases ascertainment. Multiple 
overlapping sources are used to register patients including daily visits to acute wards in the 
hospitals serving the study area, weekly checks of brain imaging, and reviews of bereavement 
officers and of bed manager records.  
Trained field workers collect all data prospectively within 48 hours of stroke. Data collected 
on the initial assessment includes: age, gender, ethnicity, stroke severity measures and stroke 
subtype. Three months after stroke, one year after stroke and annually thereafter, patients are 
followed up. Assessments carried out at follow-up include measures of depression (Hospital 
Anxiety and Depression Scale), cognitive impairment (Abbreviated Memory Test or Mini 
Mental Exam), Disability (Barthel Index) and Quality of life (SF 12 and SF 36) 
Results: 4022 patients were registered in the SLSR between 1995 and 2009. Registration of 
strokes occurring in the area has been estimated to be 88% complete.  
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Conclusion: the data from these patients constitutes a unique framework to estimate the 
natural history, predictors and associated outcomes of depression up to 15 years after stroke, 



















The objectives of this chapter are: 
- To describe the characteristics and methodology of the South London Stroke Register, 
database used in this thesis.  
- To outline the rationale for using a population based register to investigate depression after 
stroke 
3.3 IMPORTANCE OF A POPULATION BASED STROKE REGISTER 
The development of disease management programmes, as a way to improve the health care 




 Population based, 
disease specific, registers have received special attention.
80
 The strong evidence that is 
obtained from them can make an important contribution to the improvement of health 
services.
199
 Measurements of the overall health status of the populations that quantify the 
impact of disease are important for clinicians, researchers and policy makers. These 
measurements can include prevalence, incidence, and mortality rates.  
However, to measure the impact of illness, indicators that fully reflect the effect of disease on 
society such as long term outcomes of the disease must also be included.
80
 Most hospital 
based studies assessing outcomes from chronic disabling diseases are restricted to selected 
patients, such as those admitted to hospital or those referred to rehabilitation. Major 
disadvantages of these studies are various forms of selection bias which may lead to the 
wrong estimation of the real clinical course and prognosis of the disease. The variable case-
mix of hospital based studies often limits the degree to which results can be applied to other 
groups of patients. An important limitation, in epidemiological terms, of hospital or 
rehabilitation based studies is the lack of reliable denominator and therefore the impossibility 
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to obtain good quality frequency measurements, such as disease incidence or prevalence. A 
comprehensive picture of the disease outcome requires the inclusion of patients not admitted 
to the hospital, including very severe or very mild cases; hence, the concept of a population 
based disease register (PDR) ascertaining all cases of a condition. To achieve complete case 
ascertainment the PDR has to be truly population based. Some stroke registers are not so and 
they have hospital cases only, assuming that no stroke patients remain in the community.  
3.4 THE SLSR DEFINITION 
Solomon and colleagues
200
 described a PDR as: A database of identifiable persons within a 
population containing a clearly defined set of health and demographic data collected for a 
specific public health purpose. This definition is most appropriate for the SLSR which is a 
prospective longitudinal population based stroke register, established on 1
st
 January 1995, in 
a multi-ethnic, inner city population of 271,817. Data are collected for first in a lifetime 
stroke patients of all ages. Wherever possible, follow-up data for subjects in the SLSR are 
collected at three months after stroke, one year after stroke and annually thereafter. The 
SLSR contains a defined set of demographic and health data with clear purpose of estimating 
the impact of stroke by providing broader measures of stroke outcome.  
3.5 CRITERIA FOR REGISTER 
The SLSR is based on standardised criteria: 
201 202
 
Core criteria for a comparable study of stroke incidence: 
 Standard definitions: 
- WHO definition 
- First ever in a lifetime stroke 
70 
 
 Standard methods: 
- Complete community based case ascertainment based on multiple overlapping 
sources 
- Prospective study design, ideally with “hot pursuit of cases” 
-Large, well defined stable population 
-Reliable method for estimating denominator 
 Standard data presentation 
-Whole years of data 
- Not >5 years of data aggregated together 
- Men and women presented separately 
- Includes ages up to and above 85 years  
- Standard mid-decade age bands used in publications 
- Unpublished five year age bands available for the comparison with other studies 
- Presentation of 95% confidence intervals around incidence rates 
3.6 DEFINITION OF STROKE 
The SLSR uses the World Health Organisation definition of stroke: Rapidly developing 
clinical signs of focal or global neurological deficit lasting more than 24 hours or leading to 





Patients with focal neurological signs recovering within 24 hours, haemorrhages originated in 
cerebral tumours or, cerebrovascular events secondary to trauma, are not included in the 
SLSR. 
3.7 POPULATION COVERED BY THE SLSR 
Cases of first ever stroke are identified in an area defined by postcodes of Lambeth and 
Southwark, South London. The total population was 271,817 according to the 2001 census 
data from the Office for National statistics. This populations consists of 63% white, 28% 
black (15% African-Caribbean, 9% Black African and 2% Black mixed) and 9% of other 
ethnic groups.  
3.8 DATA COLLECTION 
Multiple overlapping sources of notification of stroke are used to ascertain stroke cases. 
These sources are exploited by “hot” pursuit of cases to achieve a high level of case-
ascertainment e.g.: the sources are actively pursued by the register staff to detect any stroke 
cases rather than passively wait for their notification from various sources. This concept is 
essential for any population based stroke register aiming to improve accurate estimates of 
various stroke outcomes. Hospital surveillance of admissions for stroke includes three 
teaching hospitals within (Guy’s, St. Thomas’ and King’s) and others outside the study area. 
Community surveillance of stroke includes patients under the care of all general practitioners 
(GP) within and on the borders of the study area.  
These sources of notification include: 
1- Telephone contact is made with all wards at St Thomas’, Guy’s and King’s hospitals twice 
a week. St George’s, Chelsea & Westminster and Queen Square hospitals are also contacted 
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once a week. The register staff also visit some wards personally, especially wards where 
stroke patients are most likely to be admitted, such as the stroke units. 
2- Consultants and junior doctors particularly in neurology, elderly care medicine and general 
medicine are encouraged to notify any strokes that they may see in their clinical practice, 
both as in-patients and outpatients.  
3- Records of Head CTs or MRIs are screened two to three times a week Patients with results 
suggesting a stroke are investigated further for possible registration.  
4- Records in bereavement offices are regularly checked and the notes of all cases, where 
stroke is mentioned on the death certificate, are then examined to detect stroke cases. 
5- Death and Coroner’s records: Death certificates from the Health Authority serving the 
SLSR population and post-mortem records from the local coroner’s office are also searched 
every three months. 
6- GP surgeries notify the register of any strokes by telephone, electronic mail or by post. 
GPs are made aware of the register and kept informed of progress and any changes.   
7- Therapists from the local community hospitals (Whittington, Pulross and Lambeth 
Community Care Centre) notify the register of cases. They are also sent regular newsletters to 
update them on the project. 
8- To ascertain the strokes that occur out of area, the Lambeth, Southwark and Lewisham 
Health Authority is contacted every six months for details of billing from other Authorities 
for their treatment. 
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9- An updated list is sent every six months to the Office for National Statistics (ONS) of all 
patients who were alive who were known to be deceased but for whom there was no death 
record. They inform the register every two to three months of any patients that have died. 
10- Miscellaneous: Notification by relatives or informal carers of stroke patients. 
A capture-recapture analysis conducted with the data on incident strokes registered in the 
SLSR in 1995 and 1996 concluded that 88% of the strokes occurring in the study area were 
being registered.
203
 NICE guidelines on management of acute stroke recommend, since their 
first edition in 2000, that all stroke patients should be assessed at the hospital.
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Implementation of these guidelines would have led to a lower number of strokes patients 
being managed exclusively in the community, with an increasing number of them receiving at 
least part of their health care at the hospital where they are easier to register. This may have 
increased the proportion of incident strokes occurring in the study area that are registered in 
the SLSR. 
3.9 INFORMATION COLLECTED ON INITAL ASSESSMENT  
Initial assessments of stroke patients are performed by SLSR field workers within 72 hours of 
onset of stroke symptoms whenever possible. The patients are assessed in hospital if 
admitted, but for non-hospitalised stroke patients they are seen at home or in an outpatient 
stroke clinic. Data are collected by acquiring information from patients, their relatives, 
friends, carers, medical records, and where necessary, their general practitioner. Thus, it is 
possible to obtain pre stroke information such as pre-morbid disability even in those patients 
who are unable to communicate at initial assessments. Registration criteria and data collected 
are checked with the patient’s general practitioner and medical records for any discrepancies. 
Any difficult cases are discussed with the senior doctors involved with the register and a 
consensus reached before registration.  
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The information collected on initial assessment relevant for this thesis is described below. A 
sample of the form used to collect data on first assessment is presented in appendix 2. 
3.9.1 Socio-demographic details: 
Socio-demographic data includes, age at the time of the stroke (and date of birth), sex, 
ethnicity, social class, work situation and living conditions prior to stroke. Ethnicity is 
stratified into three groups (1991 census question): white, black (Caribbean, African and 
mixed), and others including Asian, Indian, Pakistani, Bangladeshi, Chinese and others. 
Social class categories are grouped into non manual (I, II non manual), manual (III manual, 
IV, V) and economically inactive (student, unemployed, unable to work because of disability, 
being a carer or retirement). Only paid work before stroke is considered. Working situation is 
stratified in patients working full time or part time, unable to work due to disability, retired 
and others. Living conditions prior to stroke is stratified in living alone, living with carer, and 
living in an institution.  
3.9.2 Stroke severity measures 
Clinical state at the time of maximal impairment (within 72 hours) includes: level of 
consciousness according to the Glasgow Coma Scale (3-15) stratified into severe (3-8), 
moderate (9-12) and mild (13-15), levels of consciousness impairment;
76
 dysphagia assessed 
by the water swallowing test;
204
 visual fields defects assessed by the patient confrontation 
test; visuo-spatial neglect (inattention) assessed by the confrontation test; dysphasia assessed 
by clinical examinations to see if there is a deficit in comprehension, expression, naming, 
reading or writing out of command; dysarthria; motor weakness or paralysis on the affected 
side; sensory loss; cerebellar symptoms such as limb ataxia; urinary incontinence defined as 
loss of bladder control or catheterisation within 48 hours of assessment.  
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The SLSR has collected data on the National Institute of Health Stroke Score (NIHSS)
205
 
since 2001. This scale provides a very reliable and intuitive value for stroke severity.
206
 
However, when the SLSR started in 1995, stroke severity was registered from clinical 
findings, such as GCS and other acute impairments. Having complete NIHSS data from 1995 
would have been ideal especially in the analysis of outcomes of depression after stroke.  
However, the stroke severity variables included in the models used in this thesis were chosen 




Cognitive level is assessed with the Mini Mental Test Exam (MMSE)
209
 or the Abbreviated 
Memory Test (AMT).
210
  MMSE score under 24 or AMT 0-7 are considered cognitive 
impairment. The psychometric properties of the MMSE have been reviewed and its strengths 
and limitations have been discussed.
209
 Items measuring language have been judged to be 
relatively easy but not very useful in identifying mild language deficits. MMSE scores can 
also be affected by age, education, and cultural background. It shows higher levels of 
sensitivity for moderate-to-severe cognitive impairment. Overall reliability and construct 
validity were judged to be satisfactory by the reviewers.
209
   
The AMT performance has also been investigated, showing to be sensitivity and specificity 
of 91% and 75% when scores under eight are used to identify abnormal cognitive function.
210
  
Disability is categorised, according to Barthel Index (BI),
211
 scores of 0-14 are categorised as 
severe disability, 15-19 moderate disability, and 20 independent. While the sensitivity to 
change of the BI has been reported to be limited in severe disability (ceiling effect), evidence 
still suggests that it is a valid measure of activities of daily living. The BI was chosen for the 
analyses conducted in this thesis, after observing its strengths and weaknesses, as it is widely 
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used in clinical settings and in up to 40% of stroke trials. It also has excellent test-re-test 




A medical history of hypertension, myocardial infarction, diabetes mellitus, atrial fibrillation, 
disability (BI), past medical history of depression or pharmacological treatment at the time of 
the stroke is identified through hospital and primary care records. When considering the use 
of these variables for this thesis it was acknowledged that past medical history may not 
always be accurately or systematically recorded in medical notes. However, most of the data 
of past medical history used in this thesis is relevant for the management of stroke, and this 
probably improve its completeness and accuracy in medical records.  
Validated questions are used to assess smoking and alcohol use. Patients are categorised as 
current smoker, ex-smoker or never smoker. If applicable, the time they have been smokers 
for, and the amount of tobacco smoked per day, are also recorded. Data on alcohol use is 
collected as number of units consumed in an average week. Alcohol intake and smoking habit 
were included in the analyses presented in this thesis. However, it was noted that data on 




3.9.4 Classification of stroke subtypes 
The stroke subtype is categorised as infarct, primary intracranial haemorrhage, subarachnoid 





3.10 FOLLOW-UP ASSESSMENT 
Stroke patients registered in the SLSR are followed up at three months after their stroke, at 
one year, and annually thereafter. Follow-up is by postal questionnaire, or interview with the 
patient and/or carer, depending on the capacity of patient to respond to the questionnaire. 
Such capacity is judged by the patient, the next of kin, or the field worker in a previous 
follow-up assessment. Patients unable to complete the follow-up questionnaire, and those not 
returning them by post, are telephoned to arrange face to face interviews, or have another 
follow-up questionnaire posted. Proxy assessments by carers are conducted mainly for the 
objective portion of these assessments. The follow-up questionnaires are standardised into an 
easy to read format to enable patients to fill in the questionnaire themselves and all the forms 
for each time point are identical so that longitudinal comparisons can be made. While the 
repeated annual measure of the same items in the long term is a strength of the SLSR data, it 
is acknowledged that some variables may not be stable over time and the assessments one 
year apart may not fully reflect all the real changes that are actually happening. Patients who 
cannot be assessed at one time point, remain registered and are contacted again for 
subsequent follow-up assessments. A sample form used to collect data at follow-up is 
presented in appendix three.  
At follow-up patients are assessed for depression and anxiety, using the Hospital Anxiety and 
Depression scale (HAD).
214
 HAD was first presented in 1983 by AS Zigmond and RP Snaith 
as a tool to identify possible cases of depression and anxiety among patients in non-
psychiatric hospital clinics. It was conceived as a brief practical tool for physicians and 
surgeons, who are usually aware of the emotional components of their patients’ illnesses but, 
have little time to deal with them. It is therefore a short scale and it is limited to the two 
mental health problems that Zigmond and Snaith considered to be the most common in non 
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psychiatric hospital practice: anxiety and depression.
214
 It has two questionnaires, one for 
anxiety and another one for depression. The seven items composing the depression subscale 
were largely based on the anhedonic state since the authors of the scale considered that this 
provided the most useful information for the clinician. The seven items composing the 
anxiety subscale were chosen from previous research from the authors into the psychic 
manifestations of anxiety.
215
 Items in both scales exclude symptoms which might equally 
arise from somatic as from mental disease such as insomnia, anergia, fatigue and pessimism 
about the future.  While the deletion of somatic items from the questionnaires may avoid 
overdiagnosing depression in the medical setting, this practice risks underdiagnosing patients 
who present mostly with somatic symptoms.
19 20
 Symptoms relating to severe mental disorder 
(such as suicidal preoccupation or phobic limitation) were also excluded; although such 
symptoms are common in patients attending psychiatric clinics they were considered by 
Zigmond and Snaith to be less common in patients attending other hospital clinics and 
therefore less likely to be useful.
214
 
The degree of psychological distress is continuously distributed in the population
19 20
 
therefore questions related to “how much?” were considered by the developers or the scale to 
be more relevant than those related to “is it present?” Scales related to mood disorders make a 
better reflection of the reality if they are presented in terms of score ranges. The HAD scale is 
presented with these score ranges in both subscales. Each item on the questionnaire is scored 
from cero to three and this means that a person can score between zero and 21 for either 
anxiety or depression. Two of the seven questions on the HAD depression subscale “I feel as 
if I am slowed down” and “I have lost interest in my appearance” present negative effects of 
depression while the other five present statements such as “I feel cheerful” which the patient 
with depression has to score negatively. The scale is brief and well accepted by patients. It 




easiness makes of HAD an ideal instrument to be used in large clinical epidemiological 
studies. 
The designs of the HAD scale attempts to overcome response bias in the scale by alternating 
the order of responses. Therefore, to one item the first response indicates maximum severity 
and to another item the first response indicates minimum severity. The choice of four 
responses to each item was adopted in order to prevent the patient from opting for a middle 
grade to all the items.
214
 The use of HAD may still introduce some response bias since the 
non-responders, the intellectually impaired, the socially or educationally disadvantaged, the 
uncooperative may be those whose psychological problems may be more in need of 
detection.  
Since the HAD scale was published it has been used many times in studies assessing 
depression and anxiety amongst patients with a great variety of non-psychiatric conditions. In 
2007 it was reported to be the third most commonly used self-administered screening 
instrument.
217
 The first assessment of the HAD’s validity was carried out by its developers, 
who reported for the depression subscale 1% false positives and 1% false negatives.
214
 A 
systematic review of the properties of HAD published in 2002 reported optimum 
performance of the scale when scores above seven were used to identify anxiety and 
depression (Cronbach's alpha> 0.80; sensitivity and specificity ranging from 0.70 to 0.90).
218
 
The positive and negative predictive value of HAD when assessing stroke patients for 
depression, with cut-off point of seven, have been reported to be 0.61 and 0.90 
respectively.
219
 Finally, a more recent systematic review on HAD’s validity was published in 
2010. Twenty five studies, published between 1988 and 2005 were included. In 15 on those 
HAD had been compared with the DSM diagnostic criteria. The other ten studies compared 
HAD with other scales including the Primary Care Evaluation of Mental Disorders and the 
Geriatric Mental State interview. The conclusions of this review supported the use of cut-off 
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point of seven to identify depression and reported a sensitivity of 0.82, specificity of 0.74, 
positive likelihood ratio 3.17 (2.09-4.08) and negative likelihood ratio 0.24 (0.17-0.34).
217
  
The two factor structure of HAD has been debated.
220
 The results of one systematic review 
support the two-factor structure of HAD. In most studies, where empirically based 
exploratory factor analyses were used, HAD revealed two relatively independent dimensions 
of anxiety and depression closely identical to the anxiety and depression subscales.
218
 
Another review reported that there is sufficient evidence that both scales differ in a clinically 
meaningful way. The correlation between HAD(D) and HADS(A) is mostly due to the 
simultaneous presence  of anxiety and depression and to a lesser extent to inadequacies of the 
instrument.
216
 The stability of the results obtained with HAD was considered as some of the 
symptoms of depression may have a short duration. However, HAD(D) has been reported to 




The performance of HAD in the SLSR population was also studied carefully. HAD has been 
validated in stroke patients It shows a good performance both when it is used in a face to face 




 One of the systematic reviews observing the 
properties of HAD also reported that it has the same properties when applied to samples from 
the general population, general practice, and psychiatric patients.
218
  
Another point for discussion is that small changes in the clinical state of patients, when the 
HAD scale is used to define a binary variable, can result in patients being identified as 
depressed or not. As presented above, the cut-off point used in this thesis was reported in 
three systematic reviews to be the one that gives the scale optimum performance.
216-218
 In 
addition, the clinical interpretation of analyses of continues variables is more complex. HAD 
has been validated against criteria from the Diagnostic and Statistical Manual of Mental 
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Disorders, that also gives a binary classification of patients.
217 222
 In clinical medicine many 
health problems are routinely identified by scores above a cut-off point of a specific variable. 
E.g.:  Hypertension or diabetes when blood pressure, or fasting glucose, are above a certain 
threshold. 
In summary, it was accepted that HAD does not provide results as accurate as the clinical 
assessment of depression. However, after reading all the reviews on its performance and 
considering its strengths and weaknesses,  HAD was judged to be an appropriate tool to make 





HAD was routinely collected between 1997 and 2010. Patients registered in 1995 (n=299) 
and 1996 (n=350) didn’t have their first HAD assessment until 1997. Data on HAD was 
therefore not included from these patients in the respective estimates for early rates of anxiety 
and depression. Despite its good performance HAD is not a diagnostic scale but a tool that 
indicates risk of depression. Some authors would argue that HAD only measures risk of 
depression or symptoms of depression. However, the term “depression” will be used in this 
thesis for succinctness in patients with scores above seven. HAD cannot be answered by 
proxy so all information was collected directly from patients. Although patients with some 
degree of cognitive or communication impairment can respond to HAD, no data could be 
collected from patients with severe cognitive or communication impairment that the 
fieldworker, or the patient’s next of kin in case of a postal questionnaire, judged would give 





Depression and Anxiety Scale 
 
Items relating to Depression 
 
1. I feel as if I am slowed down: 
nearly all the time    very often               sometimes             not at all 
 
2. I still enjoy the things I used to: 
definitely as much    not quite as much   only a little            hardly at all 
 
3. I have lost interest in my appearance: 
definitely                                                       I don’t take as much care as I should 
I may not take as much care as I should       I take just as much care as ever 
 
4. I can laugh and see the funny side of things: 
as much as I always could                             definitely not so much now 
not quite so much now                                  not at all 
 
5. I look forward with enjoyment to things: 
as much as I ever did                                     definitely less than I used to 
rather less than I used to                                hardly at all 
 
6. I feel cheerful: 
not at all                   not often             sometimes              most of the time 
 
7. I can enjoy a good book or radio or TV programme: 
often                        sometimes           not often                 very seldom 
 
 
Items relating to Anxiety  
 
1. I feel tense or 'wound up': 
most of the time      a lot of the time       occasionally           not at all 
 
2. I get a sort of frightened feeling like butterflies in my stomach: 
not at all                    occasionally           quite often            very often 
 
3. I get a sort of frightened feeling as if something awful is about to happen: 
very definitely and quite badly                     yes, but not too badly 
a little, but it doesn't worry me                     not at all 
 
4. Worrying thoughts go through my mind: 
a great deal of the time  a lot of the time   from time to time      only occasionally 
 
5. I feel restless as if I have to be on the move: 
very much indeed         quite a lot             not very much           not at all 
 
6. I get sudden feelings of panic: 
very often indeed           quite often           not very often           not at all 
 
7. I can sit at ease and feel relaxed: 
definitely                       usually                 not often                    not at all 
 




Other outcomes assessed at follow-up include the following ones: 
- Residential status, categorised as living alone, with someone or in an institution. 
- Employment categorised as paid work full time or part time, unable to work due to 
disability, retired and others. 
- Cognitive function, measured with the Mini Mental Test Exam (MMSE)
209
 between 1995 
and 2000 and the Abbreviated Memory Test (AMT)
210
 between 2001 and 2009.  
- Disability using the Barthel index (BI).
211
 
- Handicap, using the Frenchay activity index (FAI) Stratified as inactive 0-15, moderate 
inactivity 16-30, or active 31-45.
223
 The metric properties of the FAI have been studied in 
stroke patients. It has been reported that the FAI could be improved by creating two subscale 
scores: domestic and outdoors activities.
223
 Male patients of some cultures may score lower 
than women as some items are about activities traditionally conducted by women. However, 
the reliability of unweighted scores has shown to be high, with a range of Cronbach's alpha-
coefficients, 0.78 to 0.87. The construct validity was supported by meaningful correlations 
between the FAI and scores on the BI and Sickness Impact Profile. Principal-components 
analysis indicated that the FAI showed two traits: instrumental disability and some aspects of 
handicap. Completion of the questionnaire was noted to be easy, taking only a few minutes. 




- Social networks are also assessed. Physical illness commonly increases patient’s needs for 
support of various kinds.
20
 Illness may also interfere the individual’s capacity to acquire and 
maintain social networks.
19 20
  One indication of the possible social origin of depression in 
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stroke survivors is the high correlations between their depression and that of their carers.
24
 
However, there has been more agreement in literature regarding what is social support and its 
potential association with health outcomes than regarding its measurement.
19 20
 Social support 
was measured by the SLSR by asking questions: Do you see as much of your relatives as you 
would like? (Yes/No or don’t have any). Do you see as much of your friends as you would 
like? (Yes/No or don’t have any). These questions regarding social isolation that were 
included in the SLSR follow-up assessments have not been validated. Since they ask about 
contact with relatives and friends they have a quantitative component aiming to see if these 
relationships exist. However, from the way the questions are phrased (… as much as you 
would like?), they also ask about the quality of these relationships. Therefore, they cover the 
quantitative and qualitative elements of social support that have been considered to be 
relevant among patients with physical conditions at risk of depression.
19 20
  Social isolation is 
currently a matter of research, approached both in observational and interventional studies, as 
it has strong association with health outcomes.
224 225
 Ideally, validated measures of social 
isolation should be used that allow generalisation and an adequate interpretation of results. 
- Quality of life (QoL) was assessed with the SF-36
226
 between 1995 and the 29
th
 of February 
1999 and SF-12
227  between the 1st of March 1999 and 31st August 2010. Two domains of 
QoL were observed mental domain and physical domain. Scores collated from the scales 
ranged from 0 to 100 with high score representing better QoL.
226 227
 The properties of both 
scales have been reviewed. One study concluded that the SF-36 seems acceptable to patients, 
internally consistent, and a valid measure of the health status of a wide range of patients.
228
 
Test-re-test reliability of both scales is over 70%. Empirical evidence and factor analysis also 





Data on deaths is collected by the SLSR follow-up team or from the Office of National 
Statistics (ONS). Finally Death certificates from the Health Authority serving the SLSR 
population and post-mortem records from the local coroner’s office are also searched every 
three months. 
The same overlapping sources used by the SLSR to identify first ever strokes are used to 
identify recurrent strokes. 
3.11 ETHICAL APPROVAL OF THE SLSR 
The ethics committees of Guy’s and St Thomas’ Hospital NHS Foundation Trust, King’s 
College Hospital Foundation, National Hospital for Nervous Diseases, Queen’s Square 
Hospital, St George’s Hospital and Westminster Hospital approved the study. 
Before being registered patients or their relatives gave written informed consent. Sample 
consent and assent forms are presented in appendix 4  
3.12 ADVANTAGES OF THE SLSR   
There are several strengths that make the SLSR an ideal and unique data-set for addressing 
the objectives proposed in this thesis: 
1- The SLSR provides a unique data-set of unbiased community based first-in a life time 
strokes of all subtypes in all ages in a multi-ethnic, inner city population. This was useful 
in accurately quantifying the association between stroke and depression, and the 
association between depression after stroke and other health outcomes. The SLSR 
overcomes the limitations of hospital based studies that do not include patients managed 
exclusively in the community (mostly very severe or very mild cases). 
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2- The SLSR has follow-up data at several time-points, over a 15 years period, which makes 
possible to conduct longitudinal comparisons of stroke outcomes over time.  
3- The SLSR has a wide collection of standardised, widely used stroke outcomes, across the 
domains of impairment, disability, handicap and health related quality of life, all of which 
provided a more holistic outcome of stroke.  
4- The SLSR has all the characteristics essential for an ideal population-based register: 
 a) A clear and concise implementation plan for the register 
b) Adequate documentation on who would manage the register, inclusion and 
exclusion criteria, definition of data sources, collection, editing, and entry procedures, 
protocols for matching to other data sources, data processing procedures, analyses that 
will be routinely conducted, confidentiality guidelines and access procedures. These 
procedures ensure that all staff works to the same objectives, identifying appropriate 
cases and documenting the relevant data. 
 c) “Hot pursuit” of cases to maximise case ascertainment 
d) Effective multiple sources of notification systems to ensure that maximum number 
of cases in the study area are registers 
e) Commitment from registry staff and local data providers including hospital 
consultants and general practitioners 
 f) Efficient methods for data collection and processing procedures 
 g) Adequate procedures to safeguard confidentiality of information in the register 
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h) Quality control procedures to ensure completeness, validity and timelines which 
determine the quality of data. Completeness is the proportion of cases on the target 
population that appear on the register. Validity in the percentage of cases in the 
register with a given characteristic, e.g.: sex or stroke subtype, which truly has this 
attribute. Timeliness may be important in those registers that identify persons needing 
critical and rapid services. The SLSR has principles that are likely to ensure quality 
control including having a manual with explicit quality control procedures and with 
regular audit of these procedures, and senior member providing feedback loop to 
inform data handlers of errors by reviewing each data set before it is entered onto the 
computer and identifying data items that are missing, out of range or inconsistent. 
3.13 LIMITATIONS OF THE SLSR 
There are limitations and practical difficulties with the SLSR that must be acknowledged. 
Limitations specific to the depression assessments are discussed in the following chapters. 
General limitations of the SLSR are presented below: 
1-  Despite the “hot pursuit” of cases and multiple overlapping sources of notification, there 
are some cases that may not have been identified. Cases difficult to identify include those 
who had a strokes while away from the study area, those who had mild stroke and were 
not referred to the register or to any of the hospitals for specialist assessment or 
investigations. 
2- Although the population denominator data derived from census data from the Office for 
National Statistics, population growth, mobility and cross boundary effects are difficult to 
estimate and may influence results derived from the SLSR. 
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3- The estimation of clinical outcomes using scales introduces some limitations. The 
strengths and weaknesses of each specific scale have been discussed in the methods 
section of this chapter. It should be noted that all scales have good performance and they 
allowed assessing a very large number of patients during a long follow-up, which would 
have been unfeasible otherwise. The imperfect measurement of variables introduced by 
the scales is a limitation associated with the epidemiological nature of this study. It is 
accepted that clinical observations are more accurate than epidemiological ones as part of 




4- As expected in a cohort of older people followed for a long time there is a natural attrition 
of the cohort due to mortality during the years. As mortality reduces the number of 
observations the statistical power drops leading to more imprecise estimates at the end of 
the follow-up. Mortality, and its association with depression, is one of the variables of 
interest of the analyses. However most of this research focuses on outcomes that can only 
be present in survivors. In order to correct some statistical analyses in which the power 
was low and the confidence intervals wide, the arcsine correction was used.
230
 This 
method is described in the chapters where it is used. 
 
5- Survival of stroke patients has improved in the recent decades so attrition is higher 
amongst patients registered shortly after the SLSR started in 1995. However, the long 
term estimates come precisely from these groups of patients, as in 2010, when the dataset 
for this thesis was defined, only patients registered before 2000 had been followed up for 
over ten years. Future studies using SLSR datasets may find higher rates of long term 
stroke survivors.  
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6- Any clinical  research involving thousands of patients, followed up for over ten years, 
will invariably have missing data due to various reasons including late registrations, loss 
to follow-up, or refusal by the patient or their carer.  
A great effort was made by the SLSR field work team to minimise the proportion of 
missing data. Measures to obtain maximum completeness included visits to patients with 
disability to help them complete the follow-up questionnaires, consideration of cultural 
background of the patients when arranging the follow-up interviews, reminders on the 
post or over the telephone for patients not filling in follow-up questionnaires, possibility 
of having telephone follow-up interviews, and meetings of the SLSR team with groups of 
patients to discuss their involvement in research.  
The residual missing data was handled in the analysis of natural history using inverse 
probability weighting. In the analysis of predictors missing data was handled using 
multiple imputation. In the analysis of outcomes of depression missing data was handled 
using sensitivity analysis. Although inverse probability weighting and multiple 
imputation are becoming more widely used, they are methods still under development. 








previous studies of depression after stroke approaching missing data with these methods 
were identified in the literature review. Acquiring the skills to apply these methods 
required specific training and in many cases discussions with the statisticians developing 
them. The management of missing data is discussed further in chapters four to six. 
7- It is particularly difficult to obtain complete data-sets from subjects who have language or 
cognitive disorders as a consequence of their stroke. Assessments of these subjects by 
proxy provide some useful information. However, the measurement of the main outcomes 
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of this study, depression, by proxy gives specially limited results as discussed further in 
chapters four to six.  
8- Given the length of the SLSR (currently in its 15th year), one practical difficulty is 
maintaining continuity of data collection at all times. Such difficulties include securing 
funding to maintain appropriate numbers of register staff and adequate overlap during 
changeover of staff. However, a regularly updated manual can circumvent this limitation 
to some extent. 
3.14 CONCLUSION 
The SLSR constitutes a unique dataset from which to estimate the natural history, predictors 
and associated health outcomes of depression in the long term after stroke.  
All the data described and analysed in the thesis have been obtained from the SLSR. Baseline 
data from patients registered between the 1st January 1995 and the 31st December 2009 (N at 
registration=4022), and follow-up data from these patients, collected between the 1st April 
1995 (first 3 months follow-up assessments) and the 31st august 2010, were used.   
3.15 PERSONAL CONTRIBUTION, EXPERIENCE AND PROFESSIONAL 
DEVELOPMENT 
Most of the data for this thesis had been collected previously, between 1995 and 2009. I was 
involved in prospective data collection from 2009 therefore I collected some of the data for 
this thesis while working in the SLSR as a clinical research fellow (2009-2013). During this 
time I gained invaluable experience in research methodology and clinical stroke medicine. I 
personally conducted all the analyses presented in this thesis including the ones regarding 
missing data.  
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All this contributed considerably to my own personal and professional development. Specific 
areas of training and experience included: comprehensive literature searches, study design, 
epidemiology field work, clinical training in acute stroke medicine, advanced statistical 
methods, scientific and academic writing, presentation of my work in national and 

















CHAPTER 4: THE NATURAL HISTORY OF DEPRESSION UP TO 15 
YEARS AFTER STROKE. 
4.1 ABSTRACT 
Background: Evidence on the natural history of depression after stroke is still insufficient to 
inform effective interventions to treat this problem. 
Objective: To estimate the incidence, prevalence, cumulative incidence, time of onset, 
duration, and recurrence rate of depression up to 15 years after stroke. 
Methods: Data from patients registered in the South London Stroke Register between 1995 
and 2009 were used (n at registration=4022). Depression was assessed in all patients with the 
Hospital Anxiety and depression scale (scores>7 =depression) three months after stroke, one 
year after stroke and annually thereafter up to 15 years after stroke. Inverse probability 
weighting was used to calculate the estimates accounting for missing data. Weighted and 
crude estimates are presented. 
Results: The prevalence of depression was around 30% and remained stable in the 15 years 
following a stroke, with incidence ranging from 7 to 21% and cumulative incidence of 55%. 
Most episodes of depression started shortly after stroke, with 33% of them starting in the 
three months following a stroke and no new episodes from year ten onwards. 50% of the 
patients with depression at three months had recovered one year after stroke. The majority of 
the patients presenting depression in the long term had had episodes of the depression shortly 
after stroke.  
Conclusion: Depression affects more than half of the stroke patients with episodes starting 
shortly after stroke, having a short duration and a high recurrence rate, leaving the overall 
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prevalence stable. This makes the natural history of depression after stroke very dynamic. 
The evidence provided in this chapter may be considered in the design of interventions. 
 
The description of the natural history of depression up to 15 years after stroke was presented 
as an oral presentation in the 2011 European Stroke Conference and has been published as an 

















The literature review presented in chapter two showed that depression after stroke has been 
investigated in numerous studies across the world. However, most of the studies had short 
follow-up and small sample size, with patients being assessed for depression only once. The 
prevalence of depression shortly after stroke was the estimate more frequently reported. 
Other estimates of natural history of depression after stroke, such as the incidence, 
cumulative incidence, the time after stroke of depression onset, the duration of depression, 
and the recurrence rates were reported by a very  little number of studies or not reported at 
all.  
Although the available studies of depression after stroke provide valuable evidence, it is still 
insufficient to understand the nature of the problem. With the available evidence it is not 
possible to develop effective interventions for depression after stroke. A Cochrane systematic 
review reported the limited effect of interventions to treat depression after stroke.
79
 Authors 
of the review questioned whether interventions had been started at the right time after stroke, 
and whether they had been given for an adequate length of time to obtain maximal sustained 
response.  
This chapter aims to provide evidence on the natural history of depression after stroke, in the 
areas where there is insufficient or it is lacking. The following questions are addressed:  
- What is the prevalence of depression up to 15 years after stroke? 
- What is the incidence of depression up to 15 years after stroke? 
- What is the cumulative incidence of depression up to 15 years after stroke? 
- When after stroke do patients become depressed? 
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- How long do episodes of depression last? 
            - What proportion of patients has recurrent depression? 
With the evidence reported in this chapter clinicians patients and carers will have a better 
understanding of the risk and the possible course of depression after stroke. It will also be 
possible to observe how different is the natural history of depression after stroke from the 
observed in studies of depression in general population. This will lead to a better 
understanding of depression in general.  
A description of the long term natural history of depression after stroke will help in the 
optimisation of available interventions. It will be possible to know when should the 
interventions be delivered and for how long. Depression after stroke has been mostly 
described a few months after the acute event allowing for interventions to be developed 
during the acute phase of stroke. During this phase hospital clinicians lead the delivery of 
interventions leaving general practitioners a secondary role. However, it is plausible that 
depression may affect patients in the long term. The description of the natural history of 
depression after stroke might help to inform interventions long time after stroke that may also 
need the involvement of primary care clinicians and other community workers.   
4.3 METHODS 
Data analysed in this chapter have been obtained from the SLSR. Baseline data from patients 
registered between 1st January 1995 and 31st December 2009 (N at registration=4022), and 
follow-up data from these patients, collected between the 1st April 1995 (first 3 months 
follow-up assessments) and the 31st August 2010, were used.  The methodology of the SLSR 
has been described in chapter three and is summarised below.  
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First-in-a-lifetime stroke patients, living in a defined area of South London were registered. 
Sociodemographic data collected at baseline included age, gender, and ethnicity. Stroke 
severity measures data collected at baseline included Glasgow coma scale score, categorized 
as severe (3–8), moderate (9–12), and mild (13–15) levels of impairment, urinary 
incontinence, and paresis. Activities of daily living were assessed seven days after stroke 
using the Barthel Index. Patients were followed up three months after stroke, one year after 
stroke and annually thereafter. At follow-up, patients were assessed for depression using the 
Hospital Anxiety and Depression (HAD) scale. Scores >7 were classified as depression. 
HAD scores were routinely collected between 1997 and 2006. Patients registered in 1995 
(n=300) and 1996 (n=349) did not have their first HAD scale assessment until 1997. Data on 
HAD scale therefore were not included from these patients in the respective estimates for 
early rates of depression. HAD scale cannot be answered by proxy, so all information was 
collected directly from patients. Although patients with some degree of cognitive or 
communication impairment can respond to the HAD scale, no data could be collected from 
patients with severe cognitive or communication impairment that the fieldworker judged 
would give invalid responses. 
Estimates and confidence intervals of prevalence, incidence, cumulative incidence, time of 
onset, duration and recurrence of depression from three months to 15 years after stroke were 
calculated.  
4.3.1 Prevalence 
Prevalence of depression was defined as the proportion of patients found to be depressed at 
each follow-up assessment, from three months to 15 years after stroke. 
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The prevalence of depression was calculated amongst survivors assessed at each time point. 
The numerator of the proportion would be patients who have depression at each time point 
and the denominator all patients assessed at each time point of the 15 years of follow-up.  
For example the prevalence in year two would be the proportion of patients with depression 
expressed as a percentage of all patients assessed in year two. 
4.3.2 Incidence 
Incidence of depression from one to 15 years after stroke was defined as the proportion of 
patients not depressed in each follow-up assessment found to be depressed in the subsequent 
one. 
 The incidence of depression was calculated amongst patients not depressed at each 
assessment, who survive and where assessed in the subsequent follow-up.  
For example incidence in year five would be the proportion of patients not depressed in year 
four becoming depressed in year five expressed as a percentage of all patients not depressed 
in year four surviving and being assessed in year five. 
Incidence of depression three months after stroke was not calculated as there were no 
depression assessments before that point, therefore at three months incident and not incident 
cases were indistinguishable.  
4.3.3 Cumulative incidence 
Cumulative incidence of depression after stroke was defined as the proportion of patients 
found to be depressed at any of the assessments during the 15 years of follow-up.  
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The cumulative incidence of depression was calculated amongst patients assessed for 
depression at any time point.   
The proportion of patients depressed at any of the assessments over 15 years was calculated 
and expressed as a percentage of all assessed patients during that time. 
4.3.4 Time of onset of depression after stroke 
The proportion of patients who become depressed for the first time at each assessment 
between three months and 15 years after stroke was calculated amongst patients with 
complete follow-up until each time point. The numerator of the proportion would be patients 
with complete follow-up becoming depressed for the first time at each time point and the 
denominator would be all patents with complete follow-up until each time point. 
For example the proportion of patients with onset of depression at year three would be 
patients with complete follow-up until year three becoming depressed for the first time in 
year three expressed as a percentage of all patients with complete follow-up until year three.  
4.3.5 Duration of episodes of depression after stroke 
Two different calculations were undertaken: 
First, the number of subsequent episodes of depression, throughout the follow-up time, was 
observed. A categorical variable was defined to assess the number of episodes of depression. 
Duration of depression could only be calculated amongst episodes that had complete data 
from onset to recovery. For example episodes lasting three years were those in which the 
patient was not depressed in one assessment, then depressed in three consecutive assessments 
and then not depressed in the last one. 
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Episodes with long duration required continuous follow-up for longer period than short 
episodes. Therefore, episodes with long duration were much more likely to have missing data 
and it could be misleading to present this category as a proportion.  Therefore only absolute 
numbers are presented. 
Second, as a large proportion of patients have their first symptoms of depression three 
months after stroke, the number of subsequent episodes of depression starting at three months 
was observed until patient recovered (was found not to be depressed). The proportion of 
patients depressed at three months who recover at each time point was calculated amongst 
patients with complete follow-up until each time point. For example patients depressed at 
three months recovering at year five would be patients with depression at three months who 
have a complete follow-up to year five, who reported to have recovered in year five, 
expressed as a percentage of all patients with depression at three months and complete 
follow-up until year five.  
4.3.6 Recurrence of depression after stroke 
Recurrence of depression was defined as a new case of depression in a patient who had been 
depressed at a previous assessment. 
The proportion of recurrences was calculated amongst patients who had three or more follow-
up assessments. The proportion of incident cases in which a previous episode of depression 
had been reported was calculated. 
For example, the proportion of recurrent cases in year seven is calculated as incident cases in 
year seven with a previous episode of depression expressed as a percentage of all incident 




4.3.7 Missing data management 
Sociodemographic and clinical characteristics of survivors completing and not completing 
HAD were compared using chi-squared test, as these variables were categorical.  
As a first step all estimates of prevalence, incidence, cumulative incidence, time of onset, 
duration and recurrence of depression were obtained only from patients with complete data, 
that is complete case (CC) analysis. This analysis is based on the assumption that missing 
data were missing completely at random (MCAR). With MCAR it is assumed that the 
distribution of depression would be the same for subjects who were followed up or lost to 
follow-up. The probability of an observation being missing does not depend on observed or 
unobserved measurements and individuals with complete data are assumed to represent a 
random sample of the population of individuals, with the similar distribution of covariates.
231 
235
 Under MCAR, the analysis of only those patients with complete data is assumed to give 
valid results.  
However, this assumption may not always be appropriate. Estimates obtained from CC 
analysis may be biased if the excluded individuals are systematically different from those 
included.
231
 Therefore, in a second step the assumption that missing data were not MCAR but 
missing at random (MAR) was considered. MAR is a term used in longitudinal data analysis 
meaning that all individuals are not equally likely to be observed. The probability of being 
observed depends only on other observed variables.
232
 For example the probability of having 
complete data in year three of the follow-up depends on the stroke severity recorded at 
baseline. 
A third possibility is to assume that missing data may be missing not at random (MNAR). 
This is the case when the probability of being observed depends on unobserved variables. For 
example the probability of having complete data in year three depends on the unobserved 
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disability in year three. However, the statistical methods needed to handle missing data under 
the MNAR assumption are computationally intensive and not routinely included in statistical 
software so they are not commonly applied.
232
 The MAR assumption was considered the 
most appropriate one to handle missing data in this thesis. 
 Several methods are available to handle missing data using the MAR assumption. Inverse 
probability weighting (IPW) and Multiple Imputation (MI) were the two methods initially 
considered for these analyses. Both methods require modelling the possibility of the data 
being complete. MI is generally a more complex method. It is more difficult to build a model 
that explains the variability of completeness with MI than with IPW.
231
 Therefore IPW was 
chosen. Using IPW cases are weighted by the inverse of their probability of being a complete 
case. To weight the probability of being complete a variable of completeness was created for 
each estimate. For example, prevalence of depression at three months 1=observed, 
0=missing. A logistic regression model was built to identify predictors of completeness. 
Variables included in the models were those considered to be associated with completeness: 
age, sex, ethnicity, stroke severity measures (GCS, incontinence and paresis) and disability at 
baseline. Only variables collected at baseline were introduced in these models. The inverse of 
the probability of being a complete case was calculated and applied to individuals with 
available data. The predicted probability for each participant represents the probability for 
participants with similar characteristics of responding to the HAD questionnaire. For 
example, a predicted probability of response for a patient of 0.5 suggests that there will be an 
identical participants who will not respond. The participant who responds will be given a 
weight of 2, (1 divided by 0.5) to represent themselves as well as an identical hypothetical 
participant that didn’t respond. Finally estimates were calculated on weighted data. Un-
weighted and weighted estimates are presented. 
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IPW was not used to estimate rate of recurrences as the number of patients available each 




Some estimates, particularly those obtained with small number of patients towards the end of 
the follow-up, had confidence intervals with values over one or under cero. In these cases the 
arcsine correction was used.
230
 When this correction was used IPW was not possible, 
therefore only crude estimates were reported. 
4.4 RESULTS  
Between 1995 and 2009 the SLSR registered 4,022 patients. When the follow-up period 
finished in August 2010, the follow-up time for survivors ranged from three months to 15 
years. The number of patients registered in each period, assessed for depression or lost to 
follow-up, at each time point, is presented in figure 4.1. Sociodemographic description of the 
cohort at each follow-up is presented in table 4.1. There were little differences between 
sociodemographic characteristics of patients who were and those who were not assessed for 
depression (Table 4.2). Up to ten years after stroke those who had had more sever strokes 









Follow-up time                                                                                                         Registration per iod  
since stroke 
 
3 months                                        1995-2009 N=4022 
 
1 year                                                                                                                       1995-2009 N=3957 
 
2 year                                                                                                                        1995-2008 N=3740 
 
3 year                                        1995-2007 N=3524 
 
4 year           1995-2006 N=3287 
 
5 year           1995-2005 N=3065    
 
6 year          1995-2004 N=2807      
 
7 year                                                                                                                         1995-2003 N=2562 
 
8 year                                                                                                                        1995-2002 N=2288 
 
9 year                                                                                                                         1995-2001N=2018 
 
10 year                                                                                                                       1995-2000 N=1726 
 
11 year                                                                                                                       1995-1999 N=1502 
 
12 year                                                                                                                       1995-1998 N=1193 
 
13 year                                                                                                                       1995-1997 N=863 
 
14 year                                                                                                                       1995-1996 N=542 
 
15 year                                                                                                                      1995-1996 N=204 
 
Figure 4.1 Number of participants included in the analysis at each follow-up time point 
N= number of patients registered.  
HAD=number of patients completing the depression scale.  




Dead <4y=1695      LTF=498    FU=1094      HAD=890 
Dead <5y=1728       LTF=517     FU=820      HAD=658 
Dead <6y=1702       LTF=395     FU=710      HAD=600 
Dead<1y=1541    LTF=558    FU=1858    HAD=1233
c
 
Dead<2y=1523      LTF=954     FU=1263      HAD=901 
Dead<3y =1652     LTF=556     FU=1316     HAD=1100 
Dead <8y=1563 LTF=251      FU=474 HAD=392
Dead <7y=1664       LTF=330     FU=568       HAD=475  
Dead <9y= 1451 LTF=211      FU=356 HAD=296
Dead <10y=1297 LTF=167    FU=262 HAD=234
Dead <11y=1165 LTF=134    FU=203 HAD=183
Dead <12y=966        LTF=99      FU=128       HAD=116 
Dead <13y=704       LTF=63        FU=96        HAD=72 
Dead <14y=451       LTF=40         FU=51        HAD=46 
Dead<15y =172        LTF=16        FU=16        HAD=16 
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FU= Number of patients followed up at each time point.  
LTF=Number of patients lost to follow-up at each time point.  
a- Some patients who were followed up could not be assessed with HAD due to cognitive or 
communication impairment. 
b- The 649 patients registered in 1995 and 1996 were not assessed for depression at this point 
as HAD was routinely collected from 1997.   
c- The 299 patients registered in 1995 were not assessed for depression at this time point as 





















Age n(%) Gender n(%) Ethnicity n(%) 
<65 >64 Male Female White Black Other Unknown 
3m 393(35.7) 708(64.3) 595(54.0) 506(46.0) 773(70.2) 247(22.4) 67(6.1) 14(1.3) 
1y 481(39.0) 752(61.0) 683(55.4) 550(44.6) 865(70.1) 276(22.4) 76(6.2) 16(1.3) 
2y 367(40.7) 534(59.3) 496(55.0) 405(44.9) 594(65.9) 233(25.9) 64(7.1) 10(1.1) 
3y 469(42.6) 631(57.4) 631(57.4) 469(42.6) 765(69.5) 254(23.1) 66(6.0) 15(1.4) 
4y 409(46.0) 481(54.0) 484(54.4) 406(45.6) 602(67.6) 217(24.4) 59(6.6) 12(1.3) 
5y 330(50.1) 328(49.8) 384(58.4) 274(41.6) 444(67.5) 155(23.6) 51(7.7) 8(1.2) 
6y 296(49.3) 304(50.7) 337(56.2) 263(43.8) 412(68.7) 144(24.0) 39(6.5) 5(0.8) 
7y 241(50.7) 234(49.3) 273(57.5) 202(42.5) 323(68.0) 118(24.8) 28(5.9) 6(1.3) 
8y 219(55.9) 173(44.1) 240(61.2) 152(38.8) 249(63.5) 114(29.1) 25(6.4) 4(1.0) 
9y 18161.1) 115(38.8) 174(58.8) 122(41.2) 199(67.2) 75(25.3) 19(6.4) 3(1.0) 
10y 146(62.4) 88(37.6) 137(58.5) 97(41.4) 159(67.9) 58(24.8) 17(7.3) (0) 
11y 101(55.2) 82(44.8) 112(61.2) 71(38.8) 126(68.8) 43(23.5) 12(6.6) 2(1.1) 
12y 70(60.3) 46(39.7) 74(63.8) 42(36.2) 82(70.7) 26(22.4) 8(6.9) (0) 
13y 48(66.7) 24(33.3) 46(63.9) 26(36.1) 49(68.1) 20(27.8) 3(4.2) (0) 
14y 29(63.0) 17(37.0) 28(60.9) 18(39.1) 30(65.2) 14(30.4) 1(2.2) 1(2.2) 
15y 4(80.0) 7(43.7) 7(43.7) 9(56.2) 10(62.5) 4(25.0) 1(6.2) 1(6.2) 
Table 4.1 Sociodemographic characteristics of the survivors assessed at each time point 



















 HAD completed / HAD not completed d 
 Age>65(%) Female gender (%) White ethnicity (%) Black ethnicity (%) 
3m 64.3/64.9 46.0/47.4 71.1/70.1 22.7/23.2 
1y 61.0/65.3* 44.6/46.2 71.1/68.3 22.7/24.8 
2y 59.3/59.5 44.9/44.1 66.7/69.3 26.1/24.0 
3y 57.4/55.6 42.6/45.2 70.5/62.8**  23.4/27.7**
 
 
4y 54.0/55.4 45.6/40.7 68.6/62.6* 24.7/28.2* 
5y 49.8/55.3* 41.6/43.8 68.3/64.5 23.8/27.3 
6y 50.7/50.7 43.8/42.4 69.2/61.5* 24.2/29.4* 
7y 49.3/48.2 42.5/40.7 68.9/59.9* 25.2/31.7* 
8y 44.1/47.2 38.8/44.2 64.2/63.8 29.4/28.0 
9y 38.8/46.9 41.2/39.8 67.9/60.3 25.6/30.7 
10y 37.6/44.4 41.4/41.8 67.9/58.1 24.8/33.5 
11y 44.8/35.7 38.8/42.2 69.6/61.4 23.8/30.7 
12y 39.7/35.1 36.2/43.2 70.7/56.0* 22.4/38.5* 
13y 33.3/40.2 36.1/44.8 68.1/61.2 27.8/30.6 
14y 37.0/39.1 39.1/37.0 66.7/63.0 31.1/30.4 
15y 43.7/50 56.2/25.0 66.7/56.2 26.7/37.5 
 
Table 4.2 Comparison of sociodemographic characteristics of the survivors assessed, 
and not assessed, with the HAD at each time point 
d- Survivors who did not complete the HAD were either lost to follow-up or unable complete 



















Barthel Index=20 (%) 
3m 90.0/84.3 ** 26.7/36.0 ** 73.2/75.1 32.5/29.1 ** 
1y 90.7/84.1 ** 25.0/34.8 ** 69.8/77.7 ** 37.8/26.3 ** 
2y 89.5/86.8 * 22.8/31.4 ** 69.3/75.5 * 41.2/28.7 ** 
3y 88.7/86.5 24.7/31.8 ** 71.0/74.0 37.0/32.7 * 
4y 90.6/86.3 
*
 23.4/30.9 ** 69.2/74.6 * 40.6/33.7 ** 
5y 89.7/88.4 21.3/28.7 ** 66.9/74.6 ** 41.9/36.9 
6y 90.6/85.8 18.1/30.7 ** 67.8/74.3 * 44.4/34.3 ** 
7y 90.2/86.1 20.0/27.4 * 66.1/74.4 ** 43.1/36.3 
8y 90.1/85.7 20.0/27.2 *  67.1/71.7 42.1/38.0 
9y 89.4/87.1 17.0/28.8 ** 66.4/72.4 46.4/32.4 ** 
10y 87.9/87.8 19.8/27.8 66.5/72.6 44.3/32.9 * 
11y 88.9/85.2 20.2/32.4 * 66.3/70.7 41.0/28.2 
12y 85.1/86.2 25.7/28.7 72.2/71.8 38.2/29.9 
13y 81.7/88.4 29.6/28.2 81.9/74.4 25.7/35.8 
14y 87.0/91.3 26.1/21.7 82.6/80.4 31.8/35.6 
15y 93.7/93.7 18.7/25.0 81.2/81.2 40.0/56.2 
 
Table 4.3 Comparison of the stroke clinical characteristics of survivors assessed, and 
not assessed, with HAD at each time point 
d- Survivors who did not complete the HAD were either lost to follow-up or unable complete 







4.4.1 What is the prevalence of depression up to 15 years after stroke? 
The prevalence of depression was stable at around 30% throughout the follow-up period. 
Weighted and crude estimates were very similar, with overlapping confidence intervals at all 
time points.  Crude and weighted estimates of prevalence of depression up to 15 years after 
stroke are presented in table 4.4. Figure 4.2 shows graphic representation of crude estimates 
and confidence intervals. 
 
Follow-up Patients assessed Patients 
depressed 
Prevalence  (95%CI) Weighted prevalence 
(95%CI) 
3months 1101 361 32.8 (30.0-35.6) 33.2 (30.0-36.4) 
1 year 1233 357 28.9 (26.4-31.5) 30.6 (27.7-33.5) 
2 year 901 266 29.5 (26.5-32.5) 30.7 (27.4-34.0) 
3 year 1100 340 30.9 (28.2-33.6) 31.6 (28.7-34.5) 
4 year 890 268 30.1 (27.1-33.1) 31.0 (27.8-34.2) 
5 year 658 194 29.5 (26.0-33.0) 30.4 (26.7-34.1) 
6 year 600 179 29.8 (26.2-33.5) 29.5 (25.6-33.4) 
7 year 475 151 31.8 (27.6-36.0) 32.1 (27.6-36.5) 
8 year 392 113 28.8 (24.3-33.3) 29.8 (25.0-34.6) 
9 year 296 106 35.8 (30.3-41.3) 37.6 (31.7-43.4) 
10 year 234 81 34.6 (28.5-40.1) 34.4 (28.0-40.7) 
11 year 183 54 29.5 (22.8-36.2) 30.5 (23.5-37.6) 
12 year 116 37 31.9 (23.3-40.5) 31.5 (22.6-40.5) 
13 year 72 28 38.9 (27.3-50.4) 35.9 (24.0-47.9) 
14 year 46 14 30.4 (16.6-44.2) 34.4 (18.5-50.3) 
15 year 16 5 31.2 (5.7-56.8) 32.3 (2.2-62.4) 





Figure 4.2 Prevalence of depression up to 15 years after stroke 
4.4.2  What is the incidence of depression up to 15 years after stroke? 
Crude estimates showed that between 7 and 21% of patients become depressed each year 
during the 15 years follow-up. Weighted estimates were very consistent with crude estimates. 
Crude and weighted estimates of incidence of depression up to 15 years after stroke are 
















          1                    3                          6                            9                          12                     15                                  
110 
 
Follow-up Patient at risk 
at the beginning 
of each year 
Patients becoming 
depressed 
Incidence (95%CI) Weighted 
Incidence (95%CI) 
1 year 518 85 16.4 (13.2-19.6) 17.8 (14.0-21.6) 
2 year 488 93 19.1 (15.6-22.6) 20.5 (16.6-24.5) 
3 year 423 69 16.3 (12.8-19.8) 16.9 (13.0-20.8) 
4 year 498 85 17.1 (13.7-20.4) 17.5 (13.7-21.2) 
5 year 356 58 16.3 (12.4-20.1) 18.5 (13.8-23.1) 
6 year 281 42 14.9 (10.7-19.1) 14.11 (9.5-18.7) 
7 year 268 52 19.4 (14.6-24.2) 22.3 (16.1-28.6) 
8 year 205 27 13.2 (8.5-17.8) 15.2 (9.4-21.1) 
9 year 159 27 17.0 (11.1-22.9) 17.9 (11.0-24.9) 
10 year 113 22 19.5 (12.0-26.9) 21.6 (11.9-31.2) 
11 year 94 15 15.9 (8.4-23.5) NR 
h
 
12 year 66 12 18.2 (8.6-27.7) NR 
h
 
13 year 43 9 20.9 (8.3-33.6) NR 
h
 










Table 4.5 Incidence of depression up to 15 years after stroke  
NR: Not reported 
g- Proportions calculated using “arcsine” correction 
h- Weights over 25 were considered too high. 
i- Estimate not reported as the arcsine correction cannot be used and weighted estimates 
included CIs with values over 1 or under 0.  
Note: since patients who were lost to follow-up one year remained registered and were 
contacted again the following year, the number of patients at risk may be higher than the 




Figure 4.3 Incidence of depression up to 15 years after stroke 
4.4.3 What is the cumulative incidence of depression up to 15 years after stroke? 
Crude and weighted estimates of cumulative incidence show that over half of the patients 
have depression at some point within 15 years of stroke. (Table 4.6) 
Patients assessed for 
depression 
Patients depressed at 
any time point 
Cumulative incidence Weighted cumulative 
incidence 
2183 1210 55.4 (53.3-57.5) 58.2 (52.9-60.5) 
Table 4.6 Cumulative incidence of depression up to 15 years after stroke.  
4.4.4 When is the onset of depression after stroke? 
The proportion of patients with complete follow-up who have their first episode of depression 
at each time point decreases along the 15 years after stroke. At three months 33% of assessed 
patients had their first detected episode of depression and this proportion gradually went 
down to 4% in year nine. There were no observations of patients having their first episode of 
depression after year nine. Crude and weighted estimates were consistent throughout the 
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up who reported their first episode of depression at each time point. Figure 4.4 shows graphic 
representations of crude proportions. 
Follow-up Number of patients 
with complete 
















and depression first 
detected 
3months 1101 361 32.8 (30.0-35.6) 33.2 (30.0-36.4) 
1 year 750 85 11.3 (9.0-13.6) 12.0 (9.4-14.7) 
2 years 450 40 8.9 (6.2-11.5) 9.4 (6.4-12.3) 
3 years 329 17 5.2 (2.8-7.6) 5.6 (2.8-8.3) 
4 years 249 16 6.4 (3.3-9.5) 5.2 (2.5-8.0) 





6 years 87 0 0 NR
h
  
7 years 44 4 8.3 (0.2-16.4)
g
 NR i 
8 years 36 0 0 NR 
h
 
9 years 27 1 3.7 (0.09-15.4) NR 
h
 
10 years 14 0 0 NR 
h
 
11 years 11 0 0 NR 
h
 
12 years 5 0 0 NR 
h
 
13 years No observations - - - 
14 years No observations - - - 
15 years No observations - - - 
Table 4.7 Proportion of patients with complete follow-up having first episodes of 
depression at each time point 
NR: Not reported 
g- Proportions calculated using the arcsine correction 
h- Weights over 25 were considered too high. 
i- Estimate not reported as the arcsine correction cannot be used and weighted estimates 
included CIs with values over 1 or under 0.  
 




Figure 4.4 Proportion of patients with complete follow-up having first episode of 
depression at each time point. 
4.4.5 What is the duration of the episodes of depression after stroke? 
Most episodes starting at any time point had recovered the following year with a much 
smaller number of episodes of longer duration. The number of episodes observed decreased 
as the duration became longer. No episodes lasting more than nine years were observed. 
(Table 4.8) 
As can be seen in Table 4.9 and figure 4.5, half of the patients who were depressed at three 
months had recovered from depression at one year. The other half recovered gradually 
between years two and nine. No cases of depression at three months recovering after year 
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Subsequent years of depression Episodes with complete data from onset to recovery (N=234) 
1 year 175 
2 years 41 
3 years 9 
4 years 5 
5 years 1 
6 years 1 
7 years 1 
8 years 0 
9 years 1 
10 years 0 
11 years 0 
12 years 0 
13 years 0 
14 years 0 















Recovery time Patients with 








the first time 
Proportion of patients 
depressed at 3months 
recovered for the first 
time (95%CI) 
Weighted proportion of 
patients depressed at 
3months recovered for the 
first time (95%CI) 
1 year 232 116 50.0 (43.5-56.5) 50.3 (43.1-57.6) 
2 years 139 19 13.7 (7.9-19.4) 13.9 (7.3-20.4) 
3 years 92 7 7.6 (2.1-13.1) 8.1 (1.6-14.7) 
4 years 74 3 4.0 (0.9-10.1)
g
 NR
 j  








7 years 12 0 0 NR 
h
 
8 years 9 0 0 NR 
h
 




10 years 5 0 0 NR 
h
 
11 years 5 0 0 NR 
h
 
12 years 2 0 0 NR
 j
 
13 years 0 - - - 
14 years 0 - - - 
15 years 0 - - - 
Table 4.9 Patients depressed at three months recovering at each time point 
NR: Not reported 
g- Proportions calculated using the arcsine correction 
h- Weights over 25 were considered too high. 
i- Estimate not reported as the arcsine correction cannot be used and weighted estimates 
included CIs with values over 1 or under 0.  




Figure 4.5 Patients depressed at three months recovering at each time point 
4.4.6 What is the recurrence rate of depression after stroke? 
The proportion of incident cases in which a previous episode had been observed rose from 
38% in year two to 100% in years 14 and 15. (Table 4.10 and Figure 4.6) 
Follow-up N incident cases  
with 3 or more 
assessments 
N of cases with at 
least one previous 
episode of 
depression 
Proportion of recurrent cases 
2 years 65 25 38.5 (26.3-50.6) 
3 years 57 26 45.6(32.3-58.9) 
4 years 68 29 42.6(30.6-54.7) 
5 years 54 31 57.4(43.8-71.0) 
6 years 40 27 67.5(52.3-82.7) 
7 years 51 31 60.7(46.9-74.6) 
8 years 26 20 76.9(59.6-94.3) 
9 years 27 17 63.0(43.5-82.4) 
10 years 22 17 77.3(58.2-96.3) 
11 years 15 12 80.0(55.0-100.0)
g
 
12 years 12 10 83.3(56.7-100.0)
g
 
13 years 8 7 87.5(54.9-99.7)
g
 
14 years 1 1 100 
15 years 1 1 100 
Table 4.10 Proportion of recurrent cases of depression after stroke 












Figure 4.6 Proportion of recurrent cases of depression after stroke 
The number of patients with missing recurrence data was low (28-0) It was not possible to 
build a stable logistic regression model to identify predictors of completeness and therefore 
the data was not weighted. Only crude estimates are presented. There were no incident cases 
from year nine with less than three assessments, therefore there was no missing data on 
recurrence from year nine onwards.  
4.5 DISCUSSION 
These observations show that depression affects half of all stroke patients at some point, with 
a stable prevalence of around 30% up to 15 years after stroke. However, the natural history of 
depression after stroke seems to be very dynamic with most patients becoming depressed 
shortly after stroke, recovering from depression in a few years and having a significant risk of 
recurrent episodes of depression in the long term. 
4.5.1 Natural History 
This thesis shows a prevalence of depression similar to the one previously reported in other 
studies with shorter follow-up conducted across the world.
60
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of prevalence up to 15 years after stroke are presented. The great stability of the observed 
prevalence should be noted as the risk of depression does not decline with time, not even in 
the very long term after stroke.  
Incidence is an estimate of natural history that had been scarcely investigated. An incidence 
of 33% 13 months after stroke was reported in one study
117
 and another study reported annual 
incidence of 10% one year after stroke.
93
 The incidence of depression observed in this thesis, 
between 7% and 21%, almost stable throughout the follow-up, is another estimate pointing 
towards the persisting risk of depression amongst stroke patients and the dynamic natural 
history of depression in the long term after stroke. 
The observed cumulative incidence shows that one in two stroke patients becomes depressed. 
Similar estimates had been reported before in only one study of stroke patients with two years 
follow-up.
236
 The cumulative incidence of depression in stroke cohorts has been so rarely 
reported in previous studies that the overall importance of depression amongst stroke patients 
can be underestimated. The repeatedly reported prevalence of 30% might have lead doctors 
and policy makers to believe that depression affects one in three instead of one in two stroke 
patients as it seems to be the case.  
As mentioned above, the HAD score is not stable over time therefore this thesis may have 
missed patients who have had depression, or have recovered from it, between the annual 
assessments. The management of missing data used in this thesis adds robustness to the 
analysis but it also has limitations, as discussed above. These limitations of may have led to 
an underestimation of the cumulative incidence of depression after stroke that may be over 
55%. Considering the obtained result, and the fact that it may still be an underestimation, the 
possibility of including assessments for depression in the routine care of long term stroke 
survivors could be raised.  
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No studies were identified in the systematic review presented in Chapter two, investigating 
time after stroke of depression onset. The results obtained of time of onset of depression 
suggest that there is a moment of high risk for depression shortly after stroke. The proportion 
of stroke patients who have their first episode of depression more than five years after stroke 
is really low and there are no new cases after year nine. These observations suggest that 
patients not becoming depressed shortly after stroke may not become depressed at all. 
Although these results should be interpreted cautiously, it seems possible to identify this 
group of patients as low risk for depression. These results will be analysed further in the next 
chapter of this thesis together with other predictors of depression in the long term after stroke. 
The duration of the episodes of depression is relatively short, with half of patients depressed 
at three months recovered at one year. Other studies of stroke patients have published similar 
results.
93 110 117
 These observations are also consistent with the natural history of depression in 
general population, in which most episodes tend to have duration under one year.
16 19 237
 
The increase in recurrent episodes observed during the 15 years of follow-up explains why 
depression starting shortly after stroke and having short duration has a stable prevalence. 
Patients recovering from an episode of depression remain at risk of having another one.  
Studies observing general population report lower frequency of depression than the one 
observed in this thesis amongst stroke patients. A cohort study observing civil servants in the 
United Kingdom reported prevalence of depression between 12 and 14% in a 20 years 
follow-up, far below the observed prevalence of 30% in our SLSR cohort.
17
 Several studies 
conducted in different countries have reported a cumulative incidence of depression between 
13 and 17% during patient’s life time and incidence between 5 and 10%.15 16 However, 
depression after stroke seems to have similarities with depression in general population, 






 As the aetiology of 
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depression is not entirely clear
19 31
 it is difficult to explain the differences and similarities 
between depression after stroke and depression in general population. It has been reported 
that medical illness increases the risk of depression.
19 241
 The World Health Survey reported a 
prevalence of depression between 10 and 14% in patients under general hospital care.
242
 







report higher prevalence of depression in patients affected by these conditions than in general 
population. Life threatening or chronic physical illness, unpleasant and demanding treatments 
and drugs that cause depression as a side effect, such as antihypertensives, corticosteroids, 
and chemotherapy agents may explain this association between ill health and depression.
19
 
Most of these apply to stroke patients. However, the increased prevalence of depression 
specifically amongst stroke patients is probably due to other causes as well, including the 
following: 1) depression is a risk factor for stroke, therefore the proportion of patients at risk 
of depression may be increased amongst stroke patients compared to general population; 2) 
depression and stroke have risk factors in common such as sedentary lifestyle, smoking and 
overeating; 3) depression is a secondary psychological reaction to stroke; 4) depression is 
secondary to other outcomes of stroke such as disability; or 5) stroke has a direct 
pathophysiologic effect on the brain or has indirect physiologic effects e.g.: increasing 
cytokine levels or other inflammatory factors that affect the brain.
247
 
4.5.2 Strengths and limitations 
To assess the natural history of depression it would have been ideal to follow patients up 
more frequently as the average duration of episodes of depression is shorter than one year.
16
 
With assessments at three months, one year after stroke, and then annually, it is not possible 
to estimate with accuracy the cumulative incidence, time of onset, duration, and the time of 
recovery of depression. It is possible that depression may not have been identified in some 
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patients. Depression may actually be affecting more than one in two stroke patients. The 
proportion of recurrent episodes may have been underestimated as well. Assessing the 
patients more frequently would have allowed obtaining more accurate estimates of 
cumulative incidence, time of onset, duration, and recurrence of depression after stroke. 
However, these are common limitations of large epidemiology studies like the SLSR.  The 
logistic, human and financial resources used to keep the SLSR running for 15 years have 
been substantial. The SLSR is probably the largest cohort of stroke patients followed for so 
long. This provides good statistical power in all the analyses of data collected in the long 
term after the acute event. Another strength of this study is that data comes from a 
multiethnic population based register, which provides the least biased sample. This makes 
estimates valuable and original despite the logistic limitations. 
Data on medication at follow-up, including antidepressants, is currently collected routinely in 
the SLSR. However, these data was incomplete in the 1995-2009 dataset used for this thesis. 
The natural history of depression observed in this thesis may have been modified by the  
treatments for depression provided by patients’ doctors. However, these modifications may 
not be very relevant since interventions to prevent or treat depression after stroke only have a 
limited effect according to two Cochrane reviews.
78 79
  
Like many other cohort studies the SLSR doesn’t have a control arm. The only way to know 
if the estimates of depression observed amongst stroke patients differ from the ones of 
general population is by comparing them with the ones reported in other studies. One 
population based study of stroke patients recruited controls to allow estimates of the relative 
risks
 
of depression after stroke.
91
 They reported that the prevalence of depression in stroke 
survivors was twice
 
that in controls, although this difference was only significant at the six 




in stroke survivors was undertaken in The Framingham Study. They reported that 
significantly more stroke survivors were
 




As in almost all cohort studies there is some missing data in this thesis. The rates of missing 
data are not only due to the difficulty following patients for so long but to the difficulty of 
some patients, particularly those with cognitive and communication impairment, to respond 
to the HAD questionnaire. The exclusion of patients with cognitive and communication 
impairment is a limitations affecting most studies of depression in stroke cohorts.
60
 Missing 
data was handled using IPW. The assumption used to justify IPW was that data was missing 
at random (MAR) and the probability of being missing was modelled using baseline 
predictors. While IPW adjusts for differences in characteristics of patients with complete and 
incomplete follow-up, it cannot adjust for unmeasured factors which may result in some 
patients being more likely to have incomplete follow-up. If the probability of being missing 
had been dependent on unobserved variables, such as disability or depression at follow-up, 
the results obtained, despite the use of IPW, may be underestimating the relevance of 
depression after stroke. In that case the actual prevalence, incidence, cumulative incidence, 
and recurrence rate could be higher than the observed ones. It is less clear how this pattern of 
missing data could have affected the estimates obtained on time of onset and duration of 
depression. However, it is widely recognised that all methods for handling missing data are 
subject to bias dependent on the missing data mechanism.
248
 IPW was chosen because it 
removed part of the bias of complete cases analysis (CC), it also has an intuitive conceptual 
base, easy to understand to the non mathematician, and obtaining a good model of missing 
patterns is easier than in multiple imputation.
231
 To obtain maximum robustness both the 
results of CC analysis and IPW are presented. It should be noted that weighted estimates are 
consistent with the crude ones, with confidence intervals overlapping in all estimates. This 
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suggests that most of the missing data is actually missing completely at random, therefore the 
validity of results from CC analysis should be considered. 
The method used to identify depression has strengths and weaknesses as well. The strengths 
and weaknesses of the HAD scale have been discussed in depth in chapter three. Despite the 
good performance of the HAD scale it is possible that some cases of depression may have 
been missed, and also that patients categorised as depressed had no depression (HAD 
sensitivity and specificity are 0.82 and 0.74 respectively).
217
  It has been reported that Stroke 
survivors who score below threshold on standard depression measures may still have 
important negative cognitions such as hopelessness, worthlessness, or suicidality.
249
  
Since the HAD scale does not have items related to somatic symptoms and neither to other 
mental health symptoms, such as suicidal thoughts, a number of depressed patients with these 
symptoms may not have been correctly categorised. The inaccuracy introduced by HAD may 
have affected the different estimates of natural history in both ways, leading to an under or 
overestimation of depression. The use of a binary variable to define depression, even when 
using a validated scale with good performance and a cut-off point supported by two 
systematic reviews,
204 205
 gives no information on the severity of depression. It is possible 
that part of the recurrent cases may also be patients moving from scores slightly below seven 
to slightly above seven. It would have been ideal to assess depression with clinical diagnostic 
tool, such as the DSM-IV
85
 or  DSM-IV TR
86
 instead than using a screening tool. However, 
the HAD scale was designed to assess depression in patients with non psychiatric medical 
problems, it has been widely used and numerous studies have reported its good performance. 
216-219 221
  In addition it would have been unfeasible to assess with DSM-IV, so many patients 




4.5.3 Implications for clinical practice 
These results show that depression is a very common outcome of stroke, which may affect 
patients many years after the acute event. According to the results obtained in this thesis 
disregarding depression in the long term after stroke could be wrong. Clinicians should 
acknowledge that depression remains a frequent active problem long after stroke even when 
stroke seems to be completely settled and many other medical issues may have happened. 
Doctors and nurses should pay special attention to patients who have recently had a stroke as 
this is the moment in which most patients become depressed. Except in those patients who 
don’t become depressed shortly after stroke, that seem to be at lower risk, depression requires 
periodic clinical attention in the long term. To ensure this kind of attention a good 
coordination between primary and secondary care clinicians would be essential. As the 
duration of the episodes of depression is similar to the ones observed in general population, 
stroke patients treated for depression may need similar duration of treatment and follow-up. 
The high rate of recurrence of depression should also be acknowledged.  Thinking that a 
patient recovering from depression is a “closed case” could lead to a late diagnosis or an 
overlooking of a further episode. An empathic communication between patient and doctor 
should allow discussing the good news of the recovery and the need to be alert about a 
possible recurrence of depression.  
As a way to increase patients involvement in clinical management
250
, patients and carers may 
need to be informed about the risk and the course of depression after stroke. It has been 
reported that 50 to 70% of the cases of depression general population remain undetected.
237
 A 
possible message to be transmitted to patients and carers could include the following: If you 
think you are depressed, do tell your doctor because he/she may be able to help you. Please 
be aware that depression can happen more than once.   
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4.5.4 Implications for future research 
The description of the natural history of depression after stroke provides valuable evidence 
for clinicians but raises other questions.  
A Cochrane systematic review reported that antidepressants improve symptoms of depression 
in physically ill patients.
54
 Another systematic review reported improvement of depression 
symptoms amongst patients with ischaemic heart disease treated for depression.
251
 A number 
of randomised controlled trials have also reported an improvement of symptoms of 
depression in diabetic patients.
252-256
 However, the Cochrane reviews on interventions to treat 
and prevent depression after stroke reported limited effect.
78 79
 Considering the similarities of 
depression after stroke with the one observed in general population, or in other physically ill 
patients, it could be hypothesized that stroke patients may also have a positive response if 
interventions were delivered at the right time, and sustained in the long term. According to 
the results presented in this chapter, interventions to screen prevent and treat depression afters 
stroke, to be tested in future clinical trials, should start shortly after stroke and be repeated 
periodically. The moment of highest risk, in which interventions can be delivered, is the first 
year after stroke. The effect of interventions can be tested shortly after being started, as most 
episodes show short duration. Patients who are not depressed shortly after stroke are less 
likely to become depressed in the long term and therefore interventions on them are less 
likely to show any effect. However, patients who have depression shortly after stroke are at 
high risk of having a recurrent episode and studies testing interventions for these patients in 
the long term are needed.  
It is unlikely that the risk of depression is equally distributed among stroke patients. The 
investigation of predictors of depression after stroke will help identifying patients at highest 
risk on which intervention should focus. This question will be addressed in the next chapter. 
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In order to treat depression after stroke, and to plan the resources required for this, the 
description of its natural history is no enough. A good understanding of the potential 
association between depression and other health outcomes is required. Chapter six will 
















CHAPTER 5.  PREDICTORS AND ASSOCIATIONS OF DEPRESSION 
AFTER STROKE 
5.1 ABSTRACT 
Background: Evidence on the predictors of depression after stroke is insufficient to identify 
the patients at highest risk on which interventions should focus. 
Objective: To identify sociodemographic and clinical predictors of depression up to 15 years 
after stroke, and to identify follow-up variables associated with depression up to 15 years 
after stroke.  
Methods: Data from the patients with first ever strokes registered in the population-based 
South London Stroke Register between January 1995 and December 2009 (N at 
registration=4022) were used. Data were collected at time of stroke and survivors were 
followed up at three months, one year and annually thereafter up to 15 years after stroke. 
Baseline data included: age, gender, ethnicity, socioeconomic status, living conditions and 
stroke severity. Follow-up included assessments of social conditions (accommodation, 
employment, and social networks), cognition (Abbreviated Mental Test or Mini Metal State 
Examination), disability (Barthel Index) and activity (Frenchay Index). Follow-up also 
included assessments for depression (Hospital Anxiety and Depression, depression subscales 
scores >7 = depression). Multivariable logistic regression models adjusted for age, gender 
and ethnicity, were used to investigate the association of baseline and follow-up variables 
with depression at different time points, and also with time of onset of depression, duration, 
and recurrence of depression. Multiple imputation was used to handle missing data 
Results: Stroke severity, disability, depression before stroke, and depression and anxiety 
three months after stroke, are the baseline variables most consistently associated with 
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depression up to 15 years after stroke. Disability, social isolation, low level of activity and 
cognitive impairment are the follow-up variables most consistently associated with 
depression at follow-up. 
Conclusion: The risk of depression after stroke is significantly higher in patients with severe 
strokes, previous depression, and low social support. Interventions for this particular group of 
patients should be considered. 
 
A summary of the results presented in this chapter was presented in the 2010 European stroke 














The following questions will be addressed in this chapter: 
- What are the predictors of depression after stroke? 
- What factors, observed at follow-up, are associated with depression after stroke? 
Clinical guidelines, based on consensus, recommend that stroke patients should be screened 
for depression and treated whenever necessary.
76 77
 The literature review presented in Chapter 
two showed that depression after stroke predicts other negative health outcomes at follow-up 
such as higher mortality. Although these results come from a small number of studies, it 
would be plausible that treating depression may also have a positive effect on health 
outcomes other than depression itself. 
However, there are some issues that make the implementation of clinical guidelines difficult 
for the clinician when it comes to intervening on depression after stroke. Depression can be 
perceived by doctors, patients and carers as a natural consequence of poor health or advanced 
age.
257
 This may lead to a quiet acceptance of the problem, underreporting of the symptoms 
can be an issue
60
, and the clinical care provided may be inadequate.
53
  
A Cochrane review concluded that selective serotonin reuptake inhibitor (SSRI), tricyclic 
antidepressant (TCA), and noradrenergic and specific serotonergic antidepressants (NaSSA), can 
benefit the patients with depression and physical illness.
54
 However, only eleven of the 50 
studies included in this review had been conducted in stroke patients. Other studies had been 
conducted in patients with other diseases including Diabetes, COPD, HIV and Parkinson’s 
disease. Two other Cochrane reviews investigating antidepressants, including SSRI, TCA and 
NaSSA, and psychotherapy, to treat and prevent depression in stroke patients, reported only a 
limited of these interventions.
78 79
 The authors of these reviews raised two points to explain 
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the limited effect of available interventions on depression after stroke.
78 79
 The first one was 
whether interventions had been given at the right time and for long enough to be effective. 
The long term natural history of depression after stroke had not been well documented 
previously and this imposes a difficulty on the time of delivery of the interventions. The 
previous chapter addressed some of the gaps in the knowledge on the natural history of 
depression after stroke, including its incidence, prevalence, cumulative incidence, duration 
and recurrence rate in the long term. This could help to decide when interventions should be 
delivered. The other issue raised by Cochrane reviewers is whether interventions had been 
given to the right patients. Depression is only one of the many possible long term outcomes 
of stroke but it does not affect all stroke patients. Acute stroke has an increasingly complex 
clinical management. Mortality during the acute phase has declined in the past decades but it 
is still high. Identifying patients at risk of depression in the long term may not be the stroke 
physician’s first priority.53 The long term follow-up of stroke survivors is mostly conducted 
in primary care. GPs and primary care nurses see patients who have had a stroke at some 
point, amongst other possible comorbidities, together with many other patients presenting 
different problems. It is very difficult for the primary care clinicians to screen individually for 
every possible long term outcome of each chronic disease of all the patients on the list. These 
factors make a challenge for primary and secondary care clinicians to screen for depression, 
and treat when needed, all stroke patients in the long term.  
The association between chronic illness, not specifically stroke, and depression has been 
documented.
191-193
 In 2009, NICE published a guideline on the treatment and management of 
depression in adults with chronic physical health problems.
258
 Many stroke survivors can be 
categorised within this group. By doing this stroke patients at risk of depression are included 




Another strategy that could be used to identify patients who may benefit from screening, 
prevention or treatment, of depression is to define the clinical profile of the patients at high 
risk of it. Focusing on high risk patients reduces the number of patients requiring attention, 
making interventions easier to deliver. Interventions will be more effective if they are given 
at the right time, and only to the patients who really need them. Furthermore, identifying 
predictors of depression, and its natural history, will not only help in the optimisation of 
available interventions but also in the development of innovative ones. Finally, treating 
depression effectively, and observing a positive effect on patient’s mood and on other 
outcomes such as disability, should help clinicians to have a more proactive attitude towards 
stroke patients at risk of depression.  
Since depression after stroke can be a chronic and recurrent problem, it would also be useful 
for clinicians and patients to know if any variables routinely observed at baseline can predict 
specific patterns of natural history e.g.: time of onset, duration or recurrence rate. 
As seen in Chapter four, depression is a frequent outcome of stroke, which can affect patients 
both in the short and in the long term. What predicts depression, and its natural history, may 
also form part of the information that clinicians give to patients and carers. This information 
might include messages such as: “Be alert at this particular moment, about depression in case 
you observe these particular signs”, “You may benefit from having your depression treated if 
we see you at the right time and we can follow you up appropriately” or “Depression in a 
patient with your profile is likely to last that long”. A better understanding on predictors of 
depression should also help patients to seek medical care more appropriately and to have a 
better knowledge on the prognosis of the condition. 
Although the main aim of this chapter is to identify predictors and associations of depression 
after stroke that can be used in clinical practice, it may also give valuable information on the 
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aetiology of depression. While the aetiology of depression is not entirely clear, it is widely 
accepted that there are biological, psychological and sociological factors involved.
19 31
 Some 
of the variables investigated in this thesis will simply be statistically associated with 
depression. They will only be useful in clinical settings as predictors or associations of 
depression. Other variables statistically associated with depression will actually be 
aetiological factors of depression after stroke. 
As presented in Chapter two, some studies have investigated potential predictors of 
depression after stroke. However, most of these studies have limitations including small 
sample size, short follow-up and weak analysis. From the available evidence, it is difficult to 
identify the patients at high risk of depression.
62
 The contribution of these studies to the 
knowledge of the aetiology of depression is limited. It is also difficult to improve available 
interventions or to design innovative ones with the results we have. The available evidence 
can make very little difference to the decisions that clinicians, patients and carers take 
regarding depression after stroke.  
This chapter tests the hypothesis that some socio-demographic and clinical variables are 
associated with depression after stroke making it possible to identify patients at highest risk.  
The first aim of this chapter is to provide evidence on predictors of depression after stroke. 
Since the natural history of depression after stroke is very dynamic, this chapter will also 
investigate predictors of time of onset, duration, and recurrence, of depression after stroke. 
The second aim is to identify variables observed at follow-up that, together with the baseline 
predictors, may help clinicians to identify patients at high risk of depression in the long term. 
A good report of baseline predictors and associations of depression after stroke will help 
describing the clinical profile of the patients at highest risk, on which future clinical trials and 




Data from the South London Stroke Register, described in Chapter three, were used. The 
variables analysed in this chapter were selected for their potential clinical value to identify 
patients at highest risk of depression, and summarised below.  
Sociodemographic and clinical variables collected at baseline were investigated as potential 
predictors of depression. Sociodemographic data included age, which was categorised into 
groups to investigate the potential effect of stroke in depression below and above the 
traditional age for retirement: below and above 65 years old at the time of stroke. Other 
sociodemographic variables investigated were gender, ethnicity  (white, black and other 
ethnicity), employment status (working, unemployed, not working due to disability, retired, 
and other), socioeconomic status (manual, non manual, army), education level (no formal 
education, primary, secondary or tertiary) , and living conditions prior to stroke (alone, with 
someone, in a sheltered home, or in an institution). The distribution of sociodemographic 
variables investigated as predictors of depression is presented in table 5.1  
Clinical variables investigated as predictors included risk factors for depression, stroke 
severity measures and depression and anxiety three months after stroke. Risk factors included 
past medical history of depression, treatment for depression at the time of stroke, smoking 
habit (never smoked, ex-smoker, smoker), alcohol consumption, amount of alcohol consumed 
per week, diabetes pre-stroke, ischaemic heart disease pre-stroke, depression three months 
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3 6 9 12 15 

















>64 752 (57.4) 631 (57.4) 304 (50.7) 115 (38.8) 46 (39.7) 7 (43.7) 
Gender 
 
Male 683 (55.4) 631 (57.4) 337 (56.2) 174 (58.8) 74 (68.8) 7 (43.7) 

















Black 276 (22.4) 254 (23.1) 144 (24.0) 75 (25.3) 26 (22.4) 4 (25.0) 
Other 76 (6.2) 66 (6.0) 39 (6.5) 19 (6.4) 8 (6.9) 1 (6.2) 




















35(2.8) 43(3.9) 29(4.8) 23(7.8) 7(6.0) 2(40.0) 
Unable to 
work 
79(6.4) 76(6.9) 42(7.0) 21(7.1) 10(8.6) 1(20.0) 
Retired 780(63.3) 675(61.4) 324(54.0) 135(45.6) 51(44.0) 1(20.0) 
Student / 
Carer 
30(2.4) 23(2.1) 15(2.5) 10(3.4) 5(4.3) 2(12.5) 


















Manual 731 (59.3) 685 (62.3) 372 (62.0) 193 (28.4) 79 (68.1) 11 (68.7) 
Army 93 (7.5) 67 (6.1) 32 (5.3) 17 (5.7) 4 (3.4) 1 (6.2) 



















Primary 37 (3.0) 22 (2.0) 8 (1.3) 1 (0.3) 0 0 
Secondary 386 (31.3) 219 (19.9) 24 (4.0) 5 (1.7) 1 (0.9) 0 
Tertiary 39 (3.2) 24 (2.2) 6 (1.0) 0 0 0 






















644 (52.3) 556 (50.5) 301 (50.2) 144 (48.6) 76 (65.5) 10 (62.5) 
Sheltered 
home 
57 (4.6) 30 (2.7) 8 (1.3) 1 (0.3) 1 (0.9) 1 (6.2) 
Institution 13 (1.0) 5 (0.4) 3 (0.5) 0 1 (0.9) 0 
Unknown 150 (12.2) 175 (15.9) 131 (21.8) 77 (26.0) 7 (6.0) 0 
 
Table 5.1 Sociodemographic variables investigated as predictors of depression after 





 Time (years after stroke) 
 1 y 
 




No 589 (47.8) 502(45.6) 189 (31.5) 134 (45.3) 88 (75.9) 12 (75.0) 
Yes 79 (6.4) 61 (5.5) 36 (6.0) 26 (8.8) 19 (16.4) 3 (18.7) 
Unknown 564 (45.8) 
 





No 1006(81.6) 890 (80.9) 461 (76.8) 220 (74.3) 105 (90.5) 15 (93.7) 
Yes 70 (5.7) 52 (4.7) 25 (4.2) 8 (2.7) 5 (4.3) 1 (6.2) 
Unknown 157 (12.7) 
 
158 (14.4) 114 (19.0) 68 (23.0) 6 (5.2) 0 
Smoking 
Never 421(32.4) 357(32.4) 207(34.5) 97(32.8) 37(1.9) 6(37.5) 
Ex-smoker 353(28.7) 319(29.0) 146(24.3) 64(21.6) 29(25.0) 7(43.7) 
Smoker 432(35.1) 396(36.0) 238(39.7) 132(44.6) 50(43.1) 2(12.5) 
Unknown 25(2.0) 
 




No 408(33.1) 330(30.0) 174(29.0) 77(26.0) 21(18.1) 3(18.7) 
Yes 731(59.3) 673(61.2) 370(61.7) 195(65.9) 91(78.4) 12(75.0) 
Unknown 93(7.5) 
 




0 407(33.0) 329(29.9) 174(29.0) 77(26.0) 21(18.1) 3(18.7) 
1-14 412(33.4) 383(34.8) 200(33.3) 99(33.4) 52(44.8) 11(68.7) 
14-21 57(4.6) 46(4.2) 22(3.7) 10(3.4) 2(1.7) - 
>21 155(12.6) 157(14.3) 94(15.7) 56(18.9) 30(25.9) 1(6.2) 
Unknown 202(16.4) 
 
185(16.8) 110(18.3) 54(18.2) 11(9.5) 1(6.2) 
Diabetes 
pre-stroke 
No 962(78.0) 856(77.8) 456(76.0) 233(78.7) 97(83.6) 14(87.5) 
Yes 224(18.2) 194(17.6) 102(17.0) 43(14.5) 15(12.9) 2(40.0) 
Unknown 47(3.8) 
 





No 865 (70.1) 863 (78.4) 469 (78.2) 242 (81.8) 97 (83.6) 13 (81.2) 
Yes 185 (15.0) 193 (17.5) 94 (15.7) 34 (11.5) 15 (12.9) 3 (18.7) 
Unknown 183 (14.8) 44 (4.0) 37 (6.2) 20 (6.8) 4 (3.4) 0 
Table 5.2 Risk factors investigated as potential predictors of depression after stroke n (%) 
Stroke severity measures investigated as potential predictors, collected during the acute phase 
of stroke included the following: Glasgow Coma Score (GCS) at the time of maximum 
impairment, which was categorised as 3-8 severe, 9-12 moderate, and 13-15 mild impairment 
of consciousness, dysphagia, urinary incontinence, visual field defects, neglect, dysphasia, 
dysarthria, paresis, cerebellar symptoms and stroke subtype (ischaemic or haemorrhagic). 
Cognitive function was also assessed at baseline with the Mini Mental State examination 
(MMSE)
209 259
 except from the period between 2001 and 2006 when the Abbreviated 
Memory Test (AMT)
210
 was used. Patients with MMSE score <24 or AMT Scores 0-7 were 
considered cognitively impaired.
209 210
 Finally, disability was assessed seven days after 
stroke, using the Barthel Index (BI)
211 260
: scores of 0-14 were categorised as severe 
136 
 
disability, 15-19 moderate disability, and 20 independent. The distribution of clinical 
variables investigated as predictors of depression is presented in tables 5.3 and 5.4 
Follow-up was by postal questionnaire or interview at three months, one year after stroke and 
annually thereafter. At follow-up patients were assessed for depression and anxiety, using the 
Hospital Anxiety and Depression scale (HAD).
214
 Patients with a score > 7 in the depression 
or anxiety subscales were considered to have depression or anxiety respectively.
218
  HAD was 
routinely collected between 1997 and 2006. Patients registered in 1995 (n=299) were not 
assessed at three months and one year but were in subsequent follow-ups. Patients registered 
in 1996 (n=350) were not assessed at three months but were at subsequent follow-ups. Data 
on HAD was therefore not included from these patients in the respective estimates for early 
rates of depression. As HAD cannot be answered by proxy, no data could be collected from 
patients unable to respond to the questionnaire. These included patients who had a cognitive 
deficit, severe disability, communication difficulties or multiple comorbidities that the 
fieldworker, or the patient’s next of kin in case of a postal questionnaire, judged such that the 










  Time (years after stroke) 
 
 1 y 
 




3-8 40 (3.2) 40(3.6) 21(3.5) 15(5.1) 7(6.0) 1(6.25) 
9-12 71 (5.8) 81(7.4) 34(5.7) 16(5.4) 10(8.6) 0 
13-15 1089(88.3) 946(86.0) 528(88.0) 261(88.2) 97(83.6) 15(93.7) 
Unknown 33 (2.7) 
 
33(3.0) 17(2.8) 4(1.3) 2(1.7) 0 
Swallowing 
test results 
Pass 873 (71.0) 787(71.6) 444(74.0) 225(76.0) 82(70.7) 14(87.5) 
Fail 241(19.6) 222(20.2) 114(19.0) 55(18.6) 29(25.0) 2(12.5) 
Unknown 115(9.4) 
 




No 896(72.7) 801(72.8) 469(78.2) 240(81.1) 84(72.4) 13(81.2) 
Yes 298(24.2) 263(23.4) 104(17.3) 49(16.5) 29(25.0) 3(18.7) 
Unknown 39(3.2) 
 
36(3.3) 27(4.5) 7(2.4) 3(2.6) 0 
Visual field 
defect 
No 793(64.3) 828(75.3) 467(77.8) 236(79.7) 87(75.0) 15(93.7) 
Yes 195(15.8) 201(18.3) 100(16.7) 43(14.5) 15(12.9) 1(6.2) 
Unknown 245(19.9) 
 
71(6.4) 33(5.5) 17(5.7) 14(12.1) 0 
Neglect 
No 826(67.0) 851(77.4) 481(80.2) 234(79.0) 88(75.9) 16(100) 
Yes 222(18.0) 193(17.5) 86(14.3) 39(13.2) 14(12.1) 0 
Unknown 185(15.0) 
 
56(5.1) 33(5.5) 23(7.8) 14(12.1) 0 
Dyphasya 
No  834(67.6) 823(74.8) 449(74.8) 219(73.9) 84(72.4) 15(93.7) 
Yes 230(18.6) 249(22.6) 134(22.3) 72(24.3) 28(24.1) 1(6.25) 
Unknown 28(2.5) 
 
28(2.5) 17(2.8) 5(1.7) 4(3.4) 0 
Dysarthria 
No 525(42.6) 519(47.2) 269(44.8) 133(44.9) 53(45.7) 9(56.2) 
Yes 417(33.8) 392(35.6) 200(33.3) 84(28.4) 46(39.7) 7(43.7) 
Unknown 291(23.6) 
 
189(17.2) 131(21.8) 79(26.7) 17(14.7) 0 
Paresis 
No 326(26.4) 315(28.6) 191(31.8) 99(33.4) 32(27.6) 3(18.7) 
Yes 752(70.0) 773(70.3) 402(67.0) 196(66.2) 83(71.5) 13(81.2) 
Unknown 155(12.6) 
 
12(1.1) 7(1.2) 1(0.3) 1(0.9) 0 
Cerebellar  
symptoms 
No 966(78.3) 878(79.8) 494(82.3) 253(85.5) 100(86.2) 15(93.7) 
Yes 224(18.2) 178(16.2) 84(14.0) 31(10.5) 7(6.0) 1(6.2) 
Unknown 43(3.5) 
 
44(4.0) 22(3.7) 12(4.0) 9(7.8) 0 
Subtype 
Infarct 1032(83.7) 887(80.6) 473(78.8) 225(76.0) 85(73.2) 11(68.7) 
Haemorr. 171(13.9) 175(15.9) 108(18.0) 61(20.6) 25(21.5) 4(25.0) 
Unknown 30(2.4) 
 
38(3.4) 19(3.2) 10(3.2) 6(5.2) 1(6.2) 
Cognitive 
level 
 Impaired 230(18.6) 200(18.2) 83(13.8) 39(13.2) 24(20.7) 2(12.5) 
Intact 639(51.8) 511(46.4) 260(43.3) 127(42.9) 51(44.0) 13(81.2) 
Unknown 364(29.5) 
 
389(35.4) 257(42.8) 130(43.9) 41(35.3) 1(6.2) 
Disability 
(Barthel 




442(35.8) 381(34.6) 181(30.2) 85(28.7) 47(40.5) 5(31.2) 
Mild 
disability 
222(18.0) 207(18.8) 100(16.7) 48(16.2) 21(18.1) 4(25.0) 
Indepen-
dence 
403(32.7) 345(31.4) 224(37.3) 115(38.8) 42(36.2) 6(37.5) 
Unknown 166(13.5) 167(15.2) 95(15.8) 48(16.2) 6(5.2) 1(6.2) 




  Time (years after stroke) 
 
 1 y 
 




No 518 (42.0) 369 (33.5) 177 (29.5) 63(21.3) 16(13.8) 0 
Yes 232 (18.8) 152(13.8) 71(11.8) 25(8.4) 11(9.5) 0 
Unknown 483 (39.2) 
 




No 512(41.5) 361(32.8) 160(26.7) 55(18.6) 14(12.1) 0 
Yes 243(19.7) 163(14.8) 92(15.3) 33(11.1) 13(11.2) 0 
Unknown 478(38.8) 576(52.4) 348(58.0) 208(70.3) 89(76.7) 16 (100) 
Table 5.4 Depression and anxiety in the three months after stroke n (%) 
Data collected at follow-up, investigated as potential associations of depression after stroke is 
presented in tables 5.5 and 5.6. It included living circumstances (alone, with other, or in an 
institution), employment (working, unemployed, unable to work due to disability, retired and 
other), smoking habit (smoker or non smoker), alcohol intake, amount of alcohol consumed 
per week, cognitive impairment, disability, and activity level. Activity level was assessed 
with the Frenchay Activity Index (FAI) (inactive 0-15, moderate inactivity 16-30, or active 
31-45).
223
 Finally social networks were examined with two questions: Do you see as much of 
your relatives as you would like? (Yes/No/Don’t have any). Do you see as much of your 















Private house alone 375(30.4) 334(30.4) 176(29.4) 100(33.8) 34(29.3) 3(18.7) 
P. house with other 669(54.3) 575(52.3) 336(56.7) 153(51.7) 53(45.7) 6(37.5) 
Institution 174(14.1) 168(15.3) 75(12.5) 37(12.5) 23(19.8) 6(37.5) 
Other 9(0.7) 8(0.7) 3(0.5) 3(1.0) 0 0 
Unknown 
. 




Working 89(8.6) 114(10.4) 77(11.7) 25(8.5) 9(8.0) 2(12.5) 
Unemployed 17(1.6) 132(12.0) 109(18.2) 73(24.8) 58(51.3) 12(75.0) 
Unable 163(15.7) 154(14.0) 74(12.4) 41(13.9) 8(7.1) 0 
Retired 587(56.7) 575(52.5) 338(56.5) 152(51.7) 35(31.0) 0 
Carer 7(0.7) 3(0.3) 0 0 0 0 
Unknown 
. 





Yes 1024(83.0) 949(86.3) 561(93.5) 277(93.6) 106(91.4) 14(87.5) 
No 49(4.0) 44(4.0) 32(5.3) 14(4.7) 6(5.2) 2(12.5) 




Yes 749(60.7) 687(62.4) 426(71.0) 212(71.6) 88(75.9) 14(87.5) 
No 293(23.8) 287(26.1) 158(26.3) 74(25.0) 24(20.7) 2(12.5) 
Don’t have any 30(2.4) 19(1.7) 13(2.2) 5(1.7) 2(1.7) 0 
Unknown 
 




Yes 739(59.9) 671(61.0) 409(68.2) 202(68.2) 89(76.7) 14(87.5) 
No 272(22.1) 260(23.6) 150(25.0) 78(26.3) 24(20.7) 2(12.5) 
Don’t have any 58(4.7) 61(5.5) 36(6.0) 11(3.7) 1(0.9) 0 
Unknown 164(13.3) 108(9.8) 5(0.8) 5(1.7) 2(1.7) 0 
 
 
Table 5.5 Sociological variables collected at follow-up investigated as associations of 










Time (years after stroke) 1y                3y                 6y                9y                12y               15y 
Smoking 
status 
No 867(70.5) 809(73.5) 461(77.3) 227(76.9) 92(80.0) 13(81.2) 
Yes 353(28.7) 289(26.3) 133(22.3) 67(22.7) 23(20.0) 3(18.7) 
Unknown 
. 





No 613(49.8) 559(50.9) 292(48.8) 135(45.6) 62(53.9) 10(62.5) 
Yes 615(49.9) 536(48.8) 305(51.0) 159(53.7) 53(46.1) 6(37.5) 
Unknown 
. 






None 611(49.5) 556(50.8) 290(48.4) 139(46.9) 64(55.2) 10(62.5) 
<1 115(9.3) 0 69(11.5) 39(13.2) 8(6.9) 0 
<14  330(26.8) 395(35.9) 142(23.7) 68(23.0) 27(23.3) 2(12.5) 
14-21 55(4.5) 53(4.8) 36(6.0) 10(3.4) 3(2.6) 0 
>21 76(6.2) 54(5.9) 25(4.2) 20(6.8) 2(1.7) 2(12.5) 
Unknown amount 22(1.8) 6(0.5) 17(2.8) 6(2.0) 6(5.2) 1(6.2) 
Unknown if drinks 
 
24(1.9) 33(3.0) 20(3.3) 14(4.7) 6(5.2) 1(6.2) 
 
Anxiety No 818(64.3) 739(67.2) 395(65.8) 195(65.9) 69(59.5) 9(56.3) 
Yes 394(31.9) 343(31.2) 197(32.8) 97(32.8) 46(39.7) 7(43.7) 
Unknown. 
 




Impaired 216(19.9) 198(18.0) 99(16.5) 45(15.2) 15(12.9) 3(18.7) 
Intact 743(68.6) 618(56.2) 389(64.8) 191(64.5) 42(36.2) 5(31.2) 
Unknown. 
 





Severe disability 211(17.1) 190(17.3) 97(16.2) 57(19.3) 36(31.0) 4(25.0) 
Mild disability 442(35.8) 396(36.0) 241(40.2) 108(36.5) 30(25.9) 6(37.5) 
Independence 562(45.7) 472(42.9) 257(42.8) 122(41.2) 41(35.3) 0 
Unknown. 
 





Inactive 490(39.7) 450(40.9) 231(38.5) 116(39.2) 52(44.8) 9(56.2) 
Moderately active 420(34.0) 386(35.1) 216(36.0) 106(35.8) 32(27.6) 3(18.7) 
Active 249(20.2) 203(18.4) 114(19.0) 53(17.9) 14(12.1) 1(6.2) 
Unknown. 
 
74(6.0) 61(5.5) 39(6.5) 21(7.1) 18(15.5) 3(18.7) 
 
Table 5.6 Clinical variables collected at follow-up investigated as associations of 
depression n (%) 
5.3.1 Statistical Methods 
Predictors, or associations, of depression assessed every three years during the 15 years of 
follow-up were investigated, that is predictors or associations of depression identified at one, 
three, six, nine, twelve and fifteen years after stroke. There were several reasons why the 
analyses were limited to depression observed in three years intervals: The study of the natural 
history of depression after stroke presented in Chapter four showed that most episodes of 
depression last less than one year, therefore observing patients in three years intervals should 
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be long enough yet not too long to give a clear image of incident and recurrent cases. Making 
six observations during a period of 15 years gives a consistent picture of the variables 
predictive of, or associated with depression in the long term. These analyses avoid examining 
associations at all time points as that would results in a great number of statistical 
associations by chance. 
Potential predictors or associations of depression were first investigated with unadjusted 
logistic regression models. Variable showing association with depression at any time point 
(p<0.1), were then investigated with multivariate logistic regression, adjusting all models for 
age, gender and ethnicity. The multivariate statistical models were built following guidelines 
for prospective studies in stroke cohorts: The analysis was conducted using logistic 
regression as it is the recommended statistical approach when the outcome is the presence of 
depression.
74
 Other approaches, such as linear regression, have been recommended for the 
analysis of severity of depression. Age, gender and ethnicity were considered potential 
confounders and therefore were included in the models.
74
 There is no statistical test to 
identify a confounder so the variables introduced in a model remain a matter of judgement. It 
was decided not to force other variables into the model as the independence of variables 
representing clinical severity could not be demonstrated. The interpretation of the results 
would have been more difficult as well. The models used intended to give a clear indication 
of the possible association between the variable investigated and depression after stroke. The 
models served a double purpose. In the first part of the analysis, the focused was on 
predictive models (aiming to calculate the probability that an event occurring) and only 
included readily available pre- and acute stroke variables. In the second part of the analysis, 
the models intended to explain the relationship between each independent variable and 
depression. They were therefore explanatory and also included variables collected at the same 
time as depression was assessed.
74
 The sample size was adequate to build the model. The 
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guideline is ten outcome events per independent variable entered into a logistic regression 
model.
74
 The number of cases with the outcome of interest (depression) and the total number 
of cases in the sample were reported.  All independent variables (or risk factors) have been 
clearly described, including when the variable was measured, how it was measured and 
coded, and in what form it was entered into the model. There was also an adequate number of 
people with each risk factor for the model. Important confounders, such as age, gender and 
ethnicity, were included into the model. Automated methods, which can select data only for 
being statistically significant rather that clinically meaningful, were not used.
74 185
 Reporting 
the usefulness of the model included 95% confidence intervals around odds ratios. As age 
could modify the association between some of the variables analysed and depression, 
interactions between age and all predictors showing significant association with depression 
were examined. The interactions between age and employment, Barthel score, Frenchay score 
and cognitive impairment at follow-up, were also analysed.
26 88
 
In a second stage the natural history of depression was investigated by examining the 
predictors of the following outcomes: depression identified at any time point of the follow-
up; time of onset of depression, this is the point after stroke in which patients were first 
observed to be depressed; duration of depression; recurrence of depression. Predictors were 
first investigated in univariate logistic regression models. Those variables showing 
association with the outcome (p<0.1) were then investigated adjusting for age, gender and 
ethnicity following the statistical methods described above. 
To analyse the predictors of time after stroke of depression onset a binary variable was 
defined: 0 (depression starting after three months), 1 (depression starting at three months).  
Another binary variable was defined to analyse the predictors of duration of depression 
starting at three month: 0 (short duration: depression at three months recovered at one year), 1 
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(long duration: depression at three months recovering after one year). These analyses focused 
on depression at three months and one year as three months after stroke is the point of highest 
risk for depression and half of the patients depressed at this point have recovered one year 
after stroke (Chapter four).  
To analyse predictors of recurrent depression a binary variable was defined 0 (patients with 
incident depression at any time point, alive in year two, who had got at least one depression 
assessment before and were not depressed) and 1 (patients with incident depression at any 
time point, alive in year two, who have been found to be depressed in at least one assessment 
before). 
In order to define the profile at baseline of patients at highest risk of depression at any time 
point, predictors of depression identified in the analysis, e.g.: inability to work and paresis, 
were combined into a single binary variable 0/1 were 1 represented unable to work with 
paresis. These variables allowed to quantify the risk of having depression for patients fitting a 
specific profile and ultimately to define the profile of patients at highest risk. In a similar way 
the profile of patients at lowest risk of depression was investigated. Low risk was defined as 
risk of depression below 15% during the 15 years of follow-up as several studies conducted 
in different countries have reported a cumulative incidence of depression in general 
population between 13 and 17% during patient’s life time.15 16 Several variables combining 
predictors of high or low risk were created. The number of individual variables included was 
kept to the minimum to identify a clinical profile as wide as possible, of patients with high or 
low risk of depression. 
5.3.1.1 Missing data management: 
Only patients with the outcome variable observed were included, this is patients who had 
been assessed for depression. Most variables analysed as potential predictors had some 
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missing data. A separate category was assigned to it e.g.: Dysphasia 0 (No), 1 (Yes), and 2 
(Missing). Sensitivity analysis was conducted to compare estimates obtained when the 
category for missing data was included and when it was not included. Estimates and standard 
errors obtained when using a missing data category were stable and similar to those based on 
complete data. Therefore, in order to use the maximum available data, for these variables, we 
reported the results using the categories for missing data.  
However, as detailed in previous chapter, this approach can still introduce bias when patients 
with missing data are different from those with complete data. There are three patterns of 
distribution for missing data.
261
 One of them assumes that data is missing completely at 
random (MCAR), which is the possibility of being missing is not associated with any 
observed or unobserved variables. The second one assumes that distribution of missing data 
depends on observed variables, which is missing at random (MAR). The last pattern assumes 
that missing data depends on not observed variables, which are missing not at random 
(MNAR). It was not possible to assume that data was MCAR, as there were associations 
between some of the observed variables and the possibility of being missing e.g.: Patients 
with higher levels of disability or cognitive impairment were less likely to respond to the 
follow-up questionnaire than those not disable and without impaired cognition. Therefore the 
MAR assumption was more plausible. The possibility of data being missing depending on not 
observed variables (MNAR) was also considered. However, some of the observed variables 
were actually associated with the possibility of being missing. Furthermore, the methods 
needed to conduct statistical analysis under the MNAR assumption are still being developed 
and are not routinely used. Hence the MAR assumption was chosen as it was plausible and 
the knowledge and software to work with it was available. How could the results be biased if 
the MNAR assumption was true is also discussed at the end of this chapter.  
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Estimates of the effect of variables with more than 15% of missing data missing can be 
specially biased. Therefore, in order to remove bias coming from missing data, under the 
MAR assumption, a second multivariate analysis was conducted using multiple imputation 
(MI).
233
 MI was considered the most appropriate method as simpler methods can only deal 
with missing outcomes but not with missing covariates. Other methods for missing covariates 
are much more complex. The sophisticated statistical software needed to conduct MI analysis 
is available.
234
 MI aims to allow for the uncertainty about the missing data by creating several 
different plausible imputed data sets and appropriately combining results obtained from each 
of them.
233 262
 The first stage is to create multiple copies of the dataset, with the missing 
values replaced by imputed values. These are sampled from their predictive distribution 
based on the observed data. The imputation procedure accounts for all uncertainty in 
predicting the missing values by injecting appropriate variability into the multiple imputed 
values; we can never know the true values of the missing data. MI is very flexible as it covers 
many data structures. The second stage is to use standard statistical methods to fit the model 
of interest to each of the imputed datasets. Estimated associations in each of the imputed 
datasets will differ because of the variation introduced in the imputation of the missing 
values, and they are only useful when averaged together to give overall estimated 
associations. Valid inferences are obtained because we are averaging over the distribution of 
the missing data given the observed data. 
For variables with missing data under 15% the sensitivity analysis was considered enough to 
obtain robust reliable estimates and therefore MI was not used. For variables with missing 
data over 25% the impact of imputation error was considered too large. MI was used for 
variables with 15 to 25 % missing data.
234 263
 Variables in the imputation models included the 
outcome variable (depression), all the variables included as confounders in the analysis of 
predictors, that is age, gender and ethnicity, the predictor being investigated, and finally 
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variables considered to be associated with the possibility of being missing: GCS, paresis, 
incontinence and Barthel index at baseline. The number of imputations equalled the 
percentage of patients with at least one missing variable.
234
 MI was conducted, as well as the 
rest of the statistical analysis of this thesis with Stata 11 
5.4 RESULTS: 
Between 1995 and 2009, 4022 patients were registered in the SLSR. The number of patients 
registered in each period, assessed for depression or lost to follow-up, at each time point, has 
been presented in figure 4.1. 
5.4.1 Predictors of depression 1, 3, 6, 9, 12, and 15 years after stroke: 
All the baseline variables except the amount of alcohol consumed per week, dysarthria, 
cerebellar symptoms and stroke subtype, were associated with depression in the univariate 
analysis (p>0.1) at least at one time point post stroke. In the adjusted analysis being unable to 
work at baseline was the sociodemographic variable more frequently associated with 
depression, showing a significant association in years 1, 3 and 6. Female gender predicted 
depression in years one and three. Age under 65 predicted depression in year three and 
manual socioeconomic status predicted depression in year nine. The ORs and 95% CIs of the 
associations between all investigated sociodemographic variables and depression at 1, 3, 6, 9, 
12 and 15 years after stroke adjusted by age, sex and ethnicity are presented in table 5.7. 
In the adjusted analysis, depression three months after stroke and anxiety three months after 
stroke, together with dysphagia, paresis, impaired cognition, being a smoker, and severe 
disability in the acute phase were all associated with depression in at least three time points. 
Ischaemic heart disease pre stroke, low GCS score, urinary incontinence, visual defect and 
neglect in the acute phase were also identified as clinical predictors of depression.  The ORs 
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and 95% CIs and p values of the association between clinical variables and depression up to 
15 years after stroke are presented in table 5.8, 5.9 and 5.10. No significant interactions were 
identified in the analysis of predictors.  
The association between some of the variables and depression more than six years after 

















 Time (years after stroke) 
  1  3 6 9 12 15 
Age 
 
0-64 1 1 1 1 1 1 






























Ethnicity White 1 1 1 1 1 1 



























Working 1 1 1 1 1 1 
Unemploy


















































Social class Non 
manual 
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Table 5.7 Sociodemographic predictors of depression after stroke 




 Time (yeas after stroke) 





















































































































Table 5.8 Risk factors predictors of depression after stroke 
* p<0.05, ** p<0.01 
 Time (Years after stroke) 









































Table 5.9 Depression and anxiety at 3 months after stroke predictors of depression in the long 
term 




 Time (years after stroke) 




































































































































































Table 5.10 Stroke severity measures predictive of depression  
 * p<0.05  ** p<0.01 
As detailed in the methods section, at certain time points some variables had 15 to 25% 






Outcome Exposure OR and CI obtained on 
non imputed data 










Barthel score 0-14 1 1 








   
Depression in 
year 6 
Living home alone pre 
stroke 
1 1 




















Barthel Score 0-14 1 1 
















Barthel score 0-14 1 1 









Table 5.11 Predictors of depression after stroke. Comparison of results obtained with 
and without multiple imputations 
* p<0.05, ** p<0.01 
In most cases results obtained with MI were not significantly different from the ones obtained 
using a category for missing data. The association between Barthel score 20, showing 
independence for activities of daily living, and depression in year nine became not significant 
after using multiple imputation. Despite the change in statistical significance in one of the 
estimates, the difference between results was very small and of little clinical meaning. 
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5.4.2 Predictors of depression at any time point 
All the sociodemographic variables, except living condition pre-stroke, were associated with 
depression at any time point in the univariate analysis. Among the clinical variables 
investigated, smoking and drinking habit pre-stroke, amount of alcohol consumed per week, 
diabetes pre-stroke, ischaemic heart disease pre-stroke, GCS score, visual defects, dysarthria, 
cerebellar symptoms and stroke subtype were not associated with depression at any time 
point in the univariate analysis. All the other variables were associated with depression at any 
time point in the univariate analysis.  
Being unable to work, retired or unemployed, at baseline, and treatment for depression before 
stroke together with depression three months after stroke and anxiety three months after 
stroke are the main predictors of depression at any time point. Table 5.12 shows the ORs and 
CIs of the associations between sociodemographic, and clinical variables, and depression at 
any time point. 
The OR and CI for the association between treatment for depression before stroke and 
depression at any time point after stroke showed no difference with the one calculated with 
MI (Table 5.13). Similarly the results of the initial analysis for the association between 
neglect and depression at any time point were not different from the MI analysis. Finally, 
when MI was used, the association between Barthel score and depression was not different 
















F 1.25 (1.05-1.48)* 
Ethnicity White 1 
Black 1.16 (0.95-1.43) 
Other 1.93 (1.33-2.78)** 
Employment Working 1 
Unemployed 1.71(1.03-2.82)* 
Unable to work 2.31(1.54-3.46)** 
Retired 1.76(1.32-2.35)** 
Student/Carer 1.45(0.79-2.67) 
Social class Non manual 1 
Manual 1.39 (1.15-1.68)** 
Education level No formal education 1 
Primary 0.63 (0.15-2.62) 
Secondary 0.33 (0.88-1.25) 
Tertiary 0.19 (0.05-0.80)* 
Depression pre-stroke  1.62 (1.12-2.35)* 
Treatment for depression pre-stroke  2.00 (1.33-2.99)** 
Depression 3months after stroke  3.41 (2.51-4.62)** 
Anxiety 3 months after stroke  2.96 (2.12-3.86)** 
Fail Swallowing test   1.46 (1.17-1.81)** 
Urinary Incontinence  1.51 (1.24-1.84)** 
Neglect  1.53 (1.20-1.94)** 
Dysphasia  1.30 (1.04-1.62)* 
Paresis  1.73 (1.41-2.13)** 
Barthel  
index 7 days post-stroke 
 
0-14 1 
15-19 0.92 (0.71-1.18) 
20 0.47 (0.38-0.59)** 
Impaired Cognitive level  1.53 (1.21-1.94)** 
 
Table 5.12 Predictors of depression at any time point 




. OR (95% CI) OR (95%CI) MI analysis 
Treatment for depression pre-stroke 2.00 (1.33-2.99)** 2.00 (1.34-3.00)** 
Neglect 1.53 (1.20-1.94)** 1.48 (1.20-1.94)** 
Barthel score 7 days post-stroke   
                                            0-14 
1 1 
                                           15-19 0.92 (0.71-1.18) 0.89 (0.69-1.14) 
                                             20 0.47 (0.38-0.59)** 0.50(0.40-0.61)** 
 
Table 5.13 Predictors of depression at any time point. Comparison between results 
obtained with and without MI. 
* p<0.05, ** p<0.01 
5.4.3 Predictors of time after stroke of depression onset 
58.9% (n=361) of the patients with depression at any time point, assessed at three months, 
were depressed at three months. 
The only variables associated in univariate analysis with onset of depression at three months 
were not drinking alcohol pre-stroke, amount of alcohol consumed per week, dysphagia, 
urinary incontinence and paresis at baseline. These associations were still significant after 
adjusting for age, sex and ethnicity, except the association between not drinking alcohol and 
onset of depression. Patients drinking less than 14 units of alcohol per week had reduced risk 
of having depression at three months compared with patients not drinking any alcohol at all  
OR: 0.64(0.42-0.96) p=0.034. Consumption of other amounts of alcohol was not associated 
with depression starting at three months. Patients with dysphagia at baseline had increased 
risk of depression starting at three months compared with patients without dysphagia OR: 
1.71 (1.14-2.56) p=0.009. Patients with incontinence had increased risk of depression starting 
at three months OR: 1.60 (1.10-2.31) p=0.013. Patients with paresis at baseline also had 
increased risk of depression starting at three months OR: 1.64 (1.09-2.45) p=0.016. No 
significant interactions were identified. 
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5.4.4 Predictors of duration of depression 
50% (n=116) of the patients depressed at three months, assessed at one year had recovered 
from depression. 
The only variable associated in univariate analysis with depression lasting more than a year 
was dependence for activities of daily living at baseline. The association was still significant 
after adjusting for age, sex and ethnicity. Patients with mild disability (Barthel Index 15-19) 
were less likely to have long lasting depression than those with severe disability OR: 0.32 
(0.16-0.65) p=0.002. No significant interactions were identified. 
5.4.5 Predictors of recurrent depression 
Among the patients who were alive in year two, with incident depression observed at any 
time point, who had got at least three assessments, 56.2% (n=203) had recurrent depression. 
Only two baseline variables were associated with recurrent depression in univariate analysis. 
GCS over eight was associated with lower risk, and neglect was associated with a higher risk 
of recurrent depression. Both associations were still significant after adjusting for age, gender 
and ethnicity. Compared with patients with GCS three to eight, patients with GCS nine to 
twelve had lower risk of recurrent depression OR: 0.08 (0.009-0.76) p=0.027, and patients 
with GCS above twelve OR: 0.12 (0.01-0.98) p=0.048. Patients with neglect at baseline had 
higher risk of recurrent depression OR: 2.12 (1.15-3.91) p=0.016. 
5.4.6 Profile of patients at high risk of depression 
Female patients under 65, not working at the time of stroke, of manual social class, no formal 
education, severe stroke and previous history of depression seem to be the group at higher 
risk of depression at any time point after stroke. Amongst the predictors identified only 
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inability to work, treatment for depression before stroke, Barthel score 0-14 at baseline, 
depression three months after stroke, and anxiety three months after stroke, showed more 
than two fold increased risk of depression. However, there were only few patients in the 
register showing these predictors simultaneously. There were only nine patients assessed for 
depression, with treatment for depression before stroke, unable to work at the time of stroke, 
and Barthel score 0 to 14. All of them had depression at some point of the follow-up. Another 
55 patients had treatment for depression before stroke and Barthel score 0 to 14. The risk of 
depression at any time point for them was 76.4%. And finally 1365 patients had inability to 
work before stroke and Barthel score 0 to 14, of which 60.7% had depression at some point.   
5.4.7 Profile of patients at low risk of depression 
The results of this analysis also allow to define the profile of the patient at lower risk of 
depression: male patient, over 64 years of age, of non manual social class, tertiary education, 
no medical history of, or treatment for, depression pre-stroke, working at the time of stroke, 
intact cognitive level, absence of stroke severity measures (dysphagia, incontinence, neglect, 
dysphasia, paresis) and Barthel score of 20 seven days after stroke. There were no patients 
with this profile in the register. The risk of depression was calculated dropping one by one all 
these variables. The variables that could be dropped without raising the risk of depression 
over 15% (risk in general population) were gender, social class, education,  medical history 
or treatment for depression pre-stroke, intact cognitive level, and stroke severity measures. 
Therefore the profile of the stroke patients in which the risk of depression at any time point is 
lower than the one in general population is: patients over 65, working at the time of stroke, 
with Barthel score of 20 seven days after stroke. There were 20 patients observed with this 
profile of which only one (5%) had depression at some point time point after stroke.  
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5.4.8 Variables observed at follow-up associated with depression 1, 3, 6, 9, 12 and 15 
years after stroke 
All the variables investigated in the univariate analysis as potential associations were 
significantly associated with depression in at least one time point. In the multivariate analysis 
disability, not drinking alcohol, particularly not drinking 1 to 14 units a week, not having any 
one to turn to, not seeing relatives enough, not seeing friends enough, low level of activity, 
anxiety and cognitive impairment at follow-up, had significant association in at least three 
time points. Living in an institution, living alone, being unemployed or retired and smoking 
at follow-up are also associated with depression. The ORs and 95% CIs of the associations 
between depression at 1, 3, 6, 9, 12 and 15 years after stroke and follow-up variables, 
adjusted by age, sex and ethnicity are presented in tables 5.14 and 5.15. Not significant 
interactions were identified in the analysis of associations. 
Variables with 15 to 25% missing data were re-analysed as potential associations of 
depression at different time points using multiple imputation. Results obtained with multiple 
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Table 5.14 Sociological associations of depression after stroke 
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Table 5.15 Clinical associations of depression after stroke 






 Outcome Exposure OR and CI obtained on 
non imputed data 
OR and CIs obtained on 
imputed data 
Depression in year 6 Impaired cognitive 
level 
2.81(1.75-4.51)** 2.78(1.70-4.51)** 
Depression in year 9 Impaired cognitive 
level 
4.27(2.14-8.52)** 4.11 (2.06-8.18)** 
Depression in year 12 Frenchay score 0-15 1 1 
Frenchay score 16-30 0.15(0.04-0.52)** 0.15 (0.04-0.49)** 
Frenchay score 31-45 0.07(0.01-0.62)* 0.07 (0.008-0.58)** 
 
Table 5.16 Associations of depression after stroke. Comparison of ORs and CIs 
obtained with and without multiple imputation. 
* p<0.05, ** p<0.01 
 
5.5 DISCUSSION 
Depression at three months of stroke is the predictor most consistently associated with 
depression in the long term. Having disability at baseline consistently predicted a higher risk 
of depression. Anxiety three months after stroke, inability to work pre-stroke, being a smoker 
at baseline, and stroke severity were also predictors of depression. At follow-up, disability, 
low level of activity, not drinking alcohol, poor social networks and cognitive impairment 
were the variables most consistently associated with depression. In the analysis of predictors 
of depression at any time point, depression shortly after stroke and having no formal 
education compared with tertiary education, were the main predictors of depression. Stroke 
severity measures were also relevant predictors of depression at any time during the follow-
up, depression starting early after stroke and recurrence of depression. Patients over 65, 
working at the time of stroke and independent for activities of daily living at baseline had an 
overall lower risk of depression, while patients unemployed at the time of stroke, disable at 
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baseline and with depression and/or anxiety shortly after stroke had a higher risk of having 
depression at some point during the follow-up. 
5.5.1 Predictors and associations of depression 
Disability both at baseline and at follow-up and low activity level at follow-up showed strong 
association with depression. Similar associations were observed previously
98 105 165
 It has 
been reported that the scale used to measure disability (BI) has a ceiling effect and does not 
provide accurate assessments on patients with very severe disability.
199
 Therefore, in very 
disabled patients the association between depression and disability may be stronger than the 
one observed. Patients active at follow-up were approximately ten times less likely to be 
depressed than those who are inactive. It was noted that some male patients score lower in the 
activity scale (FAI) not only because of their disability but because of the role they have in 
their families. However, the association between inactivity and depression was observed after 
adjusting for gender. Inactivity was the variable with the strongest association with 
depression. Inactive patients should be particularly considered for their high risk of 
depression after stroke.  
Stroke severity, assessed by GCS, paresis, incontinence and other clinical variables, was a 
strong predictor of depression. Although some stroke severity measures like dysphagia were 
associated with depression up to 12 years after stroke, the associations were more consistent 
in the first three years of follow-up. Patients may become depressed shortly after stroke due 
to the experience of a life threatening event and its treatment. In the medium and long term, 
other variables like disability and isolation may be more relevant.
79
 For the analysis of the 
association between stroke severity and depression having data on the National Institute of 
Health Stroke Score (NIHSS)
205
 would have been ideal. This scale provides a very reliable 
and intuitive value for stroke severity.
206
 The case mix variables included in the models were 
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chosen for their clinical relevance and their prognostic value,
207 208
 and therefore provide 
informative estimates on the association between stroke severity and depression. The 
association between stroke severity and depression may be explained by the overall impact 
that a severe stroke has on patients and their families. Stroke severity is not a variable 
reflecting only biological changes. However, the association between severity and depression 
would also support the hypothesis of the direct links between neurological damage and 
depression.
264
 A previous systematic review of depression and stroke lesion location 
concluded that the evidence did not support the risk of depression after stroke being affected 
by the location of the brain lesion.
190
 The results of the literature review presented in Chapter 
two did not show a consistent association between depression and neurological damage, 
including stroke location, stroke size and stroke subtype. A severe stroke is a negative life 
event that puts the patient at risk of depression.
177 265
 This psychological effect, and not the 
neurological damage, may explain the association between stroke severity and depression. 
Stroke severity is in any case a predictor of clinical value, as it makes patients at high risk of 
depression identifiable right from the acute phase. 
The association between cognitive impairment and depression has been reported previously.
99
 
The associations between cognitive impairment, disability and depression are very complex 
as each of the three can be cause and or effect of the other.
62 63
 The association between 
disability and both cognitive impairment and depression may explain partly the association 
between depression and cognitive impairment. It has been reported that patients of lower 
educational attainment and older age may score lower in the cognition tests.
209
 The 
associations between cognitive impairment and depression were observed after adjusting for 
age. However, they may still be an overestimation in patients with low level of education.  
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Depression, and treatment for depression, before stroke were associated with depression at 
some point during the follow-up although no specific time points for this association were 
identified. A past medical history of depression may not be very relevant during the clinical 
management of a patient at the time of stroke. These data of past medical history may not 
have been accurately recorded in the medical notes and therefore it may not have been 
collected by the SLSR. It is possible that some patients who were depressed at some point 
before stroke may have been categorised as not having past medical history of depression. 
This would have led to an underestimation of the association between depression before 
stroke and after stroke. A systematic review of the predictors of depression after stroke 
reported no evidence of association between depression before stroke and depression after 
stroke.
62
 The differences in methods, sample size or time to follow-up may explain the 
difference between the previous studies and the results of this thesis. The aetiology of 
depression remains unclear.
31
 Factors such as biochemical disorders, genetics or personality, 
which may be involved in the aetiology of depression before stroke, are still present after the 
event and they may explain why depression before stroke in this dataset is associated with 
depression after stroke.  
A high long term risk of depression amongst patients depressed three months after stroke was 
also observed. Interventions targeting patients depressed at three months should consider the 
long term prognosis of depression shortly after stroke.  The association between anxiety at 
three months and depression in the long term may be explained by the strong association 
between anxiety and depression all along the follow-up. The risk of depression in patients 
with anxiety in general population is well documented.
266
 Traditional diagnostic and 
treatment approaches have used a hierarchical approach with depressive symptoms taking 
preference. Furthermore, some argue that certain forms of anxiety should be conceptualised 
as a residual or severity marker of depression.
267
 However, factor analysis has found that 
164 
 
anxiety and depression appear to be distinct 
266 268 269
 and differential response to treatment 
between the two conditions has been observed.
270
  In any case anxiety may be a clinical sign 
easy to recognise, alerting the clinician about the high risk of depression in the long term. 
Inability to work or being unemployed before stroke and at follow-up showed an association 
with depression. That was an expected result as patients with disability have a well reported 
high risk of depression.
271 272
 Up to 60% of patients in this study were under 65 years of age, 
the traditional age for retirement. Fear of economic stability, loss of job or job dissatisfaction 
have been previously reported as being associated with depression after stroke.
273
  
An association was observed between social isolation and depression. As described in chapter 
three, this variable was assessed with two non validated questions. However, these 
observations are very plausible. The association between isolation and depression in stroke 





. The negative impact that social isolation has on general health
194 195
 may play a role in its 
association with depression after stroke.  
The association between not drinking alcohol and depression was consistent during the 
follow-up. This association was especially consistent in patients drinking less than one unit a 
week. A lower risk of depression was identified also in a fewer number of time points for 
patients drinking one to 21 units a week, and no associations were found between drinking 
between more than 21 units a week (excessive drinking)
277
 and depression. These 
associations remained unchanged after adjusting for family and friends support. It seems that 
the association between drinking a low amount of alcohol and lower risk of depression is 
independent of the social behaviour. These results have to be interpreted with caution. 
Alcohol drinking behaviour is a  major concern in clinical medicine and public health.
277
 A 
recent systematic review showed a strong association between drinking alcohol excessively 
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and depression in general population.
23
 Our results did not show association between 
drinking over 21 units a week and depression. The case of stroke patients may be different 
from general population, or maybe the low number of SLSR patients in these categories 
(n<77) did not give statistical power enough to show the association. Many studies have 
investigated the association between excessive alcohol intake and depression
23
. The effect of 
moderate drinking on mental health outcomes may be investigated in future studies to 
confirm if low amounts of alcohol have a beneficial effect on mental health similar to the one 
observed on cardiovascular outcomes.
278
 It should also be mentioned that participants may 
not have reported their drinking habits truthfully. The lower response to epidemiological 
questionnaires that have sensitive items has been observed before.
213
 A large number of 
patients who drink heavily, reporting not to drink, could explain these results. 
Female patients had a higher risk of depression at two points of the follow-up. Most of the 
studies included in the systematic review presented in Chapter two found a higher risk of 
depression in women, although the difference was not statistically significant in most cases. 
In the general population the prevalence of depression is higher in women.
279
 Two large 




 for women compared to men. This thesis 
observed higher risk in women only at one and three years after stroke, and the ORs were 
1.29 and 1.41. The OR for depression in women observed during the whole follow-up period 
was 1.25. Stroke and its consequences reduce the difference in risk of depression between 
women and men although some difference can still be observed. Previous studies may not 
have had enough statistical power to detect this. 
Studies of the general population consistently show that the risk of depression is 




. However, in this thesis 
patients aged under 65 only had lower risk of depression at one time point. When the risk 
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over the whole follow-up was calculated the OR was 1.26 for patients under 65 compared to 
patients 65 or over. Stroke seems to be more relevant as an aetiological factor for depression 
than the other factors that lead to higher risk in younger individuals from general population. 
Therefore, after stroke age becomes a less important predictor of depression. 
Ischaemic heart disease pre stroke only predicted depression at nine years of stroke. Diabetes 
did not predict depression at any time points. None of them was associated with a higher risk 
of depression during the follow-up time. The association between chronic diseases and 
depression that has been reported in general population
258
 was not observed in this thesis. It 
seems that stroke and its consequences are more important factors for depression than other 
chronic diseases present prior to stroke. 
 The hypothesis suggesting that there are biological psychological and social factors involved 
in the aetiology of depression is widely accepted
19 31 279
. This thesis aimed mostly to 
investigate predictors of depression that could be useful in clinical medicine and public 
health. The role of biological factors such as stroke severity, psychological factors such as 
anxiety, and social factors such as social isolation, was observed. Most predictors were not 
purely biological, psychological or social, and in many cases there was strong colinearity 
amongst them.  
There were a low number of variables predicting outcomes of the natural history of 
depression after stroke. The risk of depression at some point after stroke can be predicted 
with sociodemographic and clinical observations but the association of these variables with 
the natural history of depression is much weaker. Stroke severity measures predicted 
depression starting within three months of the acute event and an increased risk of recurrent 
depression. Disability predicted depression lasting more than a year. These results confirm 
the hypothesis that patients may become depressed at different times for different reasons, 
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with stroke severity being more relevant shortly after the acute event, and disability in the 
long term. The rest of observed variables showed no significant association with any 
outcomes of the natural history of depression after stroke. 
5.5.2 Strengths and limitations 
The population based register data and long follow-up provide some of the strengths of this 
analysis. The high statistical power derived from the large sample size allows building stable 
regression models of predictors even long after stroke, when mortality has reduced the cohort 
of patients importantly. This study of predictors has also been conducted according to 
accepted criteria
88
, which includes minimisation of selection bias, assessment of mood with a 
validated tool, proper description of the statistical methods, adequate sample size, correct 
description of explanatory variables, inclusion of confounders in the models, reporting of 
ORs and CIs and production of clinically meaningful results. Hackett et al, in their systematic 
review of studies of predictors of depression after stroke, discussed that a previous history of 
depression could be included in the statistical models as a potential confounder. They also 
mentioned other potential confounders to be considered such as comorbidities, cognitive 
impairment (which may modify any psychological reaction), physical disability, social 
support or bereavement, as they are common amongst stroke survivors.
26
 Since the election 
of confounders is a matter of judgement, this observation may be right. However, these 
variables may not only be confounders but variables in the causal pathway between the 
exposure and the outcome. The results of an analysis including these variables in the models 
would have been more difficult to interpret. 
As discussed in chapter three, the estimation of clinical outcomes using scales has some 
limitations. Nonetheless, all scales have good performance and they allowed assessing a very 
large number of patients during a long follow-up, which would have been unfeasible 
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otherwise. The potential error introduced by each individual scale is acknowledged in the 
discussion of the different results.  
The interpretation of these results should account for the possible residual and unmeasured 
confounding. When analysing epidemiological data, the true model is not known; the 
variables actually confounding the association of interest, the form in which they should enter 
the model, or the time scale over which they act are uncertain. It has been suggested that 
confounders can be identified by evaluating the change in the exposure-outcome estimate. 
For example, if the estimate adjusted for a variable differs by more than 15% from the 
estimate obtained without adjusting, the variable should be considered a confounder. 
However, strict adherence to such a rule could lead to true confounders' being disregarded. In 
this thesis, the variables included in the models were informed by the systematic review 
presented in chapter two.  In some studies, confounders are omitted from the analysis because 
of missing data leading to loss of information. In this chapter this potential source of bias due 




The personal and technical resources involved to follow-up so many stroke patients for so 
long have been substantial. As all cohort studies, the SLSR has some missing data. It should 
be noted that an important reduction of the sample size during the follow-up is due to 
mortality and not to loss to follow-up. As presented in chapter four, there were little 
differences between sociodemographic characteristics of patients who were and those who 
were not assessed for depression. Up to ten years after stroke those who were not assessed 
tended to have more severe strokes. However, two different statistical methods have been 
used to remove the bias coming from the missing data:  sensitivity analysis and MI, for the 
analysis of predictors with 15 to 25% missing data. MI was conducted under the assumption 
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that missing data was missing at random (MAR). The results of MI are quite consistent with 
the ones obtained without it. An important part of the missing data may be missing 
completely at random (MCAR), therefore not introducing bias. It could still be assumed that 
the possibility of being missing might be associated with not observed variables, which is a 
pattern of data missing not at random (MNAR). Probably this is the case for some of the 
missing data. However, it should be acknowledged that MI and complete case estimates were 
always consistent. This suggests that, while part of the sociodemographic groups are more 
likely to be missing than others, this had little impact on the estimates of predictors of 
depression after stroke.  
An important limitation that could not be managed during the field work and neither during 
the statistical analysis is that some patients were unable to respond to the HAD questionnaire. 
Our analysis was restricted to patients with the outcome variable observed. The proportion of 
patients with severe strokes, cognitive impairment, and other variables predicting depression 
is higher amongst those not responding to HAD than in those who respond. The proportion of 
patients with depression may also be higher amongst those not responding to HAD. Therefore 
the bias could not be completely removed. The association between the predictors identified 
and depression may be stronger than what has been observed in this chapter, higher ORs. 
This is a limitation affecting most studies not only of depression after stroke but of 
depression in general.
79
 Even in patients in whom depression was assessed, the assessments 
were done with a scale. Although the psychometric properties of HAD are good and the cut-
off point used to identify cases of depression was the one recommended by a systematic 
review, ideally depression should be diagnosed with the DSM-IV criteria. The use of a scale 
was needed as the annual assessment of such a large number of patients with DSM-IV criteria 
would have been unfeasible.  
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5.5.3 Implications for clinical practice 
This chapter shows that 60% of the patients with disability at baseline, who were unable to 
work at the time of stroke, had depression at some point. This profile of high risk is easy to 
identify for the clinician.  The number of patients fitting this profile was large (1365). 
Interventions should focus in this particular group of survivors as the need for medical 
treatment for depression may be specially needed. 
Patients over 65 years of age working at the time of the stroke, with no disability had lower 
risk of depression than the general population. However, the number of patients fitting these 
profiles is low. Most of these predictors were not present at the same time in the same patient. 
Therefore it remains difficult to describe a clinical profile for patients at low risk of 
depression which may not require interventions at all. Clinicians should still be aware of the 
overall high risk of depression after stroke even in patients not fitting the high risk profile, in 
both the short and the long term.  
Depression can be screened with two questions: During the past month, have you often been 
bothered by feeling down, depressed, or hopeless? and During the past month, have you often 
been bothered by little interest or pleasure in doing things? If the response is "yes" to either 
question patients should be assessed further.
281
 This very simple tool has 97% sensitivity and 
67% specificity in adults.
282
 Stroke physicians and GPs should be able to use the screening 
tool and also to use the DSM criteria
85 86
, in case the screening indicates so, to make a formal 
diagnosis of depression. Since depression is so frequent after stroke, the time of highest risk 
is shortly after the acute event, and the screening tool is so simple, it could be suggested that 
all stroke patients are routinely screened for depression during the acute phase. After 
discharge patients should be screened periodically in the long term by the primary care team. 
The high risk of patients with inability to work before stroke and disability after stroke should 
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be acknowledged by clinicians. GPs and primary care nurses should also be aware not only of 
the baseline predictors but also the associations of depression that may be present at follow-
up.  It should be noted that the risk of depression decreases very significantly if a patient is 
not depressed shortly after stroke. Policy makers could consider the inclusion of this need for 
clinical action in the primary care guidelines.
283
  
In order for these interventions to have a positive clinical effect, cooperation from patients 
and carers is required. Doctors must make sure that patients and carers understand that 
depression is likely to present shortly after stroke and that it can be approached medically. 
They have to know the symptoms of depression that should make them seek medical advice 
promptly.  Finally, patients should know that most episodes of depression have relatively 
short duration. 
5.5.4 Implications for future research 
Since most interventions implemented so far were based on poor epidemiological evidence, it 
will be necessary to re-examine the benefits of screening, prevention and treatments when 
they are used at the time of maximum risk with the right patients. 
Most predictors of depression are not only biological. These include unemployment, 
disability, low level of activity, not drinking alcohol and poor social networks. Other 
predictors, such as anxiety, depression shortly after stroke and cognitive impairment, have a 
biological component as well as a social and/or psychological one. However, the most 
common approach to treating depression is still antidepressants.  In the future researchers 
should also consider a more complex approach that may have to be delivered in cooperation 
with professionals working outside the health service. These interventions may include group 
physical activity programmes, peer support groups, and behavioural couples’ therapy.   
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Like in other areas of medicine, whether interventions are effective or not may depend on 
patients, carers and clinicians views, opinions and beliefs. Qualitative research studies on this 


















CHAPTER 6: ASSOCIATIONS BETWEEN DEPRESSION IN THE FIRST YEAR 
AND OTHER HEALTH OUTCOMES UP TO 15 YEARS AFTER STROKE 
6.1 ABSTRACT 
Background: Evidence on the association between depression after stroke and other health 
outcomes in the long term is insufficient to understand the overall relevance of depression 
after stroke. 
Objective: To investigate the association between depression in the first year after stroke and 
mortality, stroke recurrence, disability, cognitive impairment and quality of life up to 15 
years after stroke. 
Methods: Data from patients with first ever strokes registered in the population-based South 
London Stroke Register between January 1995 and December 2009 (N at registration=4022). 
Patients were followed up three months after stroke and then every year for up to 15 years. 
Follow-up included assessments for depression (Hospital Anxiety and Depression,  
depression subscales scores >7 = depression) disability (Barthel Index), cognition 
(Abbreviated memory test or Mini-mental estate examination), and health related quality of 
life (SF-12 or SF-36). Multivariable regression models were used to investigate the 
association between depression within a year of stroke and mortality, stroke recurrence, 
disability, cognitive impairment and quality of life up to 15 years after stroke. Models were 
adjusted for age, sex, ethnicity, stroke severity (Glasgow coma score, urine incontinence and 
hemiparesis) disability in the acute phase of stroke. 
Results: Depression in the first year after stroke was associated with higher mortality up to 
15 years after stroke.  No significant association was identified between depression and 
stroke recurrence. Disability and cognitive impairment rates were also significantly higher 
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amongst patients depressed in the first year after stroke. Depression after stroke also showed 
a consistent association with lower quality of life at follow-up.  
Conclusion: Depression is independently associated with negative health outcomes. These 
finding should be considered when assessing the clinical relevance of depression after stroke. 
Future interventions for depression after stroke may have an effect on these outcomes as well. 
 
The analysis of outcomes of depression up to 15 years after stroke was presented as an oral 
presentation in the 2011 European Stroke Conference. (Appendix one) 
A paper with the results presented in this chapter has been published in the Journal of 













The analysis of the natural history of depression after stroke described on Chapter four shows 
that depression is a frequent, chronic and recurrent problem among long term stroke 
survivors. However, in order to understand the clinical impact of depression after stroke, it is 
also necessary to investigate the association between depression and other health outcomes in 
the long term.  
The literature review included five studies reporting an association between depression and 
other health outcomes.  Nonetheless, most of these studies had limitations including small 
sample size, short follow-up, and a poor description of the statistical methods used for the 
analysis.  Therefore, the association between depression after stroke and other health 
outcomes remains poorly understood.  
This Chapter will address the following question: 
- What are the long term associations of depression after stroke? 
6.2.1 Depression and mortality 
The systematic review presented in Chapter two identified two studies where depression after 
stroke was associated with higher mortality
177 178
 and a third one reporting no association 
between depression and mortality.
117
 The two studies reporting that depression after stroke 




. They recorded 
whether patients were still alive 17 months, and 8 to 11 years after stroke respectively, and 
reported increased mortality amongst depressed patients with Odd Ratio (95%CI): 3.7 (1.1-
12.2) and 8.1 (0.9-72.9). The study where depression after stroke did not predict higher 
mortality had a sample size of 163 and the data on mortality was collected 13 months after 
stroke. No numerical result was presented for this lack of association.
117
 The description of 
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the methods in the three studies was very brief. The variables included in the predictive 
models were not reported, therefore it was not possible to know whether the statistical 
analysis had been conducted according to quality criteria.
88 198
 It is difficult to interpret the 
inconsistency observed in these three studies. Their validity, and therefore the clinical 
implication, of these studies is unclear. The electronic search identified other studies 
including two of good quality, from which patients with haemorrhagic strokes had been 
excluded, observing an association between depression and mortality. The interpretation of 
these results was made with caution as the difference in the populations with the studies of 
unselected stroke patients was noted.
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Previously, higher mortality has been observed in patients with depression in the general 
population (not disease specific samples) 
284 285
 and also amongst patients with depression 




 and ischaemic heart disease.
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Depression after stroke has some similarities with depression in general population
15
 such as 
the chronic recurrent course reported in the Chapter four of this thesis. It would be plausible 
that depression after stroke may be associated with increased mortality in the long term as 
opposed to a null hypothesis of no association between depression after stroke and mortality. 
Testing this hypothesis should provide evidence on the impact of depression in stroke 
patients and should help to develop effective interventions for it. 
6.2.2 Depression and stroke recurrence 
Patients surviving an initial stroke are known to be at significantly increased risk for further 
strokes compared to the general population.
288
 An association between depression and an 
increased cardiovascular risk has been reported in a systematic review. However, the authors 
of this review noted that studies were very heterogeneous and therefore they recommended 
that the results of the meta-analysis should be interpreted with caution.
289
 Two systematic 
177 
 
reviews reported an association between depression and a stroke specific increased risk.
289 290
 
In 2007 Van der Kooy and colleagues reported a pooled OR for patients with depression 
compared with those not depressed of 1.43 (1.17-1.75).
289
 In 2011 Pan and colleagues 
reported pooled adjusted HRs of 1.45 (95% CI, 1.29-1.63) for total stroke, 1.55 (95% CI, 
1.25-1.93) for fatal stroke, and 1.25 (95% CI, 1.11-1.40) for ischemic stroke.
290
 Considering 
this evidence it could be hypothesized that depression after stroke may be associated with a 
higher rate of stroke recurrence. However, a previous study conducted with ten years follow-
up data from the SLSR did not identify depression after stroke as a predictor of stroke 
recurrence.
291
 In this study depression was included in a model with other potential predictors 
of recurrence and backward stepwise logistic regression was used. This statistical method has  
limitations, as there is a chance that the automated selection may not include all the clinically 
relevant variables, such as depression, in the final model.
292
 The systematic review presented 
in Chapter two did not identify any other studies where patients had been assessed for 
depression after stroke and then for stroke recurrence at a later time point.  In this chapter, 
using 15 years follow-up data from the SLSR, it will be tested whether depression after stroke 
predicts stroke recurrence or not.  
6.2.3 Depression and disability 
The association between depression and disability at a later time point has been documented 
in general population.
293
 This association has also been observed in patients with other 
conditions such as chronic obstructive pulmonary disease, heart failure and diabetes.
294 295
 
However, most studies conducted in stroke patients have investigated disability as a predictor 
of depression, or as an association present at the same time. The systematic review  
conducted for this thesis identified one study of unselected stroke patients reporting that 
depression in the acute phase predicts disability one year after stroke.
179
 Although the quality 
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 it still had some limitations such a 
short follow-up. In any case the results coming from only one paper may not be enough to 
inform significant changes in clinical practice. A previous systematic review identified other 
studies reporting an association between depression after stroke and disability.
63
 However, 
most studies in that review had some limitations including selection of patients of specific 
age groups and assessments for depression and disability at the same time point after stroke. 
The analysis presented in Chapter five showed that disability during the acute phase of stroke 
predicts depression at follow-up and also that disability and depression present 
simultaneously during the 15 years following a stroke. Whether or not depression after stroke 
is independently associated with disability at follow-up remains unclear.  
6.2.4 Depression and cognitive impairment 
Cognitive impairment has been widely reported in patients with depression in general 
population.
296
 It has also been reported as an outcome of stroke.
259
 However, the systematic 
review presented in Chapter two did not identify any studies of good quality where patients 
assessed for depression after stroke had been assessed for cognitive impairment at a later time 
point. The effect of depression in the cognitive status of stroke patients remains unknown.  
6.2.5 Depression and quality of life 
Two studies included in the literature review (Chapter two) identified depression after stroke 
as a predictor of lower quality of life one year after stroke.
179 180
 However, only one of them 
described properly the methods used in the analysis.
179
 The association between depression 
after stroke and the quality of life in the long term has not been investigated.  
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The evidence on the association between depression after stroke and quality of life, as well as 
the association between depression after stroke and mortality, stroke recurrence, disability, 
and cognitive impairment, is weak. 
6.3 METHODS: 
Data from patients registered in the SLSR between 1
st
 January 1995 and 31
st
 December 2009 
(N at registration=4022) were used to address the question. Follow-up data from these 
patients, collected between the 1
st
 April 1995 (first three months follow-up assessments) and 
the 31
st
 August 2010, were used. The number of patients available for each follow-up has 
been presented in chapter four (Figure 4.1). Patients were registered during the acute phase of 
stroke and then they were followed up The methodology of the SLSR has been described in 
chapter three and is summarised below. 
Assessments for depression were performed using the Hospital Anxiety and Depression scale 
(HAD).
214
 Patients with a score > 7 in the depression subscale were considered to have 
depression.
218
  HAD was routinely collected between 1997 and 2006. Patients registered in 
1995 (n=299) were not assessed at three months and one year but they were assessed in 
subsequent follow-ups. Patients registered in 1996 (n=350) were not assessed at three months 
but they were assessed at subsequent follow-ups. Data on HAD was therefore not included 
from these patients in the respective estimates for early rates of depression. As HAD cannot 
be answered by proxy, no data could be collected from patients unable to respond to the 
questionnaire, which included patients who had a cognitive deficit, severe disability, 
communication difficulties or multiple comorbidities that the fieldworker judged such that 
the completion of the questionnaire would be invalid.  
Disability was assessed at each follow-up with the Barthel index. 
211 260
 Scores of 0-14 were 
categorised as severe disability, 15-19 moderate disability, and 20 independent. 
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Cognitive function was also assessed at each follow-up with the Mini Mental State 
examination (MMSE)
209 259
 except from the period between 2001 and 2006 when the 
Abbreviated Memory Test (AMT)
210
 was used. Patients with MMSE score <24 or AMT 
Scores 0-7 were considered cognitively impaired.
209 210
 
Quality of life (QoL) was assessed with the SF-36
226
 between 1995 and the 29
th
 of February 
1999, and the SF-12
227
  between the 1
st
 of March 1999 and the 31
st
 August 2010. Two 
domains of QoL were observed mental domain and physical domain. Scores collated from the 
scales ranged from 0 to 100 with high score representing better QoL.
226 227
 
Mortality data was collected by the SLSR follow-up team or from the Office of National 
Statistics (ONS). An updated list was sent every six months to the Office for National 
Statistics of all patients who were alive or who were known to be deceased but for whom 
there was no death record. They informed the register of any patients that had died. Finally 
Death certificates from the Health Authority serving the SLSR population and post-mortem 
records from the local coroner’s office were also searched every three months. 
The same overlapping sources used by the SLSR to identify first ever strokes were used to 
identify recurrent strokes. 
6.3.1 Statistical Methods: 
The analysis of the natural history of depression after stroke, presented in Chapter four, 
showed that most patients have the first symptoms of depression within a year of stroke with 
less than 10% of patients presenting their first episode of depression after that time. In this 
chapter depression at three months and one year after stroke, or at either of these two time 
points, were used as the exposure variable in all the analyses. Mortality, stroke recurrence, 
disability, cognition and quality of life up to 15 years after stroke were the outcome variables. 
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The number of patients was higher in the first five years of follow-up, allowing for a much 
more stable regression models and higher statistical power, therefore the analysis focused on 
outcomes observed during this period. However, in order to make the best possible use of the 
long term data, and provide evidence on the long term impact of depression after stroke, 
associations between depression an outcomes observed after year five years of follow-up 
were also reported.  
Table 6.1 shows the distribution of variables included in the models. These are 
sociodemographic and clinical variables measured at baseline, and depression during the first 
year after stroke.  
The statistical methods needed to handle missing data on outcomes are computationally 
intensive and not routinely included in statistical software so they are not commonly 
applied.
232
 Therefore, only patients with complete outcome data were included in the 
analysis. Most variables analysed as potential predictors had some missing data. A separate 
category was assigned to them e.g.: Paresis 0 (No), 1 (Yes), and 2 (Missing). Sensitivity 
analysis was conducted to compare estimates obtained in multivariate analysis when the 
category for missing data was included and when it was not included. Estimates of the 
analysis conducted with and without the missing data category are reported. 
 Univariate analyses, using Kaplan–Meier curves, log rank tests and Cox regression models, 
were used to test the association between depression at three months, one year, and at either 
of these two time points, and mortality up to 15 years after stroke.  At a second stage, 
potential confounders, including case severity (GCS, incontinence and hemiparesis), together 







  N (%) 
Age 0-64 1248 (31.03) 




Gender Male 2029 (50.45) 




Ethnicity White 2889 (71.83) 
Black 805 (20.01) 




G-C-S 3-8 652 (16.21) 
9-12 450 (11.19) 




Paresis No 714 (17.75) 




Incontinence No 2025 (50.35) 




Barthel score 0-14 1775 (44.13) 
15-19 521 (12.95) 




Depression at 3 months No 740 (25.02) 




Depression at 1 year No 876 (33.11) 




Depression at either 3 months  
or  1 year 
No 982 (34.9) 
Yes 602 (21.4) 
Unknown 1232 (43.7) 
Table 6.1. Variables included in the models. 
In a similar way, univariate analyses using Kaplan–Meier curves, log rank tests and Cox 
regression models were used to test the association between stroke recurrence up to 15 years 
after stroke in patients depressed and not depressed at three months, one year after stroke and 
at either of these two time points. At a second stage, potential confounders, including case 
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severity (GCS, incontinence and hemiparesis), together with disability at baseline, age, sex 
and ethnicity were included in the Cox models.
297-309
  
Univariate multinomial logistic regression models were used to analyse the association 
between depression three months after stroke, one year after stroke, and at either of these two 
time points, and disability at follow-up. Then multivariate analyses were conducted in which 
models were adjusted for age, gender, ethnicity, stroke severity measures (GCS, Incontinence 
and hemiparesis) and disability at baseline. Data used in the analyses is presented in 
Appendix five. 
The association between depression at three months, one year and either of these two time 
points, and cognitive impairment was analysed with univariate logistic regression. In a 
second stage models were adjusted for age, gender, ethnicity, stroke severity measures (GCS, 
incontinence and hemiparesis) and disability at baseline. Data used in these analyses are 
presented in Appendix six 
Univariate linear regression models were used to investigate the association between 
depression at three months, one year and either of these two time points and quality of life at 
follow-up. Then models were adjusted for age, gender, ethnicity, stroke severity measures 
(GCS, incontinence and hemiparesis) and disability at baseline. Data used in these analyses is 
presented in Appendices seven and eight. 
The multivariate statistical models were built, in the analyses of outcomes following 
guidelines for prospective studies in stroke cohorts: The regression method was chosen 
depending on the outcome. Important potential confounders were included in the models. 74 
185
 The models intended to be useful in clinical practice, they were therefore predictive 
models (aiming to calculate the probability that an event occurring) and only included readily 
available pre-stroke and acute stroke variables. The sample size was adequate to build the 
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model and when the sample size introduced any limitations it was reported. The number of 
cases with the outcome of interest and the total number of cases in the sample were reported. 
74 185
  All independent variables have been clearly described, including when each variable 
was measured, how it was measured and coded, and in what form it was entered into the 
model. There was also an adequate number of people with each risk factor for the model. 
Automated methods, which can select data only for being statistically significant rather that 
clinically meaningful, were not used. Reporting the usefulness of the model included 95% 
confidence intervals around odds ratios. Interaction terms for age and Barthel score, were 




6.4.1 Depression and mortality 
In the 15 years of follow-up death was reported in 1448 patients who were alive at three 
months and 1136 patients alive at one year. The mortality rate was higher for patients who 
were depressed at three months, one year or at either of these two time points in the 
univariate analyses. Figures 6.1, 6.2 and 6.3 show the Kaplan-Meir survival curves, and the 
results of log rank tests, for these associations. 
In the adjusted analysis, depression at three months, depression in the first year and 
depression during year one were still associated with higher mortality. However, when the 
analysis was conducted with patients with complete data only, the evidence of association 
between depression at one year and mortality became weaker HR: 1.22 (0.98-1.54). Tables 
6.2 and 6.3 show the Hazard ratios for these associations for multivariate analysis conducted 






Log rank test p=0.0031 
Figure 6.1 Survival of patients by depression state at 3 months 
 
 
Log rank test p=0.0102 
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Log rank test p=0.0012 
Figure 6.3 Survival state by depression state during year 1 (depressed at either 3 
months or 1 year) 
 
Hazard ratio CI p 
Depressed at 3 months 1.25 1.03-1.53 0.023 
Depressed at 1 year 1.25 1.02-1.54 0.029 
Depressed during year 1 1.25 1.06-1.47 0.007 
 
Table 6.2 Mortality at follow-up of patients depressed at different time points. 
Multivariate analysis. Category for missing data included. 
 
 Hazard ratio CI p 
Depressed at 3 months 1.37  1.08-1.73 0.009 
Depressed at 1 year 1.22 0.98-1.54 0.080 
Depressed during year 1 1.34 1.11-1.62 0.002 
 
Table 6.3 Mortality at follow-up of patients depressed at different time points. 
Multivariate analysis for patients with complete data only. 
6.4.2 Depression and stroke recurrence 
In the 15 years of follow-up stroke recurrences were recorded in 314 patients, and in another 
205 patients, who were alive and recurrence free at three months and at one year respectively. 
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of recurrence at follow-up in univariate analysis. Figures 6.4, 6.5 and 6.6 show the Kaplan-
Meier curves, and the log rank test results, for these associations. 
 
 
Log rank test p=0.7613 























Log rank test p=0.8458 
Figure 6.5 Recurrence rate by depression state at 1 year 
 
Log rank test p=0.8274 









































The multivariate analysis did not show any significant difference in the risk of recurrence 
between patients with and without depression at three months, one year or during year one. 
(Table 6.4 and table 6.5) 
 Hazard ratio CI p 
Depressed at 3 months 1.03 0.64-1.65 0.903 
Depressed at 1 year 1.18 0.69-2.00 0.550 
Depressed during year 1 0.97 0.60-1.55 0.893 
Table 6.4 Recurrence at follow-up of patients depressed at different time points. 
Multivariate analysis. Category for missing data included 
 Hazard ratio CI p 
Depressed at 3 months 1.09 0.61-1.94 0.779 
Depressed at 1 year 0.83 0.45-1.54 0.558 
Depressed during year 1 0.73 0.41-1.28 0.268 
Table 6.5 Recurrence at follow-up of patients depressed at different time points. 
Multivariate analysis. Category for missing data not included. 
The Kaplan-Meier curves showed some difference in the time free of recurrence in the first 
few years after stroke. Therefore the analysis was repeated but the time was limited to three 
years after stroke and then to five years after stroke. The univariate and multivariate analysis 
showed no difference in the risk of recurrence for patients with and without depression at 
three months, one year or either of these two time points, when the analysis was limited to 
three and five years after stroke.  
6.4.3 Depression and disability 
The univariate analyses showed that depression at three months, one year, and during year 
one was consistently associated with disability in the first five years of follow-up. The 
associations between depression and disability after year five were still consistent until year 
seven. There were some associations after year seven although they were not consistent and 
no significant associations were found from year 13 onwards. The relative risk was 
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consistently higher for the association between depression and severe disability than for the 
association between depression and mild disability. 
The multivariate analyses produced similar results, with depression in the first year after 
stroke consistently showing an independent association with disability in the first five years. 
The associations were still consistent until year seven and then some less consistent 
associations were identified until year 12. The relative risk was also consistently higher for 
the association between depression and severe disability than for the association between 

















Depression at 3 months 
RR (95%CI) 
Depression at 1 year 
RR (95%CI) 
Depression during year 1 
RR (95%CI) 
1 year Mild 2.80(1.93-4.07)** 2.05(1.49-2.82)** 2.45(1.85-3.26)** 
Severe 
 
4.71(2.96-7.48)** 4.26(2.86-6.33)** 4.87(3.39-7.00)** 
2 year Mild 2.62(1.72-3.99)** 1.62(1.10(2.39)* 1.85(1.33-2.58)** 
Severe 
 
3.61(2.08-6.26)** 2.53(1.52-4.21)** 2.75(1.77-4.27)** 
3 year Mild 1.96(1.24-3.09)** 2.34(1.52-3.60)** 2.00(1.39-2.87)** 
Severe 
 
3.62(2.07-6.33)** 3.78(2.22-6.44)** 3.54(2.25-5.58)** 
4 year Mild 1.73(1.05-2.84)* 2.12(1.30-3.44)** 2.05(1.36-3.08)** 
Severe 
 
3.28(1.74-6.17)** 3.38(1.82-6.27)** 3.61(2.14-6.09)** 
5 year Mild 1.51(0.83-2.75) 1.69(0.91-3.11) 2.03(1.22-3.38)** 
Severe 
 
2.83(1.37-5.84)** 2.67(1.31-5.46)** 3.40(1.84-6.27)** 
6 year Mild 1.50(0.79-2.87) 2.52(1.34-4.72)** 1.73(1.03-2.92)* 
Severe 
 
2.50(1.16-5.39)* 3.09(1.47-6.51)** 2.73(1.47-5.06)** 
7 year Mild 3.27(1.49-7.14)** 2.39(1.13-5.05)* 3.07(1.62-5.81)** 
Severe 
 
3.14(1.12-8.80)* 2.92(1.21-7.01)* 2.91(1.34-6.35)** 
8 year Mild 1.57(0.64-3.88) 1.86(0.80-4.32) 1.92(0.93-3.94) 
Severe 
 
1.47(0.53-4.03) 3.35(1.30-8.61)* 2.58(1.14-5.80)** 
9 year Mild 2.78(0.87-8.90) 3.28(1.13-9.51)* 2.83(1.18-6.81)* 
Severe 
 
2.47(0.67-9.12) 5.53(1.73-17.67)** 2.84(1.05-7.66)* 
10 year Mild 1.57(0.35-7.06) 2.06(0.52-8.20) 1.60(0.52-4.93) 
Severe 
 
1.62(0.31-8.46) 3.78(0.83-17.19) 1.66(0.48-5.78) 
11 year Mild 1.67(0.25-11.07) 1.30(0.33-4.78) 1.36(0.40-4.63) 
Severe 
 
2.29(0.33-15.61) 5.06(1.12-22.80)* 4.05(1.01-16.20)* 
12 year Mild 1.30(0.09-17.91) 1.63(0.14-19.11) 2.58(0.35-18.93) 
Severe 
 
5.11(0.29-88.38) 7.54(0.82-69.40) 8.61(1.07-69.17)* 
13 year Mild - 2.35(0.09-57.23) 2.35(0.10-57.23) 
Severe 
 
- 3.51(0.10-120.77) 3.52(0.10-120.77) 
14 year Mild -. - - 
Severe 
 
- - - 
15 year Mild - - - 
Severe - - - 
Table 6.6  Disability at follow-up in patients with depression at different time points. 










Depression at 3 months 
RR (95%CI) 
Depression at 1 year 
RR (95%CI) 
Depression during year 1 
RR (95%CI) 
1 year Mild 2.75(1.75-4.30)** 2.42(1.67)** 2.58(1.84-3.61)** 
Severe 
 
4.12(2.33-7.31)** 4.07(2.53-6.54)** 4.27(2.75-6.61)** 
2 year Mild 3.00(1.84-4.87)** 1.89(1.20-2.97)** 2.10*(1.42-3.10)** 
Severe 
 
3.29(1.72-6.29)** 2.18(1.20-3.95)** 2.19(1.31-3.67)** 
3 year Mild 2.05(1.23-3.40)** 2.32(1.45-3.71)** 2.13(1.42-3.18)** 
Severe 
 
3.28(1.74-6.18)** 3.78(2.11-6.75)** 3.27(1.97-5.41)** 
4 year Mild 1.75(1.00-3.07)* 2.05(1.21-3.47)** 1.95(1.25-3.06)** 
Severe 
 
3.23(1.55-6.72)** 2.93(1.50-5.72)** 3.10(1.72-5.56)** 
5 year Mild 1.16(0.58-2.29) 1.26(0.64-2.49) 1.64(0.93-2.91) 
Severe 
 
2.61(1.13-6.03)* 2.49(1.13-5.46)* 3.06(1.54-6.07)** 
6 year Mild 1.03(0.50-2.12) 1.99(1.02-3.89)* 1.40(0.79-2.47) 
Severe 
 
1.68(0.67-4.22) 2.89(1.27-6.57)* 2.16(1.06-4,43)* 
7 year Mild 3.04(1.25-7.42)* 2.05(0.89-4.74) 2.66(1.30-5.47)** 
Severe 
 
1.56(0.36-6.68) 2.44(0.88-6.78) 2.19(0.86-5.58) 
8 year Mild 3.23(0.98-10.63) 1.67(0.66-4.23) 2.42(1.06-5.53)* 
Severe 
 
1.76(0.45-6.97) 3.25(1.11-9.48)* 3.06(1.11-8.42)* 
9 year Mild 5.53(0.83-36.63) 2.91(0.82-10.30) 2.81(0.99-7.94) 
Severe 
 
5.81(1.01-33.49)* 4.31(1.16-15.93)* 2.51(0.83-7.60) 
10 year Mild 0.09(0.002-3.46) 20.58(1.22-346-67)* 2.54(0.53-12.27) 
Severe 
 
0.14(0.002-9.45) 78.17(2.89-2112-77)* 2.75(0.39-19.28) 
11 year Mild - - 2.22(0.38-13.00) 
Severe 
 
- - 13.11(1.26-136.21)* 
12 year Mild - - - 
Severe 
 
- - - 
13 year Mild - - - 
Severe 
 
- - - 
14 year Mild - - - 
Severe 
 
- - - 
15 year Mild - - - 
Severe - - - 
Table 6.7  Disability at follow-up in patients with depression at different time points. 








6.4.4 Depression and Cognitive Impairment 
The univariate analysis showed that depression three months after stroke was associated with 
cognitive impairment in the first five years after stroke only in years one and two. After year 
five a significant association in year six was identified. Depression in year one was 
consistently associated with cognitive impairment in years one to five. After year five the 
associations were still consistent until year eight. Depression at either three months or one 
year was consistently associated with cognitive impairment in the first five years of follow-
up. After that the associations were also significant in year six and in year eight 
The multivariate analysis showed that depression after stroke was independently associated 
with cognitive impairment up until year eight. However, these associations were not entirely 
consistent for all the depression measurements and the cognitive impairment at all time 
points. (Table 6.8) 
When the sensitivity analysis was conducted and the category for missing data was not 
included, depression at three months was not associated with cognitive impairment in any of 
the follow-up time points. Depression in year one, or at either three months or one year, were 











Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year 1.66(1.11-2.47)* 1.84(1.30-2.62)** 1.53(1.12-2.09)** 
2 year 1.49(0.96-2.30) 1.97(1.29-3.01)** 1.77(1.23-2.55)** 
3 year 1.22(0.75-1.98) 2.01(1.28-3.14)** 1.49(1.01-2.19)* 
4 year 1.05(0.61-1.80) 1.67(1.01-2.77)* 1.29(0.84-1.99) 
5 year 1.51(0.79-2.86) 2.20(1.20-4.05)* 1.75(1.05-2.92)* 
6 year 2.36(1.09-5.13)* 2.25(1.15-4.38)* 2.21(1.23-3.96)** 
7 year 1.63(0.65-4.08) 2.40(1.07-5.43)* 2.11(1.03-4.30)* 
8 year 1.48(0.49-4.43) 2.81(1.06-7.44)* 2.56(1.11-5.92)* 
9 year 1.19(0.23-6.01) 1.79(0.44-7.29) 1.78(0.52-6.13) 
10 year -- 0.42(0.04-4.37) 0.24(0.02-2.37) 
11 year 2.78(0.18-42.02) 2.00(0.33-12.17) 2.11(0.36-12.44) 
12 year 4.50(0.16-125.02) 0.83(0.03-23.18) 1.00(0.06-15.69) 
13 year - - - 
14 year - - - 
15 year - - - 
Table 6.8 Cognitive impairment at follow-up in patients with depression at different 





Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year 1.61(1.00-2.60) 1.89(1.29-2.78)** 1.54(1.07-2.21)* 
2 year 1.31(0.79-2.16) 2.00(1.24-3.21)** 1.89(1.24-2.90)** 
3 year 1.51(0.86-2.65) 2.15(1.33-3.47)** 1.84(1.20-2.84)** 
4 year 0.75(0.40-1.40) 1.66(0.95-2.88) 1.23(0.75-2.00) 
5 year 1.09(0.49-2.44) 1.70(0.87-3.32) 1.20(0.66-2.16) 
6 year 1.61(0.61-4.22) 3.30(1.51-7.19)** 2.81(1.41-5.63)** 
7 year 1.44(0.39-5.25) 2.34(0.89-6.18) 1.95(0.84-4.53) 
8 year 2.29(0.37-14.34) 4.56(1.30-15.95)* 3.76(1.20-11.83)* 
9 year - - - 
10 year - 3.60(0.10-129.36) 2.48(0.07-91.29) 
11 year - - 18.37(0.52-646.98) 
12 year - - 1.24(0.02-95.23) 
13 year - - - 
14 year - - - 
15 year - - - 
Table 6.9 Cognitive impairment at follow-up in patients with depression at different 






6.4.5 Depression and mental domain of Health related quality of life (QoL) 
Univariate analyses showed that depression after stroke was consistently associated with 
lower scores in the mental domain of QoL in the first eleven years of follow-up. Multivariate 
analyses showed that depression three months after stroke was associated with lower scores 
in the mental domain of QoL in years the first five years of follow-up. After that, the 
associations were still consistent until year seven and then in year eleven. Depression at year 
one, and at either three months or one year, was associated with lower scores in the mental 
domain of QoL in years one to nine. Depression at either three months or one year also 
predicted lower scores of the mental domain of QoL in year eleven. (Table 6.10) When the 
missing data category was not included in the analyses the results remained similar except for 
depression at three months that predicted lower scores also in year nine and depression at one 





Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year -8.19(-10.23- -6.15)** -13.63(-15.17- -12.08)** -11.53(-12.97- -10.08)** 
2 year -6.52(-8.42- -4.62)** -7.76(-9.56- -5.97)** -7.03(-8.57- -5.50)** 
3 year -6.34(-8.53- -4.15)** -7.06(-9.18- -4.94)** -6.84(-8.61- -5.07)** 
4 year -6.90(-9.08- -4.72)** -6.42(-8.58- -4.26)** -6.23(-8.04- -4.42)** 
5 year -6.24(-8.93- -3.55)** -5.11(-7.79- -2.43)** -6.21(-8.42- -4.00)** 
6 year -3.85(-6.88- -0.81)* -7.41(-10.24- -4.59)** -5.86(-8.27- -3.44)** 
7 year -4.98(-8.61- -1.35)** -6.58(-10.24- -3.45)** -6.78(-9.65- -3.91)** 
8 year -2.83(-7.08- 1.41) -5.73(-9.66- -1.79)** -3.95(-7.32- -0.58)* 
9 year -4.44(-9.97-0.69) -8.18(-12.91- -3.44)** -6.78(-10.78- -2.77)** 
10 year -2.22(-8.76-4.31) -2.06(-8.05-3.93) -2.48(-7.56-2.60) 
11 year -10.27(-17.64- -2.91)** -5.76(-11.66-0.14) -7.97(-13.47- -2.47)** 
12 year -0.71(-10.69-9.27) 0.96(-7.61-9.53) -2.01(-9.98-5.97) 
13 year - -5.25(-19.33-8.83) -5.25(-19.33-8.83) 
14 year - - - 
15 year - - - 
Table 6.10 Mental domain of quality of life at follow-up in patients with depression at 










Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year -9.05(-11.38- -6.72)** -14.85(-16.53- -13.17)** -12.40(-14.05- -10.74)** 
2 year -7.80(-9.96- -5.63)** -7.96(-9.99- -5.94)** -7.94(-9.72- -6.17)** 
3 year -6.67(-91.13- -4.22)** -7.83(-10.11- -5.56)** -7.47(-9.43- -5.51)** 
4 year -7.47(-9.96- -4.98)** -6.40(-8.71- -4.09)** -6.21(-8.26- -4.16)** 
5 year -6.26(-9.24- -3.28)** -5.94 (-8.79- -3.08)** -6.70(-9.12- -4.28)** 
6 year -4.14(-7.79- -0.50)* -7.90(-11.29- -4.51)** -6.79(-9.74- -3.83)** 
7 year -5.29(-9.54- -1.05)* -7.52(-11.21- -3.83)** -6.71(-10.00- -3.42)** 
8 year -3.10(-7.81-1.61) -5.88(-10.03- -1.70)** -4.79(-8.58- -1.01)* 
9 year -7.76(-14.96- -0.56)* -10.19(-15.66- -4.73)** -8.19(-12.65- -3.72)** 
10 year -6.08(-17.86-5.69) -5.51(-13.35-2.07) -3.64(-10.80-3.53) 
11 year -13.03(-20.41- -5.65)** -8.47(-14.88- -2.07)* -9.91(-15.65- -4.17)** 
12 year 2.18(-10.50-14.87) -2.94(-12.23-6.35) -2.39(-10.545.75) 
13 year - -5.34(-29.30-18.62) -5.34(-29.30-18.62) 
14 year - - - 
15 year - - - 
Table 6.11 Mental domain of quality of life at follow-up in patients with depression at 
different time points. Missing data category not included.  
* p<0.05 
**p<0.01 
6.4.6 Depression and physical domain of Health related quality of life (QoL) 
Univariate analysis showed that depression after stroke was consistently associated with 
lower scores in the physical domain of QoL up to year 13. Multivariate analysis showed that 
depression at three months predicted lower scores of the physical domain of QoL in years one 
to seven. Depression at one year predicted lower scores in years one to eight. Finally 
depression at either three months or one year predicted lower scores in years one to nine and 
eleven to thirteen. (Table 6.12). When the missing data category was not included in the 
analyses the results were similar except for depression at one year that predicted lower scores 
also in year thirteen and depression at either three months or one year that no longer predicted 








Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year -4.53(-6.41- -2.65)** -5.06(-6.59- -3.53)** -5.60(-6.99- -4.20)** 
2 year -5.33(-7.21- -3.45)** -3.95(-5.77- -2.14)** -4.73(-6.27- -3.20)** 
3 year -6.03(-8.19- -3.87)** -4.90(-7.03- -2.78)** -5.85(-7.61- -4.09)** 
4 year -4.67(-6.84- -2.50)** -5.22(-7.37- -3.06)** -5.67(-7.46- -3.88)** 
5 year -5.14(-7.91- -2.38)** -5.34(-8.08- -2.60)** -5.96(-8.22- -3.69)** 
6 year -4.06(-7.11- -1.02)** -5.47(-8.35- -2.60)** -5.36(-7.80- -2.92)** 
7 year -5.61(-9.15- -2.08)** -6.96(-10.47- -2.91)** -7.00(-9.78- -4.22)** 
8 year -2.39(-6.51-1.72) -6.69(-10.47- -2.91)** -5.66(-8.90- -2.42)** 
9 year -4.07(-9.29-1.13) -6.18(-10.38-0.70) -5.64(-9.53- -1.74)** 
10 year 0.61(-5.49-6.70) -5.09(-10.65-0.47) -3.31(-8.03-1.40) 
11 year -5.54(-12.65-1.57) -6.31(-14.60-1.99) -5.35(-10.60- -0.09)* 
12 year -6.53(-16.22-3.15) -15.16(-26.73- -3.60) -9.38(16.95- -1.81)** 
13 year - - -15.16(-26.73- -3.60)* 
14 year - - - 
15 year - - - 
Table 6.12 Physical domain of quality of life at follow-up in patients with depression at 







Depression at 3 months 
OR (95%CI) 
Depression at 1 year 
OR (95%CI) 
Depression during year 1 
OR (95%CI) 
1 year -4.59(-6.78- -2.40)** -6.24(-7.96- -4.53)** -6.37(-7.96- -4.78)** 
2 year -5.24(-7.37- -3.10)** -4.63(-6.66- -2.61)** -4.71(-6.47- -2.96)** 
3 year -5.76(-8.20- -3.33)** -4.55(-6.80- -2.30)** -5.11(-7.03- -3.19)** 
4 year -4.33(-6.78—1.87)** -5.24(-7.58- -2.89)** -5.38(-7.40- -3.36)** 
5 year -4.76(-7.86- -1.66)** -4.86(-7.75- -1.97)** -5.63(-8.11- -3.14)** 
6 year -4.24(-7.70- -0.78)* -4.98(-8.06- -1.90)** -5.36(-8.06- -2.66)** 
7 year -7.43(-11.86- -3.00)** -7.32(-11.31- -3.32)** -7.92(-11.38- -4.46)** 
8 year -2.28(-7.15- 2.58) -6.60(-10.63- -2.57)** -5.04(-8.68- -1.39)** 
9 year -2.95(-9.78- 3.87) -8.78(-14.05- -3.50)** -6.97(-11.35- -2.59)** 
10 year -3.45(-17.04-10.13) -4.55(-12.38-3.27) -3.34(-10.37-3.69) 
11 year -5.10(-15.22-5.03) -6.28(-14.00-1.43) -5.92(-12.88-1.05) 
12 year -4.41(-16.80-7.98) -9.02(-18.33-0.29) 10.26(-18.03- -2.48)* 
13 year - -29.38(-50.62- -8.13)* -29.38(-50.62- -8.13)* 
14 year - - - 
15 year - - - 
 
Table 6.13 Physical domain of quality of life at follow-up in patients with depression at 






Depression in the first year was independently associated with higher mortality, disability, 
cognitive impairment and lower quality of life up to 15 years after stroke. The consistency of 
these associations was different for each outcome. However, depression was not associated 
with stroke recurrence. 
A previous systematic review
63
 reported many possible health outcomes associated with 
depression after stroke, including higher disability rates, higher mortality, poor involvement 
in rehabilitation, longer hospital stay and poor cognitive function up to ten years after the 
acute event. However in that review, they included studies were depression and its potential 
outcomes had been assessed at the same time. This makes it difficult to know whether 
depression is actually cause or consequence of the variable investigated as potential outcome. 
6.5.1 Depression and mortality 
The association between depression and higher mortality after stroke had been reported 
before in two prospective studies of shorter follow-up and smaller sample size.
177 178
 
Although the results of previous studies were not consistent, as another study found no 
association with high mortality at follow-up.
117
 The SLSR data show a consistent rise of 
mortality associated with depression, independent of stroke severity, in the long term. This 
association maybe explained by the risk factors that depression and other life threatening 
diseases have in common, such as low level of exercise. Two systematic reviews reported the 




 A bio-behavioural model to 
explain the association between depression and cardiovascular diseases (CVD) has been 
proposed.
46 47
 This model includes variables varying from an increased presence of classical 
risk factors for CVD (such as smoking, hypertension and diabetes) to changes in the immune 
system and dysregulation of the autonomic nervous system.  
199 
 
6.5.2 Depression and stroke recurrence 
No association was found between depression after stroke and stroke recurrence. Considering 
that a stroke recurrence is a cardiovascular event, the results presented in this chapter are not 
consistent with the ones reported in two systematic reviews that showed an increased 




 It seems that after a first stroke, 
depression is a less relevant cardiovascular risk factor than before stroke. The results 
presented in this chapter confirm the results previously obtained with a smaller SLSR dataset 
and different analysis.
291
 The predictors of stroke recurrence identified in that study were 
atrial fibrillation, previous myocardial infarction, hypertension and old age, which are 
classical risk factors for stroke. The same bio-behavioural model that may explain the 
association between depression and cardiovascular risk
46 47
 doesn’t seem to be valid for the 
association between depression and stroke recurrence.  
Since the methods used to register first ever strokes and recurrent ones were similar, and 
strokes are well recorded as major events in medical notes, it was considered unlikely that a 
large number of recurrent strokes had been missed. Therefore, it was judged that missed 
recurrences did not have a relevant effect on these results. 
6.5.3 Depression and disability 
The association between depression after stroke and disability at follow-up had been reported 
before in a hospital study where 293 patients were assessed for depression during the acute 
phase of stroke and a year later they were assessed for disability. The OR for disability in 
depressed patients was 2.51 (1.35-4.68).
179
 The ORs presented in this chapter range from 1.75 
to 4.14. It was also observed in this chapter how the risk of having severe disability is more 
increased than the risk of having mild disability for patients who have depression shortly after 
stroke. The ceiling effect of the BI, which gives patients with various degrees of disability the 
200 
 
minimum score, may partly explain the difference on the strength of these associations. While 
this limitation was acknowledged, the good metric properties of the BI,
198 199
 should be noted 
as well. The association between depression and disability at follow-up may be explained by 
the poor involvement in rehabilitation that has been observed in the six weeks following a 
stroke
63
 or simply by the low level of activity they have, that was reported in the previous 
chapter of this thesis.   
6.5.4 Depression and cognitive impairment 
The association between depression and cognitive impairment remains complex, as both can 
be cause and effect of each other. A systematic review of cognitive impairment in depressed 
patients from the general population reported a significant correlation between decreased 
cognitive performance and increased depression severity.
296
 Nonetheless, studies were 
cognition and depression had been assessed at the same time point were included in that 
review. Without the temporal sequence is difficult to attribute causality of one to the other. 
Cognitive impairment can be a consequence of stroke as well.
259
 However, since our analysis 
was adjusted for stroke severity measures, and depression was observed at earlier time point 
than cognitive impairment, we can infer some degree of causation in the association between 
depression shortly after stroke and impaired cognition at follow-up.  
The limitations of the MMSE and the AMT have been discussed in chapter three. The 
association between depression and cognitive impairment may be weaker than the estimated 
in patients with low level of education as they tend to score lower in the cognition tests.
209
 It 
should be noted that both scales have been validated against the clinical assessment of 






6.5.5 Depression and Quality of life 
The association between depression and lower quality of life in the first year after stroke has 
been reported before.
179 180
 This chapter shows the very consistent association between 
depression and lower quality of life, both the mental and physical domains, in the very long 
term.  Since depression affects the physical, psychological and social domains
31, of patient’s 
life, the association between depression and lower quality of life was expected. The possible 
overlapping between the HAD scale and the QoL measure may explain in part these results. 
This may be the case particularly for the associations between the depression and the mental 
health domain of QOL. 
6.5.6 Strengths and limitations 
This chapter has strengths and limitations. Using a population based register with repeated 
assessments of a large number of patients in the long term, allows to obtained results less 
biased than in hospital or rehabilitation studies. It also allows conducting robust statistical 
analyses with high statistical power able to identify minor differences between patients that 
may not have been observed in studies of smaller sample size. The description of the impact 
of depression in the long term is another strength of this chapter. However the analyses could 
only be conducted in patients with available data for depression. It is possible that the 
proportion of depressed patients amongst those who are lost to follow-up is higher than in 
those who are followed up. Some of the outcomes investigated, such as cognitive impairment 
and disability are strongly associated with depression. Therefore our analysis may still be 
underestimating the risk of cognitive impairment and disability in patients with depression.  
Since missing data on depression was over 30% in most cases it was decided not to use 
multiple imputation as it would have introduced error.
234 263
 Sensitivity analysis was then the 
method chosen to deal with missing data on depression. Estimates obtained when the 
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category for missing data was included were consistent with the ones obtained when it was 
not in the analyses. To report this consistency the tables show estimates using both the 
category for missing data and not using it.  One possible explanation for this result is that 
patients who have missing data are not very different from those with complete data.  One 
factor in favour of some similarity between patients lost to follow-up and those who were 
followed up is that depression data was not routinely collected from any patients in the first 
two years of the register. Missing data for these patients is missing completely at random for 
this period of time therefore not introducing bias. 
The estimation of clinical outcomes using scales introduces some limitations although all 
scales have good performance and they allowed assessing a very large number of patients 
during a long follow-up, which would not have been possible otherwise. 
As discussed before these results may be affected by residual and unmeasured confounding. 
The election of confounders, the form in which confounders should enter the model, or the 
time scale over which they act are uncertain. In this thesis the variables included in the 
models were informed by the systematic review presented in chapter two. The potential 
source of bias due to unmeasured confounding has been minimised using methods of dealing 
with missing data. 
280
 
6.5.8 Implications for clinical practice 
Depression after stroke deserves clinical attention as it is not only a distressing outcome of 
stroke but an independent predictor of higher mortality, disability, cognitive impairment and 
lower quality of life in the long term. Considering the difficulty that clinicians have to screen 
stroke patients for depression
53
 it is important that patients report their symptoms. Therefore, 
patients and carers should be made aware of the relevance of depression. The active role that 
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patients are supposed to have in clinical management of their problems
250
 would help in the 
prompt clinical approach to depression after stroke. 
Some patients, such as those with cognitive impairment, are particularly difficult to assess for 
depression. Clinicians should know that depression may be a treatable cause of the cognitive 
impairment observed in some stroke patients.  
6.5.8 Implications for future research 
The results of this chapter raise some questions that could be approached in further research. 
There is a wide variety of potential mechanisms underlying the possibly elevated risk of 
cardiovascular disease in depressed patients. Further studies are needed to understand the 
impact of these mechanisms. 
A randomised controlled trial recently presented a significantly better functional outcome 
three months after stroke in patients treated with fluoxetine and physiotherapy than in those 
receiving physiotherapy only.
310
 Further clinical trials could aim to confirm these results and 
also to investigate whether intervening on depression after stroke results in a reduction of 
mortality, and cognitive impairment in the long term and an improvement in quality of life. If 
effective interventions on depression after stroke actually improve the long term prognosis of 







CHAPTER 7 CONCLUSIONS FROM THIS THESIS 
As discussed in chapter one stroke and depression are both important causes of loss of 
DALYs globally. Depression is highly prevalent among patients with long term conditions 
and it may be associated with poor health.  
The results of this thesis show that depression has a dynamic natural history, it affects more 
than one in two patients at some point, with a persistent prevalence around 30%, up to 15 
years after stroke. The risk of depression is higher amongst those with previous depression, 
severe strokes, and social isolation. Finally depression is independently associated with 
negative health outcomes in the long term. While these results may have limitations, they 
show that the hypothesis raised initially has been tested, providing evidence applicable in 
clinical practice, public health and further research. 
7.1 SUMMARY OF FINDINGS OF THIS THESIS 
The systematic review presented in chapter two identified 49 studies, published between 
1983 and 2011, estimating the natural history, predictors, or associated health outcomes of 
depression after stroke. Most studies had limitations including selection bias, with only six 
population based studies, small sample size, short follow-up, and weak analysis. 
The pooled prevalence of depression after stroke was around 29%. The incidence, reported 
only in one study, was 10% one year after stroke. The cumulative incidence rates in the first 
year after stroke, reported in two studies, were 39 and 48%. Evidence was poor, or lacking, 
on the long term natural history of depression after stroke, including its prevalence, 
incidence, cumulative incidence, time of onset, duration and recurrence.   
Nine studies also reported variables present at baseline or at follow-up associated with 
depression after stroke. However, the limitations of these studies make their results difficult 
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to apply in clinical practice. The identification of stroke patients at highest risk of depression 
in the long term, on which interventions should focus, is still unclear. 
Five studies of unselected stroke patients have investigated the association between 
depression and other negative health outcomes in the long term including mortality, lower 
quality of life and disability. However, most of them did not report their methods adequately 
and therefore their results are difficult to interpret. The associations between depression and 
other relevant health outcomes, such as stroke recurrence and cognitive impairment, have not 
been investigated. To understand the impact of depression after stroke it is necessary to 
investigate the possible association between depression and mortality, stroke recurrence, 
disability, cognitive impairment, and quality of life in the long term.  
A population based cohort study of stroke patients, with large sample size, broad range of 
sociodemographic and clinical variables, collected at baseline and at follow-up, for over ten 
years, provides an ideal dataset to investigate depression after stroke in the areas where 
evidence is still insufficient. The South London Stroke Register, as a prospective longitudinal 
population based stroke register, established in a multi-ethnic, inner city population of 
271,817, meets all these criteria. The analysis of data collected by the South London Stroke 
Register between 1995 and 2009 allows estimating the natural history, predictors and 
associated health outcomes of depression up to 15 years after stroke. Some of the limitations 
of this dataset, such as the missing data, can be addressed with statistical methods, including 
inverse probability weighting, multiple imputation and sensitivity analysis. 
The results of the analyses of the SLSR data presented in this thesis showed that the 
prevalence of depression was around 30% and remained stable in the 15 years following a 
stroke, with incidence ranging from 7 to 21% and cumulative incidence of 55%. Most 
episodes of depression started shortly after stroke, with 33% of them starting in the three 
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months following a stroke, and no new episodes were identified from year ten onwards. 50% 
of the patients with depression at three months had recovered one year after stroke. The 
majority of the patients developing depression in the long term had had episodes of 
depression shortly after stroke suggesting that patients not becoming depressed shortly after 
stroke may not become depressed at all. Weighted estimates were consistent with the crude 
ones, therefore the validity of results from complete case analysis should be considered. 
Stroke severity, disability seven days after stroke, depression before stroke, and depression 
and anxiety three months after stroke, were the baseline variables most consistently 
associated with depression up to 15 years after stroke. Disability, social isolation, low level of 
activity and cognitive impairment were the follow-up variables most consistently associated 
with depression at follow-up. 
There were a small number of variables predicting outcomes of the natural history of 
depression after stroke. The risk of depression at some point after stroke can be predicted 
with sociodemographic and clinical observations. However, the association of these variables 
with other measures of the natural history of depression, including time of onset and duration 
of depression, is much weaker. 
Depression in the first year after stroke was associated with higher mortality up to 15 years 
after stroke.  No significant association was identified between depression and stroke 
recurrence. Disability and cognitive impairment rates were also significantly higher amongst 
patients depressed in the first year after stroke. Depression after stroke also showed a 





7.2 IMPLICATIONS FOR CLINICAL PRACTICE 
These results suggest that clinicians have to acknowledge that depression is a very common 
outcome after stroke, which may affect patients in the very long term. Health care 
professionals with the primary responsibility for patient care may be best situated to identify 
stroke patients who may have depression.
311
  
Since the time of highest risk for depression is shortly after the acute event, the best moment 
for the first screening may be during the acute phase. However, while screening for 
depression seems logical in stroke patients there is no evidence to show that screening alone 
improves management or treatment of depression in non mental health settings.
312
 The 
evidence suggests that screening only improves depression management when there is a clear 
treatment strategy that is monitored and has clear stopping rules.
53
 General practitioners use 
various methods to assess mental health risk, which include observing patient presentation, 
asking direct questions, decision support software and using risk assessment scales for 
detecting the risks of suicide, anxiety and depression. The main tool used in the UK is the 
Patient Health Questionnaire 9,
 
but other risk-specific tools, such as the Hospital Anxiety and 
Depression Scale
 
and the Generalised Anxiety Disorder (GAD-7) are also used.
313
 This 
diversified approach gives clinicians some flexibility, however not screening for depression 
in a systematic way means that some important pieces information may be missed. The 
assessment of depression in patients with physical conditions, stroke in particular, maybe 
more complex than in general population. This may be because of the uncertain boundaries 
among clinical and non pathological psychological symptoms and the overlap between 
symptoms of depression and physical disorder. Some of the risk assessments tools, such as 
the Hospital Anxiety and Depression scale were designed to be used in patients with other 
medical problems and show a good performace in stroke patients. Having a more systematic 
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approach to the assessment of depression after stroke would ensure coverage of all the risk 
areas which need to be considered. Screening would become more effective if the results 
presented in this thesis were considered. Screening could start shortly after stroke and 
patients could continue to be assessed periodically in primary care. The nature of screening 
and its timing requires investigation. Patients who do not become depressed shortly after 
stroke seem to be at lower risk for depression. Except in these patients, depression requires 
periodic clinical attention in the long term. The high rate of recurrence of depression should 
be acknowledged.  The assessment of patients at high risk of depression, at a moment of high 
risk, may improve the positive predictive value of the screening tools reducing the number of 
patients that receive unnecessary assessment after the first approach. 
Primary care settings have an advantage over hospitals when considering long term 
interventions as follow-up examination may be routine, brief, and easy to arrange. In the UK, 
one of the elements driving primary care is the Quality of Outcomes Framework (QOF),
283
 a 
scheme that rewards general practices for performance against clinical quality indicators. 
QOF has raised some controversy but it has also proven to improve quality of care in some 
areas including cardiovascular health.
314 315
 Unlike in diabetes or coronary artery disease, the 
assessment for depression after stroke is not a quality indicator included in the QOF. This is 
likely to lead GPs not to assess stroke patients for depression in the long term. The results of 
this thesis show that depression has a high impact on stroke patients. Therefore, policy 
makers could consider including the assessment for depression among long term stroke 
survivors at high risk of depression in the QOF. 
The Cochrane reviews on preventive and therapeutic interventions for depression after stroke 
showed a small but significant effect of psychotherapy on preventing depression and also a 





 Targeted interventions in patients at an increased risk of depression, 
and delivered at the moment of highest incidence, are likely to be more effective. This applies 
to all kind of interventions, screening, diagnosis, prevention, treatment, follow-up and re-
assessments in the long term. Therefore, especial attention should be given to patients who 
have recently had a stroke and also to patients with severe strokes, disability, depression 
before stroke, and depression and anxiety shortly after stroke. Clinicians should also be aware 
of the high risk of depression amongst patients with cognitive and communication 
impairment, who may be unable to report their symptoms. While patients with severe strokes 
are the most vulnerable and they constitute a group on which interventions should be 
developed, the strong association between depression and disability in the long term may 
make treatments for depression less effective in the most disabled patients. 
Depression after stroke should be approached holistically. Treatment that is solely directed 
towards the symptoms of depression without strengthening coping skills may leave the 
patients with a persistent vulnerability to subsequent adaptive failure and depressive 
episodes.
20
  Probably the biggest obstacle to routine use of psychological strategies is access 
to trained therapists due to scarcity of services, long waiting lists for non crises cases, and 
financial cost. However, the psychotherapeutic assitance may be provided not only through a 
formal process of psychoterapy, but also in the context of the ongoing doctor-patient 
relationship. For many people with medical conditions the relationship with a clinician who is 
prepared to listen to their experience is the most important component of their treatment.
20
  
Although the therapeutic relationship may be one of the most powerful tools to preserve and 
protect emotional well-being, this factor is often underestimated by practicing physicians. 
Appropriate training of clinicians to make the relationship with the patient psychotherapeutic 
on itself could be suggested. Some medical patients who might benefit from psychoterapy 
may be relucant to accept a treatment that implies that they are “damaged” in yet another 
210 
 
way. These patients may prefere brief and periodic interventions that emphasize 
psychoeducation. 
Considering the difficulty that clinicians have to detect depression in stroke survivors
53
 it is 
important that patients report their symptoms. Therefore, patients and carers should be made 
aware of the relevance of depression. The active role that patients are supposed to have in 
clinical management of their problems
250
 would help in the prompt clinical approach to 
depression after stroke. 
It has been suggested that health services may not have the resources to treat all the patients 
diagnosed with a more effective screening policy.
53
 Nonetheless, depression is associated 
with negative health outcomes that would be costly for the health service in the long term. 
While further research into the benefit of psychological care after stroke is needed, there is 
already some evidence suggesting that an effective management of depression after stroke 
may be a cost effective policy.
316
  
Many of the predictors of depression after stroke identified in this thesis are not specific of 
stroke. Previous history of depression or disability for example can be present in patients 
affected by other long term conditions. While depression has been approached several times 
in patients with common long term condition, such as diabetes or COPD,
22 57-59 81
 it has 
received little attention in the context of other less common diseases. The findings of this 
thesis could raise the hypothesis that depression may also be a frequent and recurrent problem 
affecting patients with other less common chronic conditions in the long term and leading to 
poor health outcomes. This hypothesis could inform both management strategies and further 
research studies.  
It has been reported that patients with multi-morbidity often receive care from different teams 
in an uncoordinated way.
80
 The results of this thesis, together with studies of depression in 
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the context of other diseases,
22 57-59 81
 suggest that depression may be relevant to patients 
affected by most long term conditions.
19
  An integrated approach to depression, not only for 
diabetics and patients with coronary artery disease, but for all the chronically ill, including 
stroke survivors and also patients with less frequent problems, might be suggested. All 
patients with long term conditions could be assessed for depression periodically in the 
primary care clinic, which is where the medical management of different problems is 
integrated. 
7.3 IMPLICATIONS FOR FUTURE RESEARCH 
Future clinical trials of interventions for depression after stroke may also consider the 
evidence provided in this thesis. The moment of highest risk, in which interventions can be 
tested, is the first year after stroke. The effect of interventions should be observed shortly 
after being started, as most episodes of depression show short duration. Patients with severe 
strokes, disability, social isolation, and anxiety in the acute phase are the ones in which future 
clinical trials should focus. Patients not depressed shortly after stroke are less likely to 
become depressed in the long term and therefore interventions on them are less likely to show 
a significant effect. However, patients who have depression shortly after stroke are at high 
risk of having a recurrent episode and interventions in the long term may also be needed. 
Future clinical trials could aim to investigate whether intervening on depression after stroke 
results in a reduction of mortality, cognitive impairment in the long term, or an improvement 
in quality of life. 
In studies of burden and outcomes of disease the years of life lived with disability (YLDs) are 
computed as the prevalence of different disease sequelae multiplied by the disability weight 
for that sequel. These studies use published estimates of prevalence, incidence, remission, 
and excess mortality of each sequel as source of data.
5
 Therefore the results on the long term 
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natural history and outcomes of depression after stroke presented in this thesis could inform 
studies of burden and outcome of stroke in the future. Similarly, studies of burden of disease 
and outcomes of depression, use estimates of natural history and mortality for their analyses.
2 
5
 The results presented in this thesis could inform these studies in the future improving the 
estimation of loss of DALYs attributed to mental and behavioural disorders.  
This thesis has reported that depression is a very frequent problem after stroke, representing 
the emotional burden of the disease, in the long term. Future interventions on stroke patients 
aiming to reduce the long term consequences of stroke may use depression as one of the 
measures of effect. Depression could also be used by health authorities to evaluate the quality 
of care provided to stroke patients both in the hospital and in the community. With the results 
of this thesis it could be hypothesized that a more effective management of stroke and better 
quality of care could lead to lower frequency of depression in the long term. 
The categorisation of patients as depressed and not depressed is clinically useful but does not 
reflect the reality of patients’ mood accurately as depressive symptoms are continuously 
distributed in populations. The severity of the depression after stroke, and its clinical 
relevance, remain a matter of further research. Tools specifically validated to assess degrees 
of severity of depression will be required in these studies. 
Patients with communication and cognitive impairment deserve to be studied specifically. 
The results of this thesis show that the risk of depression may be particularly high in these 
patients. However, they are difficult to assess and they have been excluded from many 
studies of depression after stroke. The association between depression and cognitive 
impairment remains complex, as both can be cause and effect of each other. The development 
of effective interventions for depression after stroke would clarify what is the relevance of 
depression on the aetiology of cognitive impairment. 
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There is a wide variety of potential mechanisms underlying the elevated risk of 
cardiovascular disease, other diseases, and overall mortality, in depressed patients. Further 
etiological and psychobiological studies are needed to understand the nature of these 
mechanisms.  
Observational studies on cohorts of patients with post-stroke depression should also identify 
predictors of negative health outcomes of depression that may inform future studies and 
interventions. For example, if lack of exercise and social isolation are found to be predictors 
of higher mortality amongst patients with post-stroke depression, interventions encouraging 
exercise and socialisation could be proposed for depression. Some of the potential predictors 
to be investigated may be measures that are already in place, such as attendance to day 
centres, district nurse care, or GPs’ medication reviews.  
The effect of antidepressants on depression and other outcomes of stroke deserves special 
attention as these drugs are already being prescribed to many stroke patients. The Cochrane 
review on pharmacological interventions to treat depression after stroke showed a limited 
effect of drugs on patients mood.
79
 A recent Cochrane review investigating the effect of 
antidepressants on stroke recovery reported that Selective Serotonin Reuptake Inhibitors 
appeared to improve dependence, disability, neurological impairment, anxiety 
and depression after stroke, but there was heterogeneity between trials and methodological 
limitations in a substantial proportion of the studies reviewed. Furthermore this review could 
not find enough evidence on the potential harmful effects of antidepressants.
56
 Another 
systematic review found a positive association between the use of antidepressants and stroke 
risk. The authors of this review interpreted their result cautiously considering that medication 
use could be a marker of depression severity, and many studies lacked information on dose 
and duration of medication use.
290
 Observational studies may clarify the effect of 
antidepressants on patients’ mood, functionality, and mortality after stroke. The clinical trials 
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currently running on antidepressants to improve stroke recovery,
317
 and further trials testing 
other interventions, may be informed by these observational studies.  
Most predictors of depression are not purely biological. In the development of future 
interventions a complex approach to depression, that does not include only drugs, should be 
considered. This may have to be delivered in cooperation with professionals working outside 
the health service. There is a need for trials establishing the efficacy of a broader range of 
treatment and prevention strategies including the provision of combined and collaborative 
care interventions, talking interventions delivered by trained and supervised lay workers, and 
trials of guided self help. 
One of the findings of this thesis is that depression and anxiety are strongly associated 
amongst stroke patients. However, despite being the most common mental health disorder 





Previous studies of anxiety after stroke have limitations including small sample size and short 
follow-up.
318
 There is also scant information about the long term natural history and 
predictors of anxiety after stroke.
320
 It is also poorly understood whether anxiety after stroke 
is associated with other health outcomes such as mortality, disability, stroke recurrence, 
cognitive impairment and lower quality of life in the long term. The evidence on the long 
term natural history, predictors and outcomes of anxiety after stroke, is still insufficient to 
inform prognosis and treatment strategies.
10 320
  Further studies are needed that estimate the 
incidence, cumulative incidence, prevalence and time of onset of anxiety in the long term 
after stroke, its predictors, and its potential association with mortality, disability, stroke 
recurrence, cognitive impairment and quality of life in the long term. 
In this thesis the association between stroke and depression has been discussed in depth. 
However, it has also been observed that a large proportion of stroke patients do not develop 
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depression. This is consistent with other previous epidemiological studies, showing that a 
significant proportion of patients with physical illness do not develop psychopathology, and 
introduces the concept of resilience.
20 321
 Resilience has been defined in a psychiatric context 
as the ability to thrive in the face of the adversity,
321
 to cope with stress,
322
 or to bounce back 
after adversity.
323
 Determinants of resilience have been found at different levels including 
genetic, biological, psychological, family, community, social, and environmental.
321-324
 The 
study of resilience has become more relevant in recent years as there has been a shift from 
problem-orientated approach to one that stresses prevention and the nurturing of strengths.
324
 
Resilience has been investigated in people who had gone through many different stressful 
events and situations.
321












 However, even though resilience is an interesting concept that opens a new 
way of looking at mental health problems in the medically ill, its routine application in 
clinical practice requires further research. A good conceptualization of resilience and its 
potential role in stroke patients is important as it may allow development of interventions to 
prevent and/or treat post stroke depression.  
Clinicians, patients, and carers beliefs about depression after stroke also influence the 
effectiveness of its management. We need approaches to depression after stroke which are 
sensitive to these beliefs. Further qualitative research studies investigating what doctors, 
patients and carers think about depression after stroke, and its possible clinical approach, may 
also help in the development of effective interventions. Stroke survivors should be included 
in the planning and design of further research to ensure that the outcomes and methods are 
relevant to them. Finally, future studies describing the natural history, predictors and 
outcomes of depression after stroke, and the effect of interventions, in low-and middle-
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APPENDIX 3. SLSR FOLLOW-UP FORM 
 
SOUTH LONDON STROKE REGISTER 
ANNUAL FOLLOW-UP 
 
Thank you for taking time to complete this questionnaire. It will 
help us to know how you are getting on since your stroke. 
Please read the following guidelines before beginning. 
Answer all questions. We are well aware that some questions might 
not seem relevant to you personally, but please try to answer them 
all as best you can. 
You should complete the form yourself, however if you are unable 
to then a carer or relative may help you. 
Most questions require you to select your answer from choices 
given to you by selecting the box beside the one choice which best 
describes your situation /feelings. 
 
 
1. What is today's date?              Click here to enter a date. 
 
 
2. What is your date of birth?   Click here to enter a date. 
 
3. Where do you live? 
Private household alone                     Community hospital 
Private household with others       Private hospital 
Sheltered home                             Long term hospital care  
Residential home                       Other 
Nursing home     Specify: Click here to enter text.                                                  
 
4. What is your current employment status? 
Full time employed (more than 30hrs/wk) 
Part time employed (less than 30hrs/wk) 
Unemployed and looking for work 
Retired  
Unable to work due to disability/ill-health 





5a. Have you had another stroke in the last year? 
Yes                         No                           I don't know  
5b.Have you been readmitted to hospital since the last 
follow-up? 
Yes                         No  Go to question 6 
 
5c.What was the name of the hospital? 
Click here to enter text. 
 
5d. Were you in hospital because you had had another 
stroke? 
Yes                         No                           I don't know  
 
6. In the last year have you experienced any of the 
following symptoms? 
 
a. New visual problems              Yes No   I don't know 
c. New weakness of arms/legs  Yes No   I don't know 
b. New speech problems           Yes No    I don't know        
 
6d.If yes to any of the above, did you see your GP about 
the new symptoms? 
Yes                           No 
 
7a. In the last 2 weeks, have you required help from 
another person for everyday activities (such as making a 
cup of tea)? 










7b. If yes, who did you receive most help from? 







Other professional care (paid/unpaid) 
Other- Specify: Click here to enter text. 
8. Has a member of your family given up work since the 
stroke to care for you? 
Yes                           No 
 
9. Are you still in hospital, a nursing home, or a residential 
home? 
Yes  Go to question 17                  No 
 
10. Do your friends and family help you (at least once a 
week) with any of the following?  
a. Cleaning the house             Yes                  No 
b. Preparing meals                  Yes                  No 
c. Shopping                           Yes                  No 
d. Having a bath or shower     Yes                  No 
 
11. In the last week have you had any meals on wheels? 
How many times? 
Yes                              No 
                     How many times?           . 
 
12. In the last week have you had any home help? 
Yes                              No 






13. In the last week have you attended a day centre? 
Yes                              No 
                      How many times?             . 
                        
14. In the last week have you attended a day hospital? 
Yes                              No 
                     How many times?             . 
                        
15. In the last week have you had a district nurse visit you? 
Yes                              No 
                     How many times?             . 
                        
16. In the last year, have you been admitted to a respite 
home for a short time to give yourself and your carer a 
rest? 
Yes                           No 
 
17a. Have you had any physiotherapy in the last year? 
Yes                           NoGo to question 18    
             
17b. Have you had this therapy in the last month? 
Yes                           NoGo to question 18    
 
17c.Where was the therapy received? 
Private      Acute stroke unit  Generic rehab unit 
Geriatric    Acute Medical      Community rehab centre 
ITU/HDU   Neurosurgery       Rehab at home team 
Surgery     Rehab stroke unit Other- 
                                                  Specify: Click here to enter text.     
                               
18a. Have you had any occupational therapy in the last 
year? 





18b. Do you still have this therapy? 
Yes                           NoGo to question 19    
 
18c.Where was the therapy received? 
Private      Acute stroke unit  Generic rehab unit 
Geriatric    Acute Medical      Community rehab centre 
ITU/HDU   Neurosurgery       Rehab at home team 
Surgery     Rehab stroke unit Other- 
                                                  Specify: Click here to enter text. 
 
19a. Have you had any speech or language therapy in the 
last year? 
Yes                           NoGo to question 20  
19b. Do you still have this therapy? 
Yes                           NoGo to question 20 
 
19c. Where was the therapy received? 
Private      Acute stroke unit  Generic rehab unit 
Geriatric    Acute Medical      Community rehab centre 
ITU/HDU   Neurosurgery       Rehab at home team 
Surgery     Rehab stroke unit Other- 
                                                     Specify: Click here to enter text. 
                                                                               
20a. Have you seen a GP in the last year? 
Yes                           NoGo to question 21 
 
20b. Have you seen them in the last month? 
Yes                              No 
                      How many times?              . 
                        
21a. Have you seen a specialist hospital doctor in the last 
year? 





21b. Have you seen them in the last month? 
Yes                              No 
                     How many times?             . 
                       
22a. Have you seen a specialist nurse in the community in 
the last year? 
Yes                           NoGo to question 23 
 
22b. Have you seen them in the last month? 
Yes                              No 
                     How many times?             . 
                        
23a. Has your blood pressure been checked in the last year? 
Yes                           NoGo to question 24 
 
23b. When was your blood pressure checked? 
Today                In the past week  1week-1month ago 
1-6months ago   6-12months ago 
 
23c. What was the most recent blood pressure? 
Systolic  4   .       Diastolic    .        I don't remember 
(smaller number)      (bigger number) 
 
24. Do you currently have weakness or paralysis of a 
complete body side or an arm or a leg? 
Yes                         No                         I don't know 
 
25. Do you currently have slurred speech or problems 
talking to somebody because your mouth was unable to 
articulate words or sentences correctly? 
Yes                         No                          I don't know  
 
26. Do you currently have any trouble swallowing? 




27. Have you been diagnosed with any of the following in 
the last year? 
Depression          Yes       No         I don't know  
Hypertension       Yes       No         I don't know  
High Cholesterol Yes       No         I don't know  
Diabetes               Yes       No         I don't know  
Atrial fibrillation   Yes      No         I don't know  
(Irregular heartbeat) 
Angina               Yes      No          I don't know  
Peripheral  
vascular disease  Yes     No          I don't know  
(narrowing of arteries in legs)  
Epilepsy                Yes     No          I don't know 
Myocardial  
infarction              Yes      No         I don't know 
(heart attack)                              
                  Was it within the last month? Yes       No 
28. Have tried any of the following in the last year? 
Cutting down on salt              Yes  No    Don’t Need to 
Cutting down on fatty foods  Yes  No    Don’t Need to 
Eating less to lose weight      Yes  No    Don’t Need to 
Exercising to lose weight       Yes  No    Don’t Need to 
Exercising to get fitter           Yes  No   Don’t Need to 
29a.Do you smoke? 
Yes                           NoGo to question 29d 
 
29b. If you are a smoker, how much do you smoke a day? 
Cigarettes (number)                              
Tobacco (grams)                                .  
Cigars (number)                                 .  
 
29c.If you are a smoker, have you tried to cut down in the 
last year? 





29d.If you are a non smoker now, are you an ex-smoker? 
Yes                           NoGo to question 30 
 
29e.If you are an ex-smoker, have you given up in the last 
year? 
Yes                           No 
 
30a. Do you drink any alcohol? 
Yes                           NoGo to question 31 
30b. How much do you drink a week? 
Beer (pints)                      .   
Wine (glasses)                     I don't drink every week 
Spirits                            .      
 
30c Have you cut down on the amount of alcohol you drink 
in the last year? 
Yes                  No                    Tried but didn’t 
31. Do you feel that you have made a complete recovery 
from the stroke? 
Yes                  No 
 
32. Have you had any written information about preventing 
further strokes? 
Yes                  No                    I don't know 
 
33. Have you had any advice from your GP about 
preventing strokes? 
Yes                  No                    I don't know 
 
34a. Are you currently on any medication, including 
aspirin? 






34b. Please list all the medications you are currently taking 
in the spaces provided below 
 Name of Drug Dose  How often do you take the 
drug? (Select from drop-down 
options) 
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Please answer yes or no to the following questions about 
support you receive from those around you 
 
Is anyone helping you to complete the questions in this 
section? 
No, I am answering on my own                  
Yes, my carer/family/friend is helping me 
I am a carer/family/friend answering on his/her behalf 
 
1. If you needed help, do you have anyone (e.g. friends, 
neighbours, family) that you can turn to? 
Yes                           No 
 
2. Do you have somebody (e.g. friends, neighbours, family) 
who shows that they care about you? 
Yes                  No                    I don't have any 
 
3. Do you see as much of your neighbours as you would 
like? 
Yes                  No                    I don't have any 
 
4. Do you see as much of your relatives as you would like? 
Yes                  No                    I don't have any 
 
5. Do you see as much of your friends as you would like? 













On the following two pages are some questions about your 
ability to look after yourself. They may not all seem to 
apply to you but please answer them all by selecting one 
option which you feel best describes your situation. 
 
Is anyone helping you to complete the questions in this 
section? 
No, I am answering on my own                  
Yes, my carer/family/friend is helping me 
I am a carer/family/friend answering on his/her behalf 
 
1. In the bath or shower, do you: 
manage on your own? 
need help getting in and out? 
need other help? 
need to be washed in bed? 
never have a bath or shower? 
 
2. Can you climb stairs at home: 
without anyone's help? 
with someone encouraging you? 
with someone carrying your frame? 
with physical help? 
not at all? 
don't have stairs? 
 
3. Do you get dressed: 
without any help? 
just with help with buttons? 
with someone helping you most of the time? 
 
4. Do you walk indoors: 
without anyone’s help or with a frame? 
with one person watching over you? 
with one person helping you 
with more than one person helping you? 
not at all? 
or do you use a wheelchair independently(e.g round corners) 
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5. Do you move from bed to chair: 
on your own? 
with a little help from one person? 
with a lot of help from one or more people? 
not at all? 
 
6. Do you eat food: 
without any help? 
with some help(such as cutting food or spreading butter)? 
with more help? 
 
7. Do you use the toilet or commode: 
without anyone's help? 
with some help but can do some things? 
with quite a lot of help? 
 





9. Do you lose control of your bladder? (are you 
incontinent of urine?): 
never 
less than once a week 
less than once a day 
more often 
or do you have a catheter managed for you? 
 
10. Do you lose control of your bowel movements? (Do 
you soil yourself?): 
never 
occasional accident 







We are interested in finding out how often you carry out 
some activities. As you will see, the first page is about 
activities during the last 3 months and over the page asks 
about the last 6 months. 
Please remember to select one box only for each question. 
 
Is anyone helping you to complete the questions in this 
section? 
No, I am answering on my own                  
Yes, my carer/family/friend are helping me 
I am a carer/family/friend answering on his/her behalf 
 
In the last 3 months how often have you carried out these 
activities? 
 
1. Preparing main meals (not just a snack) 
Never     Less than once a week     1 or 2 times a week         
Most days 
 
2. Washing up (Do all after one meal or share equally with 
another person) 
Never     Less than once a week     1 or 2 times a week         
Most days 
 
Over the last 3 months how often have you carried out 
these activities? 
 
3. Washing clothes (e.g. loading and unloading washing 
machine) 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
4. Light housework (e.g. dusting, or tidying small objects) 
Never     Only once or twice           1 to 4 times a month      
At least once a week  
 
5. Heavy housework (e.g. hoovering, or making beds) 
Never     Only once or twice           1 to 4 times a month      




6. Local shopping 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
7. Social occasions (including going to church) 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
8. Walking outside for over 15 minutes 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
9. Taking part in a hobby activity 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
10. Going on a bus or driving a car 
Never     Only once or twice           1 to 4 times a month      
At least once a week 
 
In the last 6 months how often have you carried out the 
following activities? 
 
11. Travel outings or car rides (travel for pleasure, not just for 
routine trips) 
Never     Only once or twice           1 to 2 times a month      
At least once a week 
 
12.Gardening 
Never    Light (e.g. occasional weeding) Moderate  
All necessary (Includes heavy digging)   
                                                                                                           
13. Household or car maintenance 
Never    Light (e.g. small repairs)   Moderate (painting)       
All necessary  
 
14. Reading books (not just magazines) 
Never      One in 6 months       Less than 1 a fortnight     




15. Paid work 
None       Up to 10hrs a week   10-30hrs a week            
More than 30hrs a week 
 
The following questions ask for your views about your 
health, how you feel and how well you are able to do your 
usual activities. 
If you are unsure about how to answer any questions 
please give the best answer you can. Do not spend too 
much time in answering as your immediate response is 
likely to be the most accurate. 
 
Is anyone helping you to complete the questions in this 
section? 
No, I am answering on my own                  
Yes, my carer/family/friend are helping me 
I am a carer/family/friend answering on his/her behalf. 
1. In general, would you say your health is: 
Excellent            Very Good             Good         Fair          
Poor 
 
2. Health and daily activities. The following questions are 
about activities you might do during a particular day. Does 
your health limit you in these activities? If so, how much? 
 
A. Moderate activities (such as moving a table, pushing a 
vacuum, bowling or playing golf) 
Yes, limited a lot              
Yes, limited a little              
No, not limited at all 
 
B. Climbing several flights of stairs 
Yes, limited a lot              
Yes, limited a little              






3. During the past 4 weeks, have you had any of the 
following problems with your work or other regular daily 
activities as a result of your physical health? (Please 
answer Yes or No to each question) 
 
A. Accomplished less than you would like 
Yes                           No 
 
B. Were limited in the kind of work or other activities 
Yes                           No 
 
4. During the past 4 weeks, have you had any of the 
following problems with your work or other regular daily 
activities as a result of any emotional problems (such as 
feeling depressed or anxious)? (Please answer Yes or No 
to each question) 
 
A. Accomplished less than you would like 
Yes                           No 
 
B. Didn't do work or activities as carefully as usual 
Yes                           No 
 
5. During the past 4 weeks how much did pain interfere 
with your normal work (including work both outside the 
home and housework)? (Please tick one box) 













6. These questions are about how you feel and how things 
have been with you during the past month. For each 
question, please indicate the one answer that comes 
closest to the way you have been feeling. (Please tick one 
box) 
 
How much time during the last month: 
       A. Have you felt calm and peaceful? 
            All of the time 
            Most of the time 
            A good bit of the time 
            Some of the time 
            A little of the time 
            None of the time 
 
B. Did you have a lot of energy? 
            All of the time 
            Most of the time 
            A good bit of the time 
            Some of the time 
            A little of the time 
            None of the time 
 
C. Have you felt downhearted and low? 
            All of the time 
Most of the time 
A good bit of the time 
Some of the time 
A little of the time 
None of the time 
 
D. Has your health limited your social activities? 
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
A little of the time 
None of the time 
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This questionnaire is designed to help us know how you 
feel. Please give the reply which comes closest to how you 
have been feeling in the past week. Don't take too long 
over your replies: your immediate reaction to each item 
will probably be more accurate than a long thought out 
response. 
 
Is anyone helping you to complete the questions in this 
section? 
No, I am answering on my own                  
Yes, my carer/family/friend are helping me 
I am a carer/family/friend answering on his/her behalf 
 
1. I feel tense or 'wound up': 
most of the time      a lot of the time       occasionally          
 not at all 
 
2. I feel as if I am slowed down: 
nearly all the time    very often               sometimes             
not at all 
 
3. I still enjoy the things I used to: 
definitely as much    not quite as much   only a little            
hardly at all 
 
4. I get a sort of frightened feeling like butterflies in my 
stomach: 
not at all                    occasionally           quite often            
very often 
 
5. I get a sort of frightened feeling as if something awful is 
about to happen: 
very definitely and quite badly   yes, but not too badly 
a little, but it doesn't worry me   not at all 
 
6. I have lost interest in my appearance: 
definitely                 I don’t take as much care as I should 
I may not take as much care as I should      
I take just as much care as ever 
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7. I can laugh and see the funny side of things: 
as much as I always could      definitely not so much now 
not quite so much now            not at all 
8. I feel restless as if I have to be on the move: 
very much indeed         quite a lot         not very much           
not at all 
9. Worrying thoughts go through my mind: 
a great deal of the time  a lot of the time   
from time to time            only occasionally 
 
10. I look forward with enjoyment to things: 
as much as I ever did        definitely less than I used to 
rather less than I used to   hardly at all 
 
11. I feel cheerful: 
not at all            not often             
sometimes        most of the time 
 
12. I get sudden feelings of panic: 
very often indeed         quite often          
not very often               not at all 
 
13. I can sit at ease and feel relaxed: 
definitely                 usually                 not often                  
not at all 
 
14. I can enjoy a good book or radio or TV programme: 













APPENDIX 5 DATA USED IN THE ANALYSES OF THE ASSOCIATION 
BETWEEN DEPRESSION AFTER STROKE AND DISABILITY AT FOLLOW-UP 
 
 Age (years) n(%) Gender n(%) Ethnicity n(%) 
Disa
bility 
0-64 >64 Male Female White Black Other Unknown 
Year 
1 
654 (35.7) 1176 (64.3) 992 (54.2) 838 (45.8) 1273 (69.6) 419 (22.9) 121  (6.6) 17     (0.9) 
2 474 (38.2) 767 (61.8) 672 (54.1) 569 (45.8) 842 (67.8) 302 (24.3) 83    (6.7) 149   (1.1) 
3 506 (40.2) 751 (59.7) 709 (56.4) 548 (43.6) 870 (69.2) 286 (22.7) 83    (6.6) 18     (1.4) 
4 449 (42.9) 598 (57.1) 566 (54.1) 481 (45.9) 701 (66.9) 255 (24.4) 77    (7.3) 14     (1.3) 
5 362 (46.6) 415 (53.4) 434 (55.9) 343 (44.1) 525 (67.6) 181 (23.3) 62    (8.0) 9       (1.2) 
6 327 (46.7) 373 (53.3) 392 (56.0) 308 (44.0) 476 (68.0) 168 (24.0) 51    (7.3) 5       (0.7) 
7 267 (48.6) 282 (51.4) 313 (57.0) 236 (43.0) 367 (66.8) 139 (25.3) 36    (6.6) 7       (1.3) 
8 251 (54.1) 213 (45.9) 271 (58.4) 193 (41.6) 298 (64.2) 128 (27.6) 32    (6.9) 6       (1.3) 
9 201 (58.4) 143 (41.6) 202 (58.7) 142 (41.3) 231  67.1) 88   (25.6) 22    (6.4) 3       (0.9) 
10 145 (58.2) 104 (41.8) 144 (57.8) 105 (42.2) 166 (66.7) 65   (26.1) 18    (7.2) 0 
11 106 (54.1) 90   (45.9) 119 (60.7) 77   (39.3) 135 (68.9) 45   (23.0) 14    (7.1) 2       (1.0) 
12 68   (58.6) 48   (41.4) 75   (64.7) 41 (35.3) 79(68.1) 28(24.1) 8 (6.9) 1 (0.9) 
13 48   (64.9) 26   (35.1) 47   (63.5) 27 (36.5) 49(66.2) 22(29.7) 3 (4.0) 0 
14 31  (64.6) 17   (35.4) 30   (62.5) 18 (37.5) 31(64.6) 14(29.2) 2 (4.2) 1(2.1) 
15 8    (57.1) 6     (42.9) 6     (42.9) 8 (57.1) 9(64.3) 4(28.6) 0 1 (7.1) 
 
 













567 (31.0) 271 (14.8) 992 (54.2) 871 (47.6) 346 (18.9) 613 (33.5) 807 (44.1) 503 (27.5) 520 (28.4) 
2 426 (34.3) 206 (16.6) 608 (49.0) 556 (44.8) 212 (17.1) 472 (38.1) 547 (44.1) 342 (27.6) 351 (28.3) 
3 382 (30.4) 170 (13.5) 705 (56.1) 542 (44.8) 178 (14.2) 537 (42.7) 535 (42.6) 279 (22.2) 443 (35.2) 
4 309 (29.5) 140 (13.4) 598 (57.1) 439 (41.9) 140 (13.4) 468 (44.7) 431 (41.2) 226 (21.6) 390 (37.2) 
5 231 (29.8) 104 (13.4) 441 (56.8) 315 (40.6) 92 (11.9) 369 (47.5) 310 (39.9) 155 (20.0) 311 (40.1) 
6 189 (27.0) 84 (12.0) 427 (61.0) 271(38.8) 87 (12.4) 341 (48.8) 278 (39.7) 135 (19.3) 287 (41.0) 
7 122 (22.2) 63 (11.5) 364 (66.3) 202 (36.8) 65 (11.8) 282 (51.4) 202 (36.8) 99 (18.0) 248 (45.2) 
8 97 (20.9) 47 (10.1) 320 (69.0) 150 (32.3) 52 (11.2) 262 (56.5) 157 (33.8) 76 (16.4) 231 (49.8) 
9 74 (21.5) 30 (8.7) 240(69.8) 110 (32.0) 36 (10.5) 198 (57.6) 114 (33.1) 53 (15.4) 177(51.4) 
10 44 (17.7) 20 (8.0) 185 (74.3) 63 (25.3) 26 (10.4) 160 (64.3) 66 (26.5) 38 (15.3) 145 (58.2) 
11 38 (19.4) 14 (7.1) 144 (73.5) 54 (27.5) 24 (12.2) 118 (60.2) 52 (26.5) 32 (16.3) 112(57.1) 
12 14 (12.1) 11 (9.5) 91 (78.4) 30 (25.9) 15 (12.9) 71 (61.2) 25 (21.5) 20 (17.2) 71 (61.2) 
13 0 0 74 (100) 13 (17.6) 5 (6.7) 56 (75.7) 13 (17.6) 5 (6.8) 56 (75.7) 
14 1 (2.1) 0 47 (97.9) 1 (2.1) 0 47 (97.9) 1 (2.1) 0 47 (97.9) 
15 0 0 14 (100) 0 0 14 (100) 0 0 14 (100) 














424(23.2) 1238 (67.6) 168 (9.2) 1231 (67.3) 546(29.8) 53 (2.9) 
2 328(26.4) 846(68.2) 67 (5.4) 861(69.4) 331(26.7) 49 (3.9) 
3 338(26.9) 907(72.2) 12 (0.9) 868(69.0) 349(27.8) 40 (3.2) 
4 293(28.0) 743(71.0) 11 (1.0) 730(69.7) 277(26.5) 40 (3.8) 
5 231(29.7) 540(69.5) 6 (0.8) 571(73.5) 184(23.7) 22(2.8) 
6 202(28.9) 489(69.9) 9 (1.3) 522(74.6) 150(21.4) 28 (4.0) 
7 165(30.0) 375(68.3) 9(1.6) 401(73.0) 123(22.4) 25 (4.5) 
8 142(30.6) 319(68.7) 3 (0.6) 345(74.3) 102(22.0) 17 (3.7) 
9 106(30.8) 235(68.3) 3 (0.9) 262(76.2) 71 (20.6) 11 (3.2) 
10 78 (31.3) 167(67.1) 4 (1.6) 185(74.3) 55 (22.1) 9 (3.6) 
11 62 (31.6) 131(66.8) 3 (1.5) 144(73.5) 47 (24.0) 5(2.5) 
12 31 (26.7) 84 (72.4) 1 (0.9) 82 (70.7) 31 (26.7) 3 (2.6) 
13 14 (18.9) 60 (81.1) 0 53 (71.6) 20 (27.0) 1 (1.3) 
14 8 (16.7) 40 (83.3) 0 37 (77.1) 11 (22.9) 0 
15 3 (21.4) 11 (78.6) 0 12 (85.7) 2 (14.3) 0 
Appendix 5. (Cont.)  
 
 Glasgow coma score n(%) Disability at baseline (Barhtel score) n(%) 
Disability 3-8 9-12 13-15 Unknown 0-14 15-19 20 Unknown 
Year 1 71 (3.9) 153  (8.4) 1569 
(85.7) 
37(2.0) 758 (41.4) 330 (18.0) 503 (27.5) 239 (13.1) 
2 42(3.4) 106 (8.5) 1052 
(84.8) 
41 (3.3) 468 (37.7) 209 (16.8) 356 (28.7) 208 (16.8) 
3 51 (4.1) 102 (8.1) 1068 
(85.0) 
36 (2.9) 490 (39.0) 235 (18.7) 359 (28.6) 173 (13.8) 
4 43 (4.1) 80 (7.6) 894(85.4) 30 (2.9) 383 (36.6) 189 (18.0) 316 (30.2) 159 (15.2) 
5 29 (3.7) 58 (7.5) 671(86.4) 19 (2.4) 267 (34.4) 142 (18.3) 247 (31.8) 121(15.6) 
6 27 (3.9) 47 (6.7) 606(86.6) 20 (2.9) 231 (33.0) 114 (16.3) 240 (34.3) 115 (16.4) 
7 22 (4.0) 36 (6.4) 475(86.5) 17 (3.1) 181 (33.0) 93 (16.9) 181 (33.0) 94 (17.1) 
8 21 (4.5) 34 (7.3) 399(86.0) 10 (2.2) 151 (32.5) 69 (14.9) 152 (32.8) 92 (19.8) 
9 15 (4.4) 26 (7.6) 297(86.3) 6 (1.7) 107 (31.1) 55 (16.0) 120 (34.9) 62 (18.0) 
10 14 (5.6) 18 (7.2) 212(85.1) 5 (2.0) 76 (30.5) 38 (15.3) 78 (31.3) 57 (22.9) 
11 10 (5.1) 17 (8.7) 167(85.2) 2 (1.0) 64 (32.6) 29 (14.8) 60 (30.6) 43 (21.9) 
12 7 (6.0) 10 (8.6) 97 (83.6) 2 (1.7) 50 (43.1) 21 (18.1) 38 (32.8) 7 (6.0) 
13 5 (6.8) 7 (9.5) 61 (82.4) 1 (1.3) 33 (44.6) 16 (21.6) 22(29.7) 3 (4.0) 
14 3 (6.2) 3 (6.2) 42 (87.5) 0 22 (45.8) 9 (18.7) 15 (31.2) 2 (4.2) 
15 1 (7.1) 0 13 (92.9) 0 5 (35.7) 3 (21.4) 5 (35.7) 1 (7.1) 







APPENDIX 6. DATA USED IN THE ANALYSES OF THE ASSOCIATION 
BETWEEN DEPRESSION AFTER STROKE AND COGNITION AT FOLLOW-UP 
 
 Age (years) n(%) Gender n(%) Ethnicity n(%) 
Cogn
ition 
0-64 >64 Male Female White Black Other Unknown 
Year 
1 
508(37.0) 866(63.0) 756(55.0) 618(45.0) 965(70.2) 315(22.9) 80(5.8) 14(1.0) 
2 387(38.5) 619(61.5) 548(54.5) 458(45.5) 691(68.7) 237(23.6) 66(6.6) 12(1.2) 
3 360(40.0) 541(60.0) 513(56.9) 388(43.1) 612(67.9) 220(24.4) 57(6.3) 12(1.3) 
4 321(43.0) 426(57.0) 406(54.3) 341(45.6) 508(68.0) 184(24.6) 47(6.3) 8(1.1) 
5 305(48.1) 329(51.9) 356(56.1) 278(43.8) 427(67.3) 149(23.5) 50(7.9) 8(1.3) 
6 258(48.0) 279(52.0) 304(56.6) 233(43.4) 371(69.1) 128(23.8) 33(6.1) 5(0.9) 
7 203(50.6) 198(49.4) 233(58.1) 168(41.9) 279(69.6) 98(24.4) 21(5.2) 3(0.7) 
8 167(52.7) 150(47.3) 189(59.6) 128(40.4) 219(69.1) 75(23.7) 21(6.6) 2(0.6) 
9 147(57.6) 108(42.3) 150(58.8) 105(41.2) 180(70.6) 60(23.5) 13(5.1) 2(0.8) 
10 94(56.6) 72(43.4) 95(57.2) 71(42.8) 115(69.3) 41(24.7) 10(6.0) 0 
11 60(50.8) 58(49.1) 70(59.3) 48(40.7) 83(70.3) 30(25.4) 4(3.4) 1(0.8) 
12 34(56.7) 26(43.3) 44(73.3) 16(26.7) 38(63.3) 18(30.0) 3 (5.0) 1(1.7) 
13 20(69.0) 9(31.0) 21(72.4) 8(27.6) 18(62.1) 9(31.0) 2(6.9) 0 
14 10(55.6) 8(44.4) 13(72.2) 5(27.8) 11(61.1) 6(33.3) 1(5.6) 0 
15 4(50.0) 4(50.0) 2(25.0) 6(75.0) 5(62.5) 2(25.0) 1(12.5) 0 
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455(33.1) 203(14.8) 716(52.1) 710(51.7) 249(18.1) 415(30.2) 655(47.7) 369(26.9) 350(25.5) 
2 364(36.2) 189(18.8) 452(45.0) 481(47.9) 177(17.6) 347(34.5) 457(45.6) 294(29.2) 254(25.3) 
3 313(34.7) 148(16.4) 440(48.8) 437(48.5) 140(15.5) 324(36.0) 428(47.5) 232(25.7) 241(26.7) 
4 237(31.7) 127(17.0) 383(51.3) 364(48.7) 115(15.4) 268(35.9) 346(46.3) 194(26.0) 207(27.7) 
5 169(26.7) 84(13.3) 380(60.0) 264(41.7) 71(11.2) 298(35.9) 263(41.5) 123(19.4) 247(39.0) 
6 139(25.9) 64(11.9) 334(62.2) 214(39.9) 65(12.1) 257(47.9) 218(40.6) 103(19.2) 216(40.2) 
7 89(22.2) 42(10.5) 270(67.3) 142(35.4) 44(11.0) 215(53.6) 142(35.4) 69(17.2) 190(47.4) 
8 65(20.5) 33(10.4) 219(69.1) 101(31.9) 34(10.7) 182(57.4) 105(33.1) 52(16.4) 160(50.5) 
9 48(18.8) 20(7.8) 187(73.3) 78(30.6) 25(9.8) 152(59.6) 77(30.2) 37(14.5) 141(55.3) 
10 20(12.0) 8(4.8) 138(83.1) 41(24.7) 12(7.2) 113(68.1) 40(24.1) 17(10.2) 109(65.7) 
11 14(11.9) 6(5.1) 98(83.0) 22(18.6) 11(9.3) 85(72.0) 19(16.1) 14(11.9) 85(72.0) 
12 7(11.7) 6(10.0) 47(78.3) 15(25.0) 6(10.0) 39(65.0) 11(18.3) 10(16.7) 39(65.0) 
13 0 0 29(100) 6(20.7) 3(10.3) 20(69.0) 6(20.7) 3(10.3) 20(69.0) 
14 1(5.6) 17(94.4) 0 1(5.6) 0 17(94.4) 1(5.6) 0 17(94.4) 
15 0 0 8(100) 0 0 8(100) 0 0 8(100) 



















354(25.8) 937(68.2) 83(6.0) 973(70.8) 359(26.1 42(3.1) 42(3.1) 91(6.6) 1212 
(88.2) 
29(2.1) 
2 282(28.0) 689(68.5) 35(3.5) 722(71.8) 239(23.8) 45(4.5) 30(3.0) 66(6.6) 878(87.3) 32(3.2) 
3 260(28.9) 631(70.0) 10(1.1) 649(72.0) 217(24.1) 35(3.9) 33(3.7) 52(5.8) 788(87.5) 28(3.1) 
4 227(30.4) 510(68.3) 10(1.3) 556(74.4) 159(21.3) 32(4.3) 28(3.7) 43(5.8) 653(87.4) 23(3.1) 
5 195(30.8) 435(68.6) 4(0.6) 477(75.2) 141(22.2) 16(2.5) 26(4.1) 46(7.3) 549(86.6) 13(2.0) 
6 165(30.7) 366(68.2) 6(1.1) 419(78.0) 98(18.2) 20(3.7) 21(3.9) 32(6.0) 469(87.3) 15(2.8) 
7 124(30.9) 271(67.6) 6(1.5) 307(76.6) 82(20.4) 12(3.0) 15(3.7) 20(5.0) 360(89.8) 6(1.5) 
8 103(32.5) 212(66.9) 2(0.6) 249(78.5) 61(19.2) 7(2.2) 16(5.0) 17(5.4) 279(88.0) 5(1.6) 
9 81(31.8) 173(67.8) 1(0.4) 198(77.6) 49(19.2) 8(3.1) 12(4.7) 14(5.5) 225(88.2) 4(1.6) 
10 47(28.3) 117(70.5) 2(1.2) 127(76.5) 34(20.5) 5(3.0) 10(6.0) 9(5.4) 145(87.3) 2(1.2) 
11 29(24.6) 87(73.7) 2(1.7) 91(77.1) 26(22.0) 1(0.8) 7(5.9) 7(5.9) 104(88.1) 0 
12 19(31.7) 41(68.3) 0 46(76.7) 13(21.7) 1(1.7) 2(3.3) 3(5.0) 55(91.7) 0 
13 5(17.2) 24(82.8) 0 22(75.9) 7(24.1) 0 3(10.3) 1(3.4) 25(86.2) 0 
14 1(5.6) 17(94.4) 0 15(83.3) 3(16.7) 0 0 1(5.6) 17(94.4) 0 
15 3(37.5) 5(62.5) 0 7(87.5) 1(12.5) 0 0 0 8(100) 0 
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 Glasgow Coma score n(%) Disability at baseline (Barhtel score) n(%) 
Cognition 3-8 9-12 13-15 Unknown 0-14 15-19 20 Unknown 
Year 1 42(3.1) 91(6.6) 1212 
(88.2) 
29(2.1) 513(37.3) 273(19.9) 413(30.1) 175(12.7) 
2 30(3.0) 66(6.6) 878(87.3) 32(3.2) 342(34.0) 179(17.8) 310(30.8) 175(17.4) 
3 33(3.7) 52(5.8) 788(87.5) 28(3.1) 300(33.3) 155(17.2) 294(32.6) 152(16.9) 
4 28(3.7) 43(5.8) 653(87.4) 23(3.1) 236(31.6) 145(19.4) 239(32.0) 127(17.0) 
5 26(4.1) 46(7.3) 549(86.6) 13(2.0) 215(33.9) 115(18.1) 200(31.5) 104(16.4) 
6 21(3.9) 32(6.0) 469(87.3) 15(2.8) 164(30.5) 91(16.9) 193(35.9) 89(16.6) 
7 15(3.7) 20(5.0) 360(89.8) 6(1.5) 128(31.9) 72(18.0) 131(32.7) 70(17.5) 
8 16(5.0) 17(5.4) 279(88.0) 5(1.6) 99(31.2) 51(16.1) 97(30.6) 70(22.1) 
9 12(4.7) 14(5.5) 225(88.2) 4(1.6) 80(31.4) 44(17.2) 92(36.1) 39(15.3) 
10 10(6.0) 9(5.4) 145(87.3) 2(1.2) 54(32.5) 28(16.9) 57(34.3) 27(16.3) 
11 7(5.9) 7(5.9) 104(88.1) 0 37(31.4) 25(21.2) 39(33.0) 17(14.4) 
12 2(3.3) 3(5.0) 55(91.7) 0 25(41.7) 12(20.0) 19(31.7) 4(6.7) 
13 3(10.3) 1(3.4) 25(86.2) 0 14(48.3) 6(20.7) 8(27.6) 1(3.4) 
14 0 1(5.6) 17(94.4) 0 9(50.0) 3(16.7) 6(33.0) 0 
15 0 0 8(100) 0 3(37.5) 0 4(50.0) 1(12.5) 






APPENDIX 7. DATA USED IN THE ANALYSES OF THE ASSOCIATION 
BETWEEN DEPRESSION AND MENTAL HEALTH DOMAIN OF QUAILTY OF 
LIFE AT FOLLOW-UP 
 
QoL  Age (years) n(%) Gender n(%) Ethnicity n(%) 
0-64 >64 Male Female White Black Other Unknown 
Year 
1 
515(38.3) 828(61.7) 735(54.8) 607(45.2) 952(70.9) 306(22.8) 69(5.1) 15(1.1) 
2 406(39.8) 614(60.2) 565(55.4) 455(44.6) 699(68.5) 246(24.1) 63(6.2) 12(1.2) 
3 394(42.0) 544(58.0) 546(58.2) 392(41.8) 651(69.4) 213(22.7) 57(6.1) 17(1.2) 
4 368(46.7) 420(53.3) 434(55.1) 354(44.9) 529(67.1) 195(24.7) 51(6.5) 13(1.6) 
5 324(50.5) 317(49.4) 373(58.2) 268(41.8) 438(68.3) 146(22.8) 49(7.6) 8(1.2) 
6 288(50.4) 283(49.6) 322(56.4) 249(43.6) 390(68.3) 146(22.8) 49(7.6) 8(1.2) 
7 237(52.8) 212(47.2) 266(59.2) 183(40.8) 304(67.7) 111(24.7) 28(6.2) 6(1.3) 
8 218(56.6) 167(43.4) 240(62.3) 145(37.7) 248(64.4) 106(27.5) 26(6.7) 5(1.3) 
9 173(60.7) 11(39.3) 174(61.0) 11(38.9) 193(67.7) 70(24.6) 19(6.7) 3(1.0) 
10 138(62.2) 84(32.8) 130(58.6) 92(41.4) 150(67.6) 70(24.6) 19(6.7) 3(1.0) 
11 93(57.1) 70(42.9) 96(58.9) 67(41.1) 113(69.3) 37(22.7) 11(6.7) 2(1.2) 
12 58(56.9) 44(43.1) 62(60.8) 40(39.2) 70(68.6) 25(24.5) 7(6.9) 0 
13 39(66.1) 20(33.9) 36(61.0) 23(39.0) 39(66.1) 19(32.2) 1(1.7) 0 
14 28(65.1) 15(34.9) 28(65.1) 15(34.9) 29(67.4) 11(25.6) 2(4.6) 1(2.3) 
15 8(53.3) 7(46.7) 6(40.0) 9(60.0 10(66.7) 4(26.7) 0 1(6.7) 
 














451(33.6) 191(14.2) 700(52.2) 750(55.9) 280(20.9) 312(23.2) 671(50.0) 386(28.8) 285(21.2) 
2 376(36.9) 174(17.1) 469(46.0) 498(48.9) 179(17.6) 342(33.6) 478(46.9) 290(28.5) 251(24.6) 
3 357(38.1) 143(15.2) 438(46.7) 474(50.5) 138(14.7) 326(34.7) 463(49.4) 230(24.5) 245(26.1) 
4 292(37.1) 130(16.5) 366(46.5) 408(51.8) 117(14.8) 263(33.4) 393(49.9) 199(25.2) 196(24.9) 
5 208(32.5) 93(14.5) 339(53.0) 290(45.3) 82(12.8) 268(41.9) 286(44.7) 141(22.0) 213(33.3) 
6 168(29.4) 69(12.1) 334(58.5) 241(42.3) 70(12.3) 259(45.4) 249(43.6) 108(18.9) 214(37.5) 
7 105(23.4) 58(12.9) 286(63.7) 180(40.1) 55(12.2) 214(47.7) 174(38.7) 89(19.8) 186(41.4) 
8 91(23.6) 38(9.9) 256(66.5) 141(36.6) 40(10.4) 204(53.0) 147(38.2) 59(15.3) 179(46.5) 
9 64(22.5) 24(8.4) 197(69.1) 99(34.7) 29(9.1) 160(56.1) 102(35.8) 42(14.7) 141(49.5) 
10 40(18.0) 19(8.6) 163(73.4) 60(27.0) 19(8.6) 143(64.4) 64(28.8) 31(14.0) 127(57.2) 
11 31(19.0) 15(9.2) 117(71.8) 46(28.2) 21(12.9) 96(58.9) 43(26.4) 28(17.2) 92(56.4) 
12 14(13.8) 11(10.8) 77(75.5) 28(27.4) 14(13.7) 60(58.8) 23(22.5) 19(18.6) 60(58.8) 
13 0 0 59(100) 11(18.6) 5(8.5) 43(72.9) 11(18.6) 5(8.5) 43(72.9) 
14 1(2.3) 0 42(97.7) 192.3) 0 42(97.7) 1(2.3) 0 42(97.7) 
15 0 0 15(100) 0 0 15(100) 0 0 15(100) 






QoL  Paresis n(%) Incontinence 
No Yes Unknown No Yes Unknown 
Year 
1 
318(23.7) 866(64.5) 158(11.8) 980(73.0) 328(24.4) 34(2.5) 
2 285(27.9) 676(66.3) 59(5.8) 750(73.5) 228(22.3) 42(4.1) 
3 279(29.7) 648(69.1) 11(1.2) 678(72.3) 225(24.0) 35(3.7) 
4 246(31.2) 530(67.3) 12(1.5) 589(74.7) 166(21.1) 33(4.2) 
5 213(33.2) 423(66.0) 5(0.8) 490(76.4) 131(20.4) 20(3.1) 
6 174(30.5) 390(68.3) 7(1.2) 441(77.2) 105(18.4) 25(4.4) 
7 149(33.2) 292(65.0) 8(1.8) 347(77.3) 83(18.5) 19(4.2) 
8 126(32.7) 256(66.5) 3(0.8) 299(77.7) 73(19.0) 13(3.4) 
9 97(34.0) 187(65.6) 1(0.3) 227(79.6) 51(17.9) 7(3.1) 
10 74(33.3) 145(65.3) 3(1.3) 173(77.9) 42(18.9) 7(3.1) 
11 53(32.5) 107(65.6) 3(1.8) 125(76.7) 33(20.2) 5(3.1) 
12 27(26.5) 74(72.5) 1(1.0) 70(68.6) 29(28.4) 3(2.9) 
13 8(13.6) 51(86.4) 0 43(72.9) 15(25.4) 1(1.7) 
14 6(13.9) 37(86.5) 0 33(76.7) 10(23.3) 0 
15 3(20.0) 12(80.0) 0 13(86.7) 2(13.3) 0 
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QoL  Glasgow coma score n(%) Disability at baseline (Barhtel score) n(%) 
3-8 9-12 13-15 Unknown 0-14 15-19 20 Unknown 
Year 1 41(3.1) 87(6.5) 1186 
(88.4) 
28(2.1) 493(36.7) 271(20.2) 431(32.1) 147(10.9) 
2 29(2.8) 71(7.0) 886(86.9) 34(3.3) 344(33.7) 182(17.8) 331(32.4) 163(16.0) 
3 33(3.5) 65(6.9) 808(86.1) 32(3.4) 318(33.9) 161(17.2) 305(32.5) 154(16.4) 
4 26(3.3) 46(5.8) 690(87.6) 26(3.3) 239(30.3) 153(19.4) 276(35.0) 120(15.2) 
5 21(3.3) 41(6.4) 560(87.4) 19(3.0) 200(31.2) 119(18.6) 226(35.3) 96(15.0) 
6 23(4.0) 34(5.9) 498(87.2) 16(2.8) 174(30.5) 94(16.5) 209(36.6) 94(16.5) 
7 19(4.2) 25(5.6) 393(87.5) 12(2.7) 138(30.7) 73(16.3) 166(37.0) 72(16.0) 
8 18(4.7) 21(5.4) 340(88.3) 6(1.6) 120(31.2) 58(15.1) 135(35.1) 72(18.7) 
9 15(5.3) 14(4.9) 253(88.8) 3(1.0) 82(28.8) 46(16.1) 112(39.3) 45(15.8) 
10 14(6.3) 12(5.4) 194(87.4) 1(0.9) 55(24.8) 34(15.3) 75(33.8) 58(26.1) 
11 8(4.9) 10(6.1) 143(87.7) 2(1.2) 48(29.4) 25(15.3) 53(32.5) 37(22.7) 
12 7(6.9) 10(9.8) 83(81.4) 2(2.0) 46(45.1) 22(21.6) 30(29.4) 4(3.9) 
13 5(8.5) 6(10.2) 47(79.7) 1(1.7) 29(49.1) 13(22.0) 14(23.7) 3(5.1) 
14 3(7.0) 3(7.0) 37(86.0) 0 19(44.2) 9(20.9) 14(32.6) 1(2.3) 
15 1(6.7) 0 14(93.3 0 5(33.3) 3(20.0) 6(40.0) 1(6.7) 







APPENDIX 8. DATA USED IN THE ANALYSES OF THE ASSOCIATION 




QoL  Age (years) n(%) Gender n(%) Ethnicity n(%) 
0-64 >64 Male Female White Black Other Unknown 
Year 
1 
514(38.3) 828(61.7) 735(54.8) 607(45.2) 952(70.9) 306(22.8) 69(5.1) 15(1.1) 
2 406(39.8) 614(60.2) 565(55.4) 455(44.6) 699(68.5) 246(24.1) 63(6.2) 12(1.2) 
3 394(42.0) 544(58.0) 546(58.2) 392(41.8) 651(69.4) 213(22.7) 57(6.1) 17(1.8) 
4 368(46.7) 420(53.3) 434(55.1) 354(44.9) 529(67.1) 195(24.7) 51(6.5) 13(1.6) 
5 324(50.4) 317(49.4) 373(58.2) 268(41.8) 438(68.3) 146(22.8) 49(7.6) 8(1.2) 
6 288(50.4) 283(49.6) 322(56.4) 249(43.6) 390(68.3) 138(24.2) 38(6.6) 5(0.9) 
7 237(52.8) 212(47.2) 266(59.2) 183(40.8) 304(67.7) 111(24.7) 28(6.2) 6(1.3) 
8 218(56.6) 167(43.4) 240(62.3) 145(37.8) 248(64.4) 106(27.5) 26(6.7) 5(1.3) 
9 173(60.7) 112(39.3) 174(61.0) 111(38.9) 193(67.7) 70(24.6) 19(6.7) 3(1.0) 
10 138(62.2) 84(37.8) 130(58.6) 92(41.4) 150(67.6) 56(25.2) 15(6.8) 1(0.4) 
11 93(57.1) 70(42.9) 96(58.9) 67(41.1) 113(69.3) 37(22.7) 11(6.7) 291.2) 
12 58(56.9) 44(43.1) 62(60.8) 40(39.2) 70(68.6) 25(24.5) 7(6.9) 0 
13 39(66.1) 20(33.9) 36(61.0) 23(39.0) 39(66.1) 19(32.2) 1(1.7) 0 
14 28(65.1) 15(34.9) 28(65.1) 15(34.9) 129(67.4) 11(25.6) 2(4.6) 1(2.3) 

















451(33.6) 191(14.2) 700(52.2) 750(55.9) 280(20.9) 312(23.2) 671(50.0) 386(28.8) 285(21.2) 
2 376(36.9) 174(17.1) 469(46.0) 498(48.9) 179(17.6) 342(33.6) 478(46.9) 290(28.5) 251(24.6) 
3 357(38.1) 143(15.2) 438(46.7) 474(50.5) 138(14.7) 326(34.8) 463(49.4) 230(24.5) 245(26.1) 
4 292(37.1) 130(16.5) 366(46.4) 408(51.8) 117(14.8) 263(33.4) 393(49.9) 199(25.2) 196(24.9) 
5 208(32.5) 93(14.5) 339(53.0) 290(45.3) 82(12.8) 268(41.9) 286(44.7) 141(22.0) 213(33.3) 
6 168(29.4) 69(12.1) 334(58.5) 241(42.3) 70(12.3) 259(45.4) 249(43.6) 108(18.9) 214(37.5) 
7 105(23.4) 58(12.9) 286(63.7) 180(40.1) 55(12.2) 214(47.7) 174(38.7) 89(19.8) 214(37.5) 
8 91(23.6) 38(9.9) 256(66.5) 141(36.6) 40(10.4) 204(53.0) 147(38.2) 89(19.8) 214(37.5) 
9 64(22.5) 24(8.4) 197(69.1) 99(34.7) 26(9.1) 160(56.1) 102(35.8) 42(14.7) 141(49.5) 
10 40(18.0) 19(8.6) 163(73.4) 60(27.0) 19(8.6) 143(64.4) 64(28.8) 31(14.0) 127(57.2) 
11 31(19.0) 15(9.2) 117(71.8) 46(28.2) 21(12.9) 96(58.9) 43(26.4) 28(17.2) 92(56.4) 
12 14(13.7) 11(10.8) 77(75.5) 28(27.4) 14(13.7) 60(58.8) 23(22.5) 19(18.6) 60(58.8) 
13 0 0 59(100) 11(18.6) 5(8.5) 43(72.9) 11(18.6) 5(8.5) 43(72.9) 
14 1(2.3) 0 42(97.7) 1(2.3) 0 42(97.7) 1(2.3) 0 42(97.7) 
15 0 0 15(100) 0 0 15(100) 0 0 15(100) 








Paresis n(%) Incontinence n(%) 




318(23.7) 866(64.5) 158(11.8) 980(73.0) 328(24.4) 34(2.5) 
2 285(27.9) 676(66.3) 59(5.8) 750(73.5) 228(22.3) 42(4.1) 
3 279(29.7) 648(69.1) 11(1.2) 678(72.3) 225(24.0) 35(3.7) 
4 246(31.2) 530(67.3) 12(1.5) 589(74.7) 166(21.1) 33(4.2) 
5 213(33.2) 423(66.0) 5(0.8) 490(76.4) 131(20.4) 20(3.1) 
6 174(30.5) 390(68.3) 7(1.2) 441(77.2) 105(18.4) 25(4.4) 
7 149(33.2) 292(65.0) 8(1.8) 347(77.3) 83(18.5) 19(4.2) 
8 126(32.7) 256(66.5) 3(0.8) 299(77.7) 73(19.0) 13(3.4) 
9 97(34.0) 187(65.6) 1(0.3) 227(79.6) 51(18.0) 7(2.5) 
10 74(33.3) 145(65.3) 3(1.3) 173(77.9) 42(18.9) 7(3.1) 
11 53(32.5) 107(65.6) 3(1.8) 125(76.7) 33(20.2) 5(3.1) 
12 27(26.5) 74(72.5) 1(1.0) 70(68.6) 29(28.4) 3(2.9) 
13 8(13.6) 51(86.4) 0 43(72.9) 15(25.4) 1(1.7) 
14 6(13.9) 37(86.0) 0 33(76.7) 10(23.3) 0 
15 3(20.0) 12(80.0) 0 13(86.7) 2(13.3) 0 
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QoL Glasgow Coma score n(%) Disability at baseline (Barhtel score) n(%) 
3-8 9-12 13-15 Unknown 0-14 15-19 20 Unknown 
Year 1 41(3.1) 87(6.5) 1186 
(88.4) 
28(2.1) 493(36.7) 271(20.2) 431(32.1) 147(10.9) 
2 29(2.8) 71(7.0) 886(86.7) 34(3.3) 344(33.7) 182(17.8) 331(32.4) 163(16.0) 
3 33(3.5) 65(6.9) 808(86.1) 32(3.4) 318(33.9) 161(17.2) 305(32.5) 154(16.4) 
4 26(3.3) 46(5.8) 690(87.6) 26(3.3) 239(30.3) 153(19.4) 276(35.0) 120(15.2) 
5 21(3.3) 41(6.4) 560(87.4) 19(3.0) 200(31.2) 119(18.6) 226(35.3) 96(15.0) 
6 23(4.0) 34(5.9) 498(87.2) 16(2.8) 174(30.5) 94(16.5) 209(36.6) 94(16.5) 
7 19(4.2) 25(5.6) 393(87.5) 12(2.7) 138(30.7) 73(16.3) 166(37.0) 72(16.0) 
8 18(4.7) 21(5.4) 340(88.3) 6(1.6) 120(31.2) 58(15.1) 135(35.1) 72(18.7) 
9 15(5.3) 14(4.9) 253(88.8) 3(1.0) 82(28.8) 46(16.4) 112(39.3) 45(15.8) 
10 15(6.3) 12(5.4) 194(87.4) 2(0.9) 55(24.8) 34(15.3) 75(33.8) 58(26.1) 
11 8(4.9) 10(6.1) 83(81.4) 2(1.2) 48(29.4) 25(15.3) 53(32.5) 37(22.7) 
12 7(6.9) 10(9.8) 83(81.4) 2(2.0) 46(45.1) 22(21.6) 30(29.4) 4(3.9) 
13 5(8.5) 6(10.2) 47(79.7) 1(1.7) 29(49.1) 13(22.0) 14(23.7) 3(5.1) 
14 3(7.0) 3(7.0) 37(86.0) 0 19(44.2) 9(20.9) 14(32.6) 1(2.3) 
15 1(6.7) 0 14(93.3) 0 5(33.3) 3(20.0) 6(40.0) 1(6.7) 
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